10-Q

/

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 26, 2022

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________ to ______________

Commission File Number: 001-39411

Vital Farms, Inc.

(Exact name of registrant as specified in its charter)

Delaware	27-0496985
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
3601 South Congress Avenue Suite C100 Austin, Texas	78704
(Address of principal executive offices)	(Zip Code)

(877) 455-3063

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.0001 per share	VITL	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     Yes ☒ No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes ☐ No ☒

As of August 1, 2022, the registrant had 40,680,033 shares of common stock, $0.0001 par value per share, outstanding.

Table of Contents

Page

Special Note Regarding Forward-Looking Statements		ii
PART I.	FINANCIAL INFORMATION	1
Item 1.	Financial Statements (Unaudited)
	Condensed Consolidated Balance Sheets	1
	Condensed Consolidated Statements of Operations	2
	Condensed Consolidated Statements of Comprehensive (Loss) Income	3
	Condensed Consolidated Statements of Redeemable Noncontrolling Interest and Stockholders' Equity	4
	Condensed Consolidated Statements of Cash Flows	6
	Notes to Unaudited Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	32
Item 4.	Controls and Procedures	32
PART II.	OTHER INFORMATION	33
Item 1.	Legal Proceedings	33
Item 1A.	Risk Factors	33
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	60
Item 3.	Defaults Upon Senior Securities	60
Item 4.	Mine Safety Disclosures	60
Item 5.	Other Information	60
Item 6.	Exhibits	61
	Signatures	62

i

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains “forward-looking statements” (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations or financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will” or “would” or the negative of these words or other similar terms or expressions. These forward-looking statements include, but are not limited to, statements concerning the following:

• our expectations regarding our revenue, expenses and other operating results;

• our ability to acquire new customers and successfully retain existing customers;

• our ability to attract and retain our suppliers, distributors and co-manufacturers;

• our ability to sustain or increase our profitability;

• our ability to procure sufficient high-quality eggs, butter, cream and other raw materials;

• real or perceived quality with our products or other issues that adversely affect our brand and reputation;

• changes in the tastes and preferences of our consumers;

• the financial condition of, and our relationships with, our suppliers, co-manufacturers, distributors, retailers and foodservice customers, as well as the health of the foodservice industry generally;

• the ability of our suppliers and co-manufacturers to comply with food safety, environmental or other laws or regulations;

• the effects of the ongoing COVID-19 pandemic, or of other global outbreaks of pandemics or contagious diseases or fear of such outbreaks, including on our supply chain, the demand for our products, and on overall economic conditions and consumer confidence and spending levels;

• the expansion of our Egg Central Station facility and its impact on revenue;

• future investments in our business, our anticipated capital expenditures and our estimates regarding our capital requirements;

• anticipated changes in our product offerings and our ability to innovate to offer successful new products;

• the costs and success of our marketing efforts, and our ability to promote our brand;

• our reliance on key personnel and our ability to identify, recruit and retain personnel;

• our ability to effectively manage our growth;

• the potential influence of our focus on a specific public benefit purpose and producing a positive effect for society;

• our environmental, sustainability and governance goals, opportunities and initiatives, as well as the standards and expectations of third parties regarding these matters;

• our ability to compete effectively with existing competitors and new market entrants;

• the impact of adverse economic conditions, including as a result of the war between Ukraine and Russia and inflation;

• the sufficiency of our cash to meet our liquidity needs;

• seasonality; and

• the growth rates of the markets in which we compete.

You should not rely on forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Quarterly Report on Form 10-Q primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition and operating results. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described in the section titled “Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q. A summary of selected risks associated with our business is set forth at the beginning of the section titled “Risk Factors.” Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an

ii

impact on the forward-looking statements contained in this Quarterly Report on Form 10-Q. The results, events and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information available to us as of the date of this Quarterly Report on Form 10-Q. And while we believe that information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements.

The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments.

iii

PART I – FINANCIAL INFORMATION

VITAL FARMS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts in thousands, except share amounts)

	June 26, 2022			December 26, 2021
	(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$	22,082		$	30,966
Investment securities, available-for-sale		68,257			68,621
Accounts receivable, net		31,110			26,938
Inventories		19,100			10,945
Prepaid expenses and other current assets		2,797			3,817
Total current assets		143,346			141,287
Property, plant and equipment, net		47,887			44,608
Operating lease right-of-use assets		2,578			—
Goodwill		3,858			3,858
Other assets		2,511			189
Total assets	$	200,180		$	189,942
Liabilities, Redeemable Noncontrolling Interest and Stockholders’ Equity
Current liabilities:
Accounts payable	$	25,258		$	22,520
Accrued liabilities		19,145			15,143
Operating lease liabilities		1,425			—
Finance lease liabilities		88			327
Income taxes payable		112			—
Total current liabilities		46,028			37,990
Operating lease liabilities, non-current		1,377			—
Other liabilities		210			192
Total liabilities	$	47,615		$	38,182
Commitments and contingencies (Note 15)		—			—
Redeemable noncontrolling interest		175			175
Stockholders’ equity:
Common stock, $0.0001 par value per share, 310,000,000 shares authorized as of June 26, 2022 and    December 26, 2021; 40,679,414 and 40,493,969 shares issued and outstanding as of June 26, 2022    and December 26, 2021, respectively		5			5
Additional paid-in capital		152,317			149,000
Retained earnings		1,571			2,746
Accumulated other comprehensive loss		(1,447	)		(281	)
Total stockholders’ equity attributable to Vital Farms, Inc. stockholders		152,446			151,470
Noncontrolling interests		(56	)		115
Total stockholders’ equity	$	152,390		$	151,585
Total liabilities, redeemable noncontrolling interest, and stockholders’ equity	$	200,180		$	189,942

See accompanying notes to the unaudited condensed consolidated financial statements.

1

VITAL FARMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Amounts in thousands, except share and per share data)

(Unaudited)

	13-Weeks Ended						26-Weeks Ended
	June 26, 2022			June 27, 2021			June 26, 2022			June 27, 2021
Net revenue	$	82,870		$	60,324		$	159,929		$	118,869
Cost of goods sold		57,931			38,391			113,289			75,606
Gross profit		24,939			21,933			46,640			43,263
Operating expenses:
Selling, general and administrative		17,007			13,544			34,632			26,726
Shipping and distribution		7,211			5,374			15,373			10,437
Total operating expenses		24,218			18,918			50,005			37,163
Income (loss) from operations		721			3,015			(3,365	)		6,100
Other income (expense), net:
Interest expense		(7	)		(13	)		(15	)		(31	)
Other income (expense), net		158			186			337			297
Total other income (expense), net		151			173			322			266
Net income (loss) before income taxes		872			3,188			(3,043	)		6,366
Income tax provision (benefit)		680			(695	)		(1,697	)		(999	)
Net income (loss)		192			3,883			(1,346	)		7,365
Less: Net loss attributable to    noncontrolling interests		(7	)		(24	)		(8	)		(34	)
Net income (loss) attributable to Vital Farms, Inc.    common stockholders	$	199		$	3,907		$	(1,338	)	$	7,399
Net income (loss) per share attributable to Vital    Farms, Inc. stockholders:
Basic:	$	0.00		$	0.10		$	(0.03	)	$	0.19
Diluted:	$	0.00		$	0.09		$	(0.03	)	$	0.17
Weighted average common shares outstanding:
Basic:		40,628,416			40,000,136			40,580,598			39,767,127
Diluted:		42,694,767			43,375,668			40,580,598			43,444,101

See accompanying notes to the unaudited condensed consolidated financial statements

2

VITAL FARMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(Amounts in thousands)

(Unaudited)

	13-Weeks Ended						26-Weeks Ended
	June 26, 2022			June 27, 2021			June 26, 2022			June 27, 2021
Net income (loss)	$	192		$	3,883		$	(1,346	)	$	7,365
Other comprehensive loss
Unrealized holding loss on available-for-sale securities, net of deferred tax    benefit of $118 and $7 for the 13-weeks ended June 26, 2022    and June 27, 2021, respectively and $361 and $14 for the    26-weeks ended June 26, 2022 and June 27, 2022, respectively		(383	)		(26	)		(1,166	)		(48	)
Total comprehensive (loss) income	$	(191	)	$	3,857		$	(2,512	)	$	7,317

See accompanying notes to the unaudited condensed consolidated financial statements

3

VITAL FARMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTEREST AND STOCKHOLDERS’ EQUITY

(Amounts in thousands, except share amounts)

(Unaudited)

	Redeemable Noncontrolling Interest		Common Stock													Total Stockholders’ Equity Attributable
	Amount		Shares		Amount		Additional Paid-In Capital			Retained Earnings (Deficit)			Accumulated Other Comprehensive Loss			to Vital Farms, Inc. Stockholders’			Noncontrolling Interests			Total Stockholders’ Equity
Balances as of December 26, 2021	$	175		40,493,969	$	5	$	149,000		$	2,746		$	(281	)	$	151,470		$	115		$	151,585
Exercise of stock options		—		102,328		—		254			—			—			254			—			254
Stock-based compensation expense		—		—		—		1,296			—			—			1,296			—			1,296
Net loss attributable to non-    controlling interests - stockholders		—		—		—		—			162			—			162			(164	)		(2	)
Other comprehensive loss, net		—		—		—		—			—			(783	)		(783	)		—			(783	)
Net loss attributable to    Vital Farms, Inc. stockholders		—		—		—		—			(1,536	)		—			(1,536	)		—			(1,536	)
Balances as of March 27, 2022	$	175		40,596,297	$	5	$	150,550		$	1,372		$	(1,064	)	$	150,863		$	(49	)	$	150,814
Exercise of stock options		—		35,573		—		143			—			—			143			—			143
Vesting of restricted stock units		—		47,544		—		(9	)		—			—			(9	)		—			(9	)
Stock-based compensation    expense		—		—		—		1,633			—			—			1,633			—			1,633
Net loss attributable to non-    controlling interests -    stockholders		—		—		—		—			—			—			—			(7	)		(7	)
Other comprehensive loss, net		—		—		—		—			—			(383	)		(383	)		—			(383	)
Net income attributable to    Vital Farms, Inc. stockholders		—		—		—		—			199			—			199			—			199
Balances as of June 26, 2022	$	175		40,679,414	$	5	$	152,317		$	1,571		$	(1,447	)	$	152,446		$	(56	)	$	152,390

See accompanying notes to the unaudited condensed consolidated financial statements.

4

VITAL FARMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTEREST AND STOCKHOLDERS’ EQUITY

(Amounts in thousands, except share amounts)

(Unaudited)

	Redeemable Noncontrolling Interest		Common Stock				Treasury Stock													Total Stockholders’ Equity Attributable
	Amount		Shares		Amount		Shares			Amount			Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Loss			to Vital Farms, Inc. Stockholders’			Noncontrolling Interests			Total Stockholders’ Equity
Balances as of December 27, 2020	$	175		44,938,958	$	5		(5,494,918	)	$	(16,276	)	$	144,311	$	14,039	$	(31	)	$	142,048		$	163		$	142,211
Exercise of stock options		—		300,266		—		—			—			525		—		—			525			—			525
Stock-based compensation expense		—		—		—		—			—			853		—		—			853			—			853
Net loss attributable to non-    controlling interests - stockholders		—		—		—		—			—			—		—		—			—			(11	)		(11	)
Other comprehensive loss, net		—		—		—		—			—			—		—		(22	)		(22	)		—			(22	)
Net income attributable to Vital    Farms, Inc. stockholders		—		—		—		—			—			—		3,491		—			3,491			—			3,491
Balances as of March 28, 2021	$	175		45,239,224	$	5		(5,494,918	)	$	(16,276	)	$	145,689	$	17,530	$	(53	)	$	146,895		$	152		$	147,047
Exercise of stock options		—		393,922		—		—			—			978		—		—			978			—			978
Vesting of restricted stock units		—		15,000		—		—			—			—		—		—			—			—			—
Stock-based compensation    expense		—		—		—		—			—			1,141		—		—			1,141			—			1,141
Net loss attributable to non-    controlling interests -    stockholders		—		—		—		—			—			—		—		—			—			(24	)		(24	)
Other comprehensive loss, net		—		—		—		—			—			—		—		(26	)		(26	)		—			(26	)
Net income attributable to    Vital Farms, Inc. stockholders		—		—		—		—			—			—		3,907		—			3,907			—			3,907
Balances as of June 27, 2021	$	175		45,648,146	$	5		(5,494,918	)	$	(16,276	)	$	147,808	$	21,437	$	(79	)	$	152,895		$	128		$	153,023

See accompanying notes to the unaudited condensed consolidated financial statements.

5

VITAL FARMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts in thousands)

(Unaudited)

	26-Weeks Ended
	June 26, 2022			June 27, 2021
Cash flows from operating activities:
Net (loss) income	$	(1,346	)	$	7,365
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation and amortization		2,287			1,620
Amortization of right-of-use assets		829			—
Amortization of available-for-sale debt securities		541			626
Stock-based compensation expense		2,929			1,994
Deferred taxes		(1,927	)		(1,184	)
Other		(260	)		125
Changes in operating assets and liabilities:
Accounts receivable		(4,186	)		2,864
Inventories		(7,784	)		(1,052	)
Prepaid expenses and other current assets		892			2,052
Deposits and other assets		38			96
Income taxes payable		112			185
Accounts payable		2,738			361
Accrued liabilities		2,867			614
Operating lease liabilities		(735	)		—
Net cash (used in) provided by operating activities	$	(3,005	)	$	15,666
Cash flows from investing activities:
Purchases of property, plant and equipment		(4,417	)		(7,811	)
Purchases of available-for-sale debt securities		(29,944	)		(27,493	)
Sales of available-for sale debt securities		—			1,436
Maturities and call redemptions of available-for-sale debt securities		28,334			24,812
Proceeds from the sale of property, plant and equipment		50			—
Net cash used in investing activities	$	(5,977	)	$	(9,056	)
Cash flows from financing activities:
Payment of contingent consideration		(38	)		(75	)
Principal payments under finance lease obligations		(252	)		(233	)
Proceeds from exercise of stock options		388			1,503
Net cash provided by financing activities	$	98		$	1,195
Net (decrease) increase in cash and cash equivalents		(8,884	)		7,805
Cash and cash equivalents at beginning of the period		30,966			29,544
Cash and cash equivalents at end of the period	$	22,082		$	37,349
Supplemental disclosure of cash flow information:
Cash paid for interest	$	15		$	32
Cash paid for income taxes		68			4
Supplemental disclosure of non-cash investing and financing    activities:
Purchases of property, plant and equipment included in accounts payable and accrued liabilities		1,398			51

See accompanying notes to the unaudited condensed consolidated financial statements.

6

VITAL FARMS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in thousands, except share and per share amounts)

(Unaudited)

Note 1. Nature of the Business and Basis of Presentation

Vital Farms, Inc. (the “Company”, “we”, “us” or “our”) was incorporated in Delaware on June 6, 2013 and is headquartered in Austin, Texas. Vital Farms packages, markets and distributes shell eggs, butter and other products. These products are sold under the trade names Vital Farms and RedHill Farms, primarily to retail and foodservice channels in the United States.

The accompanying unaudited condensed consolidated financial statements as of June 26, 2022 and for the 13-week and 26-week periods ended June 26, 2022 and June 27, 2021 have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial statements. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto on our Annual Report on Form 10-K for the fiscal year ended December 26, 2021 (“Annual Report on Form 10-K”).

In the opinion of management, the included disclosures are adequate, and the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary for a fair presentation of our consolidated financial position as of June 26, 2022, consolidated results of operations for the 13-week and 26-week periods ended June 26, 2022 and June 27, 2021, and consolidated cash flows for the 26-week periods ended June 26, 2022 and June 27, 2021. Such adjustments are of a normal and recurring nature and certain reclassifications of previously reported amounts have been made to conform to the current year presentation. The condensed consolidated results of operations for the 13-week and 26-week periods ended June 26, 2022 are not necessarily indicative of the consolidated results of operations that may be expected for the fiscal year ending December 25, 2022.

Fiscal Year: The Company’s fiscal year ends on the last Sunday in December and contains either 52 or 53 weeks. In a 52-week fiscal year, each of the Company’s fiscal quarters consist of 13 weeks. The additional week in a 53-week fiscal year is added to the fourth quarter, making such quarter consist of 14 weeks. Therefore, the financial results of certain 53-week fiscal years, and the associated 14-week quarters, will not be exactly comparable to the prior and subsequent 52-week fiscal years and the associated 13-week quarters. The quarters ended June 26, 2022 and June 27, 2021 both contain operating results for 13 weeks.

Impact of COVID-19 Pandemic: Due to the ongoing COVID-19 pandemic, the Company has implemented business continuity plans designed to address and mitigate the impact of the COVID-19 pandemic on the Company’s business. The Company does not currently anticipate that the COVID-19 pandemic will have a material impact on the timelines for the Company’s product development and expansion efforts. However, the extent to which the COVID-19 pandemic impacts the Company’s business, product development and expansion efforts, corporate development objectives and the value of and market for the Company’s common stock will depend on future developments that are highly uncertain and cannot be predicted with confidence at this time, such as the ultimate duration of the pandemic, travel restrictions, quarantines, social distancing and business closure requirements in the United States, and the effectiveness of actions taken globally to contain and treat the disease, including the effectiveness of vaccines. The global economic slowdown, the overall disruption of global supply chains and distribution systems and the other risks and uncertainties associated with the pandemic could have a material adverse effect on the Company’s business, financial condition, results of operations and growth prospects.  

Note 2. Summary of Significant Accounting Policies

The significant accounting policies and estimates used in preparation of the unaudited condensed consolidated financial statements are described in the Company’s audited consolidated financial statements as of and for the fiscal year ended December 26, 2021, and the notes thereto, which are included in our Annual Report on Form 10-K. Other than the adoption of the new accounting pronouncements as further described below, there have been no material changes to the Company’s significant accounting policies during the 26-week period ended June 26, 2022.  

Recently Adopted Accounting Pronouncements: The new accounting pronouncements recently adopted by the Company are described in the Company’s audited consolidated financial statements as of and for the fiscal year ended December 26, 2021, and the notes thereto, which are included in our Annual Report on Form 10-K. Except as described below, there have been no new accounting pronouncements adopted by the Company during the 26-week period ended June 26, 2022.

7

In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”) and also issued subsequent amendments to the initial guidance, ASU 2017-13, ASU 2018-01, ASU 2018-10, ASU 2018-11, ASU 2018-20, ASU 2019-01, ASU 2019-10, ASU 2020-02, and ASU 2020-05 (collectively, “Topic 842”). The guidance in Topic 842 supersedes the leasing guidance in Topic 840, Leases. Under the new guidance, lessees are required to recognize lease assets and lease liabilities on the balance sheet for all leases with terms longer than twelve months. Leases are classified as either finance or operating, with classification affecting the pattern of expense recognition in the unaudited condensed consolidated statement of operations. An entity may adopt the guidance either (1) retrospectively to each prior reporting period presented in the financial statements with a cumulative-effect adjustment recognized at the beginning of the earliest comparative period presented or (2) retrospectively at the beginning of the period of adoption through a cumulative-effect adjustment. The Company adopted Topic 842 as of the beginning of the period of adoption, December 27, 2021, and has not applied the new standard to comparative periods presented.

To reduce the burden of adoption and ongoing compliance with Topic 842, a number of practical expedients and policy elections are available under the new guidance. The Company elected the "package of practical expedients" permitted under the transition guidance, which among other things, did not require reassessment of whether contracts entered into prior to adoption are or contain leases, and allowed carryforward of the historical lease classification for existing leases. The Company has not elected to adopt the “hindsight” practical expedient, and therefore will measure the right-of-use (“ROU”) assets and lease liabilities using the remaining portion of the lease term at adoption on December 27, 2021.  

The Company made an accounting policy election under Topic 842 not to recognize ROU assets and lease liabilities for leases with a term of twelve months or less.  For all other leases, the Company recognizes ROU assets and lease liabilities based on the present value of lease payments over the lease term at the commencement date of the lease (or December 27, 2021 for existing leases upon the adoption of Topic 842). The Company’s recognized ROU assets also include any initial direct costs incurred and lease payments made at or before the commencement date, which are reduced by any lease incentives.

Future lease payments may include fixed rent escalation clauses or payments that depend on an index (such as the Consumer Price Index measured by the U.S. Bureau of Labor Statistics). Subsequent index changes and other periodic market-rate adjustments to base rent are recorded as variable lease expense during the period in which they are incurred. Residual value guarantees or payments for terminating the lease are included in the lease payments only when it is probable they will be incurred.

The Company has made an accounting policy election to account for lease and non-lease components in its contracts as a single lease component for all asset classes. The non-lease components typically represent additional services transferred to the Company, such as common area maintenance for real estate, which are variable in nature and recorded in variable lease expense in the period incurred.  

As an emerging growth company, the Company uses its lease-specific collateralized incremental borrowing rate to determine the present value of lease payments at lease commencement or upon the adoption of Topic 842. The adoption of the new lease standard had an immaterial impact on our consolidated net earnings and consolidated cash flows and did not result in a cumulative-effect adjustment to the opening balance of retained earnings. The adoption of Topic 842 as of December 27, 2021, resulted in the recording of right-of-use assets and lease liabilities of $4.1 million and $3.8 million, respectively.

Recently Issued Accounting Pronouncements Not Yet Adopted: In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”) and also issued subsequent amendments to the initial guidance, ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-10, ASU 2019-11, ASU 2020-02, and ASU 2020-03 (collectively, “Topic 326”), to introduce a new impairment model for recognizing credit losses on financial instruments based on an estimate of current expected credit losses. Topic 326 requires financial assets measured at amortized cost to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amounts. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances. 

The Company expects to adopt Topic 326 on December 26, 2022. Although the Company is currently evaluating the impact of its pending adoption of Topic 326, the Company does not expect it to have a material impact on its consolidated financial statements.

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which intends to simplify the guidance by removing certain exceptions to the general principles and clarifying or amending existing guidance. ASU 2019-12 is effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. The Company expects to adopt ASU 2019-12 on December 26, 2022. Although the Company is currently evaluating the impact of the adoption of ASU 2019-12, the Company does not expect it to have a material impact on its consolidated financial statements.

8

Note 3. Investment Securities

The following table summarizes the Company’s available-for-sale investment securities as of June 26, 2022:

	Amortized Cost		Unrealized Losses			Fair Value
U.S. Corporate Bonds and U.S. Dollar    Denominated Foreign Bonds	$	67,685	$	(1,866	)	$	65,819
Commercial Paper		1,293		—			1,293
U.S. Treasury		1,176		(31	)		1,145
Total	$	70,154	$	(1,897	)	$	68,257

The following table summarizes the Company’s available-for-sale investment securities as of December 26, 2021:

	Amortized Cost		Unrealized Losses			Fair Value
U.S. Corporate Bonds and U.S. Dollar    Denominated Foreign Bonds	$	64,816	$	(364	)	$	64,452
Commercial Paper		2,999		—			2,999
U.S. Treasury		1,177		(7	)		1,170
Total	$	68,992	$	(371	)	$	68,621

The securities incurred unrealized losses of $501 and $1,527, and related tax benefits of $118 and $361 for the 13-week and 26-weeks ended June 26, 2022. The unrealized losses in our U.S. corporate bond portfolio consist of losses on 97 diversified issuances with credit ratings ranging from BBB to AAA. There are no individual bonds with unrealized losses exceeding $82 and only four issuances have been in a loss position greater than 12 months with aggregate unrealized losses of $190.  

The decline in fair value has resulted primarily from rising interest rates over the last 12 months and the Company does not believe there has been any significant decline in the creditworthiness of the issuers. The Company also does not believe it is likely that the bonds will be called early given the current interest rate environment and it does not have current liquidity needs that would necessitate a sale of the investments prior to maturity. Therefore, the Company has not recorded an allowance for credit losses on the investment securities as of June 26, 2022.

Actual maturities may differ from contractual maturities because some borrowers have the right to call or prepay obligations with or without call or prepayment penalties. Contractual maturities of investment securities as of June 26, 2022 are as follows:

	Amortized Cost		Fair Value
Due within one year	$	17,070	$	16,826
Due in 1-5 years		53,084		51,431
Total available-for-sale	$	70,154	$	68,257

The following tables present information about the Company’s financial assets measured at fair value on a recurring basis for the periods presented:

	Fair Value Measurements as of June 26, 2022, Using:
	Level 1		Level 2		Level 3		Total
Assets:
U.S. Corporate Bonds and U.S. Dollar    Denominated Foreign Bonds	$	—	$	65,819	$	—	$	65,819
Commercial Paper		—		1,293		—		1,293
Money Market		12,002		—		—		12,002
U.S. Treasury		—		1,145		—		1,145
Total assets measured at fair value	$	12,002	$	68,257	$	—	$	80,259

9

	Fair Value Measurements as of December 26, 2021, Using:
	Level 1		Level 2		Level 3		Total
Assets:
U.S. Corporate Bonds and U.S. Dollar    Denominated Foreign Bonds	$	—	$	64,452	$	—	$	64,452
Commercial Paper		—		2,999		—		2,999
Money Market		20,101		—		—		20,101
U.S. Treasury		—		1,170		—		1,170
Total assets measured at fair value	$	20,101	$	68,621	$	—	$	88,722

Note 4. Revenue Recognition

The following table summarizes the Company’s net revenue by primary product for the periods presented:

	13-Weeks Ended				26-Weeks Ended
	June 26, 2022		June 27, 2021		June 26, 2022		June  27, 2021
Net Revenue:
Egg and egg-related products	$	78,107	$	56,339	$	150,228	$	110,768
Butter and butter-related products		4,763		3,984		9,701		8,101
Net Revenue	$	82,870	$	60,324	$	159,929	$	118,869

Net revenue is primarily generated from the sale of eggs and butter. The Company’s product offerings include shell eggs, hard-boiled eggs, liquid whole eggs, butter (including stick butter and spreadable tub butter) and ghee. The Company’s previous convenient breakfast product line (including egg bites and egg-based breakfast bars) was discontinued in 2022.

As of June 26, 2022 and December 26, 2021, the Company had customers that individually represented 10% or more of the Company’s accounts receivable, net, and during the 13-week and 26-week periods ended June 26, 2022 and June 27, 2021, the Company had customers that individually exceeded 10% or more of the Company’s net revenue. The percentage of net revenue from these significant customers during the 13-week and 26-week periods ended June 26, 2022 and June 27, 2021 is as follows:

	Net Revenue for the 13-Weeks Ended June 26, 2022	Net Revenue for the 13-Weeks Ended June 27, 2021	Net Revenue for the 26-Weeks Ended June 26, 2022	Net Revenue for the 26-Weeks Ended June 27, 2021
Customer A	32%	*	33%	*
Customer B	*	25%	*	25%
Customer C	10%	10%	*	11%
Customer D	13%	11%	12%	11%

*Revenue was less than 10%.

The increase in net revenue for Customer A for the 13-week and 26-week periods ended June 26, 2022 compared to the 13- week and 26-week periods ended June 27, 2021 is due to a shift in the Company’s distribution channels away from Customer B during the year ended December 26, 2021. The slight increase in net revenue for Customer D for the 13-week and 26-week periods ended June 26, 2022 compared to the 13-week and 26-week periods ended June 27, 2021 is due to new distribution gains in the current period.

10

The percentage of accounts receivable, net due from these significant customers as of June 26, 2022 and December 26, 2021 is as follows:

	Accounts Receivable, Net as of June 26, 2022	Accounts Receivable, Net as of December 26, 2021
Customer A	23%	19%
Customer B	*	*
Customer C	*	*
Customer D	13%	13%

*Accounts receivable was less than 10%.

Note 5. Accounts Receivable

Accounts receivable, net, were $31,110 and $26,938 as of June 26, 2022 and December 26, 2021, respectively.

As of June 26, 2022 and December 26, 2021, the Company recorded an allowance for doubtful accounts of $282 and $269, respectively. Changes in the allowance for doubtful accounts were as follows:

	Allowance for doubtful accounts
As of December 26, 2021	$	(269	)
Provisions Charged to Operating Results		(68	)
Account Write-off and Recoveries		—
As of March 27, 2022	$	(337	)
Provisions Released to Operating Results		24
Account Write-off and Recoveries		31
As of June 26, 2022	$	(282	)

Note 6. Inventories

Inventory consisted of the following as of the periods presented:

	June 26, 2022			December 26, 2021
Eggs and egg-related products	$	8,795		$	5,850
Butter and butter-related products		4,182			2,359
Packaging		3,829			2,166
Pullets		1,708			267
Other		642			731
Reserve for inventory obsolescence		(56	)		(428	)
	$	19,100		$	10,945

On a periodic basis, the Company compares the amount of inventory on hand with its latest forecasted requirements to determine whether provisions for excess or obsolete inventory reserves are required.

11

Note 7. Property, Plant and Equipment

Property, plant and equipment consisted of the following as of the periods presented:

	June 26, 2022			December 26, 2021
Land	$	552		$	525
Land improvements		835			—
Buildings and improvements		28,407			14,214
Vehicles		689			695
Machinery and equipment		22,832			15,523
Leasehold improvements		918			830
Furniture and fixtures		678			503
Construction in progress		2,379			21,164
		57,290			53,454
Less: Accumulated depreciation and amortization		(9,403	)		(8,846	)
Property, plant and equipment, net	$	47,887		$	44,608

As of June 26, 2022 and December 26, 2021, machinery and equipment leased under finance leases and included in property, plant and equipment, net in the unaudited condensed consolidated balance sheets was $745 and $876, respectively.

During the 13-week periods ended June 26, 2022 and June 27, 2021, depreciation and amortization of property, plant and equipment was approximately $1,339 and $835, respectively. During the 26-week periods ended June 26, 2022 and June 27, 2021, depreciation and amortization of property, plant and equipment was approximately $2,287 and $1,620, respectively.

During the 13-week period ended June 26, 2022, $21.9 million of construction in progress, related to our expansion of Egg Central Station, was put into service across various property, plant and equipment categories.

Note 8. Leases

The Company determines if an arrangement is or contains a lease at inception, which is the date on which the terms of the contract are agreed to and the agreement creates enforceable rights and obligations. Under Topic 842, a contract is or contains a lease when (i) explicitly or implicitly identified assets have been deployed in the contract and (ii) the customer obtains substantially all of the economic benefits from the use of that underlying asset and directs how and for what purpose the asset is used during the term of the contract. The Company also considers whether its service arrangements include the right to control the use of an asset.

The Company leases office facilities, warehouses and office equipment under lease agreements with initial terms approximating one to five years.  In addition, substantially all the Company’s long-term supply contracts with farms contain components that meet the definition of embedded leases within the scope of Topic 842, Leases. These arrangements convey to the Company the right to control implicitly identified property, plant and equipment as it takes substantially all the utility generated by these assets over the term of the arrangements at a variable price. The initial term of these supply agreements ranges from one to seven years. As total purchase commitments contained in these arrangements are variable, the amounts attributable to the lease components are contingent rentals; there are no minimum lease payments associated with these long-term supply contracts.

As the classification and timing of recognition of costs attributable to the eggs and embedded cost of the lease rentals are identical, the Company does not allocate the total purchase cost of eggs between the cost of the eggs and the embedded cost of the lease rentals or distinguish between them in its accounting records. The Company records the total purchase cost of eggs, which includes costs associated with the eggs and the corresponding cost of embedded lease rentals from the same arrangement, into inventory. These costs are expensed to cost of goods sold when the associated eggs are sold to customers and are also reported as part of our variable lease cost.  For the 13-week and 26-week periods ended June 26, 2022, these costs totaled $32.1 and $62.3 million, respectively.

Our office lease for our corporate headquarters facility in Austin, Texas includes an option to renew, generally at our sole discretion, with renewal terms that can extend the lease term up to five years. In addition, certain leases contain termination options, where the rights to terminate are held by the Company, the lessor, or both parties. These options to extend or terminate a lease are included in the lease terms when it is reasonably certain that the Company will exercise that option. As of June 26, 2022, it is not reasonably certain that the Company will exercise the right to extend its office lease and therefore, the Company has not included the extended term in the calculation of its ROU assets or liabilities. The Company’s leases do not contain any material restrictive covenants or residual value guarantees.

12

Operating lease cost is recognized on a straight-line basis over the lease term and is classified within cost of goods sold and selling, general and administrative cost in the unaudited condensed consolidated statement of operations for the 13-week and 26-week periods ended June 26, 2022. 

Finance lease cost is recognized as amortization expense for the ROU assets and interest expense associated with the finance lease liabilities. Amortization expense associated with our finance leases during the 13-week and 26-week periods ended June 26, 2022 was $79 and $157, respectively, and is recorded within cost of goods sold and selling, general and administrative costs in the unaudited condensed consolidated statement of operations. 

The components of lease cost for the 13-week period and 26-week period ended June 26, 2022 are below:

	13-Weeks Ended		26-Weeks Ended
	June 26, 2022		June 26, 2022
Operating lease cost	$	361	$	722
Finance lease cost - amortization of right-of-use assets		79		157
Finance lease cost - interest on lease liabilities		2		5
Short-term lease cost		11		14
Variable lease cost		32,814		63,415
Total lease cost	$	33,267	$	64,313

Supplemental cash flow information related to leases is as follows:

Cash paid for amounts included in measurement of lease liabilities:

	13-Weeks Ended		26-Weeks Ended
	June 26, 2022		June 26, 2022
Operating cash outflows - payments on operating leases	$	368	$	735
Operating cash outflows - interest payments on finance leases		2		5
Financing cash outflows - principal payments on finance leases		121		247

Right-of-use assets obtained in exchange for new lease obligations:

	As of June 26, 2022
Operating leases	$	—
Finance leases		26

Supplemental balance sheet information related to leases is as follows:

	As of June 26, 2022
Operating Leases
Operating lease right-of-use assets	$	2,578
Operating lease liabilities		1,425
Operating lease liabilities, non-current		1,377
Total operating lease liabilities	$	2,802
Finance Leases
Property, plant and equipment, net	$	745
Finance lease liabilities		88
Other liabilities		19
Total finance leases	$	107

	As of June 26, 2022
	Operating Leases			Finance Leases
Weighted-average remaining lease term (years)		2.48			1.16
Weighted-average discount rate		3.28	%		4.44	%

13

Future undiscounted cash flows are as follows:

	As of June 26, 2022
	Operating Leases			Finance Leases
Remainder of 2022	$	742		$	85
2023		1,254			6
2024		471			6
2025		338			6
2026		115			6
Thereafter		—			—
Total lease payments		2,920			109
Less imputed interest		(118	)		(2	)
Total present value of lease liabilities	$	2,802		$	107

Note 9. Accrued Liabilities

Accrued liabilities consisted of the following as of the periods presented:

	June 26, 2022		December 26, 2021
Accrued promotions and customer deductions	$	5,883	$	3,599
Accrued distribution fees and freight		4,204		3,875
Accrued employee related costs		4,011		3,039
Accrued purchases of inventory		934		1,197
Accrued marketing and broker commissions		1,138		769
Accrued property, plant and equipment		1,398		1,258
Accrued contract termination costs		70		—
Other		1,507		1,406
Accrued liabilities	$	19,145	$	15,143

Note 10. Product Exit Costs

During the 26-week period ended June 26, 2022, the Company made the determination to exit its convenient breakfast product category due to ongoing losses incurred and a shift in Company focus to product categories that are core to its operations.  Charges incurred in connection with these product exits are expected to be paid or settled by the end of the 13-week period ending September 25, 2022.  Due to the relatively short term over which the charges will ultimately be settled, the Company believes the actual charges as shown below approximate fair value.

The following table summarizes the activity related to the exit of the Company’s convenient breakfast products:

		For the 26-weeks period ended June 26, 2022
Description	Statement of Operations Classification	Charges Incurred		Amounts Paid or Settled			Ending Liability Balance
Contract terminations	Selling, general and administrative	$	1,126		(1,056	)	$	70
Inventory obsolescence	Cost of goods sold		749		(723	)		26
Customer allowances	Net revenue		146		(111	)		35
Asset write-downs	Cost of goods sold		119		—			119
Co-manufacturer charges	Cost of goods sold		135		(135	)		—
Asset disposals	Selling, general and administrative		66		(66	)		—
Total		$	2,341	$	(2,091	)	$	250

14

Note 11. Common Stock

Common Stock: As of June 26, 2022, the Company’s amended and restated certificate of incorporation authorized the Company to issue 310,000,000 shares of common stock, par value $0.0001 per share, of which 40,679,414 shares were issued and outstanding.

The voting, dividend and liquidation rights of the holders of the Company’s common stock are subject to and qualified by the rights, powers and preferences of the holders of the preferred stock. Each share of the Company’s common stock is entitled to one vote on all matters submitted to a vote of the Company’s stockholders. Holders of the Company’s common stock are entitled to receive dividends as may be declared by the Company’s board of directors, if any, subject to the preferential dividend rights of preferred stock. No cash dividends had been declared or paid during the periods presented.

As of each balance sheet date, the Company had reserved shares of common stock for issuance in connection with the following:

	June 26, 2022		December 26, 2021
Options to purchase common stock		4,712,898		4,927,033
Restricted stock units		513,226		107,867
Shares available for grant under the 2020 Equity Incentive Plan    and 2020 Employee Stock Purchase Plan		11,503,717		9,993,187
Total		16,729,841		15,028,087

Treasury Stock: In August 2021, the Company retired an aggregate of 5,494,918 shares of its common stock held in treasury. Upon retirement, the shares were redesignated as authorized but unissued shares of the Company’s common stock.

Note 12. Stock-Based Compensation

During the 13-week periods ended June 26, 2022 and June 27, 2021, the Company recognized stock-based compensation expense of $1,633 and $1,141, respectively. The Company measures compensation expense for all stock-based awards based on the estimated fair values on the date of the grant. The Company records stock-based compensation expense in selling, general and administrative expenses and cost of goods sold. During the 13-week periods ended June 26, 2022 and June 27, 2021, stock-based compensation expense of $62 and $38, respectively, was recognized in cost of goods sold.

During the 26-week periods ended June 26, 2022 and June 27, 2021, the Company recognized stock-based compensation expense of $2,929 and $1,994, respectively. During the 26-week periods ended June 26, 2022 and June 27, 2021 $91 and $60 of stock-based compensation expense was recognized in cost of goods sold, respectively.

As of June 26, 2022, total unrecognized stock-based compensation expense related to unvested stock options and the Company’s restricted stock units (“RSU”) was $13,469, which is expected to be recognized over a weighted-average period of 2.36 years.

Stock Option Activity

The following table summarizes the Company’s stock option activity since December 26, 2021:

	Number of Options			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value
Outstanding as of December 26, 2021		4,927,033		$	9.25			$	50,561,622
Granted		132,654		$	12.89
Exercised		(130,894	)	$	3.04			$	1,304,528
Cancelled		(215,895	)	$	11.69			$	1,026,027
Outstanding as of June 26, 2022		4,712,898		$	9.41		6.1	$	17,381,476
Options exercisable as of June 26, 2022		2,661,079		$	5.81		4.8	$	13,663,597
Options vested and expected to vest as of June 26, 2022		4,708,857		$	9.42		6.1	$	17,361,548

15

The fair value of shares vested during the 13-week periods ended June 26, 2022 and June 27, 2021 was $1,251 and $608, respectively. The fair value of shares vested during the 26-week periods ended June 26, 2022 and June 27, 2021 was $2,209 and $912, respectively.

Restricted Stock Unit Activity

The following table summarizes the RSU activity since December 26, 2021:

	Number of RSUs			Weighted- Average Exercise Price
Unvested as of December 26, 2021		107,867		$	27.53
Granted		491,698			12.37
Vested		(51,350	)		27.93
Forfeited		(34,989	)		15.47
Unvested as of June 26, 2022		513,226		$	13.79

2020 Equity Incentive Plan: In July 2020, the Company’s board of directors adopted its 2020 Equity Incentive Plan (“2020 Incentive Plan”), which was subsequently approved by its stockholders and became effective on July 30, 2020. Initially, the maximum number of the Company’s common stock that may be issued under the 2020 Incentive Plan was 8,595,871 shares. The 2020 Incentive Plan provides that the number of shares reserved and available for issuance under the 2020 Incentive Plan will automatically increase each January 1, beginning on January 1, 2021 and ending on (and including) January 1, 2030, by an amount equal to 4% of the outstanding number of shares of common stock on the immediately preceding December 31 or such lesser number of shares as determined by the Company’s board of directors. As of June 26, 2022, 9,811,345 shares were available for future grants of the Company’s common stock, which includes 1,619,758 shares of stock that were automatically added to the available reserve on January 1, 2022. Awards issued under the 2020 Incentive Plan generally have a three-year ratable vesting period beginning on the date of grant.

Employee Stock Purchase Plan: In July 2020, the Company’s board of directors adopted the 2020 Employee Stock Purchase Plan (“2020 ESPP”), which was subsequently approved by the Company’s stockholders and became effective on July 30, 2020. The 2020 ESPP authorizes the initial issuance of up to 900,000 shares of the Company’s common stock to eligible employees of the Company or, as designated by the Company’s board of directors, employees of a related company. The 2020 ESPP provides that the number of shares reserved and available for issuance under the 2020 ESPP will automatically increase each January 1, beginning on January 1, 2021 and ending on (and including) January 1, 2030, by an amount equal to the lesser of (i) 1% of the outstanding number of shares of common stock on the immediately preceding December 31 and (ii) 900,000, or such lesser number of shares as determined by the Company’s board of directors. As of June 26, 2022, 1,692,372 shares of the Company’s common stock were available for future issuance, which includes 404,939 shares of common stock that were automatically added to the available reserve on January 1, 2022. In November 2021, the Company’s board of directors authorized an offering period commencing on March 1, 2022 and ending on May 15, 2022.  The Company’s board of directors has subsequently authorized additional six-month offering periods, with the most recent beginning on May 16, 2022.

Note 13. Income Taxes

The Company’s effective tax rate for the 13-week periods ended June 26, 2022 and June 27, 2021 was approximately 78% and (22)%, respectively. The Company’s effective tax rate for the 26-week periods ended June 26, 2022 and June 27, 2021 was approximately 55% and (16)%, respectively. In the 13-week and 26-week periods ended June 26, 2022, the estimated annual effective tax rate was driven by permanent differences related to incentive stock options and the impact of compensation deduction limitations under Internal Revenue Code section 162(m). Tax expense has increased during these periods as a result of the impact of amended federal tax returns and increasing pre-tax income during the 13-weeks ended June 26, 2022.

For interim periods, our income tax expense and resulting effective tax rate are based upon an estimated annual effective tax rate adjusted for the effects of items required to be treated as discrete to the period, including changes in tax laws, changes in estimated exposures for uncertain tax positions, and other items.

16

Note 14. Net Income Per Share

Basic and diluted net income per share attributable to Vital Farms, Inc. common stockholders were calculated as follows:

	13-Weeks Ended
	June 26, 2022			June 27, 2021
Numerator:
Net income	$	192		$	3,883
Less: Net loss attributable to noncontrolling    interests		(7	)		(24	)
Net income attributable to Vital Farms, Inc.    stockholders’ — basic and diluted	$	199		$	3,907
Denominator:
Weighted average common shares outstanding    — basic		40,628,416			40,000,136
Weighted average effect of potentially dilutive    securities:
Effect of potentially dilutive stock options		2,048,653			3,375,052
Effect of potentially dilutive restricted stock units		17,698			480
Effect of potentially dilutive common stock    warrants		—			—
Effect of potentially dilutive redeemable    convertible preferred stock		—			—
Weighted average common shares outstanding    — diluted		42,694,767			43,375,668
Net income per share attributable to Vital Farms,    Inc. stockholders
Basic	$	0.00		$	0.10
Diluted	$	0.00		$	0.09

17

For the 13-week periods ended June 26, 2022 and June 27, 2021, options to purchase 109,494 and 196,640 shares of common stock were excluded from the computation of diluted net income per share attributable to Vital Farms, Inc. common stockholders because including them would have been antidilutive.

	26-Weeks Ended
	June 26, 2022			June 27, 2021
Numerator:
Net (loss) income	$	(1,346	)	$	7,365
Less: Net loss attributable to noncontrolling    interests		(8	)		(34	)
Net (loss) income attributable to Vital Farms, Inc.    stockholders’ — basic and diluted	$	(1,338	)	$	7,399
Denominator:
Weighted average common shares outstanding    — basic		40,580,598			39,767,127
Weighted average effect of potentially dilutive    securities:
Effect of potentially dilutive stock options		—			3,676,494
Effect of potentially dilutive restricted stock units		—			480
Effect of potentially dilutive common stock    warrants		—			—
Effect of potentially dilutive redeemable    convertible preferred stock		—			—
Weighted average common shares outstanding    — diluted		40,580,598			43,444,101
Net (loss) income per share attributable to Vital Farms,    Inc. stockholders
Basic	$	(0.03	)	$	0.19
Diluted	$	(0.03	)	$	0.17

For the 26-week periods ended June 26, 2022 and June 27, 2021, options to purchase 61,707 and 112,644 shares of common stock were excluded from the computation of diluted net income per share attributable to Vital Farms, Inc. common stockholders because including them would have been antidilutive.

Note 15. Commitments and Contingencies

Supplier Contracts: The Company purchases its egg inventories under long-term supply contracts with farms. Purchase commitments contained in these arrangements are variable depending on the quantity of eggs produced by the farms. Accordingly, there are no estimable future purchase commitments associated with these supplier contracts and there are no minimum payments associated with these long-term supply contracts. The Company records the total cost of eggs into inventory and they are expensed to cost of goods sold when the associated eggs are sold to customers.

Indemnification Agreements: In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of its board of directors and its executive officers that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. As of June 26, 2022, the Company has not incurred any material costs as a result of such indemnifications.

18

Litigation: The Company is subject to various claims and contingencies which are in the scope of ordinary and routine litigation incidental to its business, including those related to regulation, litigation, business transactions, employee-related matters and taxes, among others. When the Company becomes aware of a claim or potential claim, the likelihood of any loss or exposure is assessed. If it is probable that a loss will result and the amount of the loss can be reasonably estimated, the Company records a liability for the loss. The liability recorded includes probable and estimable legal costs incurred to date and future legal costs to the point in the legal matter where the Company believes a conclusion to the matter will be reached. If the loss is not probable or the amount of the loss cannot be reasonably estimated, the Company discloses the claim if the likelihood of a potential loss is reasonably possible.

Note 16. Related Party Transactions

Ovabrite, Inc.: Ovabrite is a related party because its founders are stockholders of the Company, with the majority stockholder in Ovabrite also serving as the Company’s executive chairman and member of the Company’s board of directors. Since Ovabrite’s incorporation in November 2016, the Company has been deemed to have had a variable interest in Ovabrite, and Ovabrite is deemed to have been a VIE, of which the Company is the primary beneficiary. Accordingly, the Company has consolidated the results of Ovabrite since November 2016. All significant intercompany transactions between the Company and Ovabrite have been eliminated in consolidation. The Ovabrite entity is immaterial as of the 26-weeks ended June 26, 2022.

Sandpebble Builders Preconstruction, Inc.: The Company utilizes Sandpebble Builders Preconstruction, Inc. (“Sandpebble”) for project management and related services associated with the construction and expansion of Egg Central Station. The owner and principal of Sandpebble is the father of an executive of the Company. In connection with the services described above, the Company paid Sandpebble $250 and $326 during the 13-week periods ended June 26, 2022 and June 27, 2021, respectively and $371 and $625 during the 26-week period ended June 26, 2022 and June 27, 2021, respectively. Amounts paid to Sandpebble are included in property, plant and equipment, net, accounts payable and accrued liabilities in the unaudited condensed consolidated balance sheets.

19

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those discussed in the forward-looking statements as a result of various factors, including those set forth in Part II, Item 1A, “Risk Factors,” and “Special Note Regarding Forward-Looking Statements” included elsewhere in this Quarterly Report on Form 10-Q. The following information should be read in conjunction with the unaudited financial information and the notes thereto included in this Quarterly Report on Form 10-Q and the audited financial information and the notes thereto included in our Annual Report on Form 10-K.

Overview

Our mission is to bring ethical food to the table, and we are disrupting the U.S. food system by developing a framework that challenges the norms of the incumbent food model, allowing us to bring high-quality products from our network of family farms to a national audience. This framework has enabled us to become the leading U.S. brand of pasture-raised eggs and the second largest U.S. egg brand by retail dollar sales. According to SPINS, LLC data, we were the fastest-growing brand by dollar sales in the egg category for the 52-week period ended June 26, 2022. Our ethics are exemplified by our focus on animal welfare and sustainable farming practices. We believe our standards produce happy hens with varied diets, which produce better eggs. There is a seismic shift in consumer demand for natural, traceable, clean label, great-tasting and nutritious foods. Supported by a steadfast adherence to the values on which we were founded, we have designed our brand and products to appeal to this consumer movement.

Our purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of each of our stakeholders (farmers and suppliers, customers and consumers, communities and the environment, crew members and stockholders). We make decisions based on what is sustainable for all our stakeholders. Our collective sustainable business practices will enable us to fulfill our purpose of improving the lives of people, animals, and the planet through food, now and long into the future. For us, it is not about short-term outcomes or a trade-off between purpose and profit. We are fierce business competitors who believe that prioritizing the long-term viability of all stakeholders will produce stronger outcomes, for everyone, over time. These principles guide our day-to-day operations and, we believe, help us deliver a more sustainable and successful business. Our approach has been validated by our financial performance and our designation and January 2022 recertification as a Certified B Corporation, a certification reserved for businesses that balance profit and purpose to meet the highest verified standards of social and environmental performance, public transparency and legal accountability.

We source our products from a network of over 300 family farms. We have strategically designed our supply chain to ensure high production standards and optimal year-round operation. We are motivated by the positive impact we have on rural communities and enjoy a strong relationship and reputation with our network of farmers.

We primarily work with our farms pursuant to buy-sell contracts. Under these arrangements, the farmer is responsible for all of the working capital and investments required to produce the eggs and manage the farm, including purchasing the birds and feed supply. We are contractually obligated to purchase all of the eggs produced by the farmer during the term of the contract at an agreed-upon price that depends upon pallet weight and is indexed quarterly in arrears for changes in feed cost.

We believe we are a strategic and valuable partner to retailers. We have continued to command premium prices for our products, including our shell eggs, which sell for as much as three times the price of commodity eggs. Our loyal and growing consumer base has fueled the expansion of our brand from the natural channel to the mainstream channel. We believe the success of our brand demonstrates that consumers are demanding premium products that meet a higher ethical standard of food production. We have a strong presence at Kroger, Sprouts Farmers Market, or Sprouts, Target and Whole Foods, and we also sell our products at Albertsons, Publix and Walmart. We offer 24 retail stock keeping units, or SKUs through a multi-channel retail distribution network. We believe we have significant room for growth within the retail and, in the medium- to long-term, foodservice channels through growing brand awareness, gaining additional points of distribution and new product innovation.

Our shell eggs are collected from farmers by a third-party freight carrier and placed in cold storage until we pack them for shipping to our customers at our state-of-the-art shell egg processing facility, Egg Central Station. Egg Central Station is approximately 150,000 square feet and utilizes highly automated equipment to grade and package our shell egg products. Egg Central Station is capable of packing approximately six million eggs per day and has achieved Safe Quality Food, or SQF Good rating, the highest level of such certification from the Global Food Safety Initiative. In addition, as of January 2020, Egg Central Station was the only egg facility to receive, and we are one of only six companies globally to have received, the SQFI Select Site certification.

Our products are distributed through a broker-distributor-retailer network whereby brokers represent our products to distributors and retailers who will in turn sell our products to consumers. We serve the majority of natural channel customers through food distributors, which purchase, store, sell and deliver our products to customers.

In the 13-week periods ended June 26, 2022 and June 27, 2021, United Natural Foods, Inc., or UNFI (which was Whole Foods’ primary distributor through March 2020 other than for the period from April 2020 to August 2021), accounted for 32% and less than 10% of our net revenue, respectively, US Foods (which was Whole Foods’ primary distributor from April 2020 until August 2021) accounted for approximately less than 10% and 25% of our net revenue, respectively. In the 26-week periods ended June 26, 2022 and June 27, 2021, UNFI accounted for 33% and less than 10% of our net revenue, respectively, and US Foods accounted for approximately less than 10% and 25% of our net revenue, respectively.

20

We have experienced consistent sales growth. We had net revenue of $82.9 million and $60.3 million, net income of $0.2 million and $3.9 million, and Adjusted EBITDA of $3.7 million and $5.1 million in the 13-week periods ended June 26, 2022 and June 27, 2021, respectively. We had net revenue of $159.9 million and $118.9 million, net loss of $1.3 million and net income of $7.4 million, and Adjusted EBITDA of $4.2 million and $9.8 million in the 26-week periods ended June 26, 2022 and June 27, 2021, respectively. See the section titled “—Non-GAAP Financial Measure—Adjusted EBITDA” below for the definition of Adjusted EBITDA, as well as a reconciliation of Adjusted EBITDA to net income, the most directly comparable financial measure stated in accordance with GAAP.

COVID-19 and Supply Chain Management

While we are not experiencing material adverse impacts at this time due to the ongoing COVID-19 pandemic, given the ongoing disruptions to global supply chains and distribution systems and the other risks and uncertainties associated with the pandemic, our business, financial condition, results of operations and growth prospects could be materially and adversely affected. We are working closely with our farmers, suppliers and third-party manufacturers to manage our supply chain activities and mitigate potential disruptions to our product supplies as a result of the ongoing global supply chain disruptions. We currently expect to have an adequate supply of eggs, butter, packaging, and freight to meet anticipated demand in fiscal 2022, as well as adequate capacity for packing and processing our eggs.

Liquidity and Capital Resources Overview

With cash and cash equivalents of $22.1 million as of June 26, 2022 and access to additional funds held as investment securities and available borrowing under our credit facility agreement with PNC Bank, National Association, or the Credit Facility, we anticipate having sufficient liquidity to make investments in our business this fiscal year in support of our long-term growth strategy. Our IPO, which was completed on August 4, 2020, resulted in net proceeds to us of approximately $99.7 million, after deducting underwriting discounts, commissions and offering costs associated with the offering. We expect that our cash and cash equivalents as of June 26, 2022, together with cash provided by our operating activities and availability of borrowings under our existing Credit Facility, will be sufficient to fund our operating expenses for at least the next 12 months and to make investments in our business in support of our long-term growth strategy.

Our future capital requirements will depend on many factors, including our pace of new and existing customer growth, our investments in innovation, our investments in partnerships and unexplored channels and the costs associated with our substantially completed expansion of Egg Central Station or future expansions of our production capacity. We may be required to seek additional equity or debt financing. However, a significant disruption of global financial markets (including a disruption due to the ongoing COVID-19 pandemic, geopolitical tensions and wars, inflation or other factors) may result in our inability to access additional capital, which could in the future negatively affect our operations. In the event that we require additional financing, we may not be able to raise such financing on terms acceptable to us or at all. If we are unable to raise additional capital or generate cash flows necessary to expand our operations and invest in continued innovation and product expansion, we may not be able to compete successfully, which would harm our business, operations and results of operations.

Our Fiscal Year

We report on a 52-53-week fiscal year, ending on the last Sunday in December, effective beginning with the first quarter of fiscal 2018. In a 52-53-week fiscal year, each fiscal quarter consists of 13 weeks. The additional week in a 53-week fiscal year is added to the fourth quarter, making such quarter consist of 14 weeks. Our first 53-week fiscal year will be fiscal 2023, which we expect to begin on December 26, 2022 and end on December 31, 2023. See “Nature of the Business and Basis of Presentation” in Note 1 to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for additional details related to our fiscal calendar.

21

Key Factors Affecting Our Business

We believe that the growth of our business and our future success are dependent upon many factors. While each of these factors presents significant opportunities for us, they also pose important challenges that we must successfully address to enable us to sustain the growth of our business and improve our results of operations.

Expand Household Penetration

We have positioned our brand to capitalize on growing consumer interest in natural, clean-label, traceable, great-tasting and nutritious foods. We believe there is substantial opportunity to grow our consumer base and increase the velocity at which households purchase our products. We intend to increase household penetration by continuing to invest significantly in sales and marketing to educate consumers about our brand, our values and the premium quality of our products. We believe these efforts will educate consumers on the attractive attributes of our products, generate further demand for our products and ultimately expand our consumer base. Our ability to attract new consumers will depend, among other things, on the perceived value and quality of our products, the offerings of our competitors and the effectiveness of our marketing efforts. Our performance depends significantly on factors that may affect the level and pattern of consumer spending in the U.S. natural food market in which we operate. Such factors include consumer preference, consumer confidence, consumer income, consumer perception of the safety and quality of our products and shifts in the perceived value for our products relative to alternatives.

Grow Within the Retail Channel

We believe that our ability to increase the number of customers that sell our products to consumers is an indicator of our market penetration and our future business opportunities. We define our customers as the entities that sell our products to consumers. With certain of our retail customers, like Whole Foods, we sell our products through distributors. We are not able to precisely attribute our net revenue to a specific retailer for products sold through such channels. We rely on third-party data to calculate the portion of retail sales attributable to such retailers, but this data is inherently imprecise because it is based on gross sales generated by our products sold at retailers, without accounting for price concessions, promotional activities or chargebacks, and because it measures retail sales for only the portion of our retailers serviced through distributors. Based on this third-party data and internal analysis, Whole Foods accounted for approximately 24% and 27% of our retail sales for the 13-week periods ended June 26, 2022 and June 27, 2021, respectively and 25% and 27% for the 26-week periods ended June 26, 2022 and June 27, 2021.

As of June 26, 2022, there were more than 21,500 stores selling our products. We expect the retail channel to be our largest source of net revenue for the foreseeable future. By capturing greater shelf space, driving higher product velocities and increasing our SKU count, we believe there is meaningful runway for further growth with existing retail customers. Additionally, we believe there is significant opportunity to gain incremental stores from existing customers as well as by adding new retail customers. We also believe there is significant further long-term opportunity in additional distribution channels, including the convenience, drugstore, club, military and international markets. Our ability to execute on this strategy will increase our opportunities for incremental sales to consumers, and we also believe this growth will allow for margin expansion. To accomplish these objectives, we intend to continue leveraging consumer awareness of and demand for our brand, offering targeted sales incentives to our customers and utilizing customer-specific marketing tactics. Our ability to grow within the retail channel will depend on a number of factors, such as our customers’ satisfaction with the sales, product velocities and profitability of our products.

Expand Footprint Across Foodservice

We believe there is significant demand for our products in the foodservice channel since we offer versatile ingredients with high menu penetrations across all commercial and non-commercial operator segments. We see considerable opportunity for medium- to long-term growth in this channel by increasing our category market share through sales to values-aligned foodservice operators and their distributors. We are working with Waypoint, a foodservice sales and marketing agency in the consumer-packaged goods industry, to increase our broadline distribution and presence in national and regional restaurant chains. We believe that most U.S. consumers' food preferences are driven primarily by what they encounter on restaurant menus, so we are also leveraging foodservice as a critical consumer touchpoint to drive brand awareness and purchase rates of our products in the retail channel. We are investing in co-marketing to reach new households. We believe that joint marketing tactics are mutually beneficial for our operator partners and enhance their perceived customer value and that our products and on-menu branding can help operators differentiate themselves, increase check sizes and drive loyalty in an industry still recovering from the pandemic and its macro-economic impacts. An example of our recent foodservice growth initiative is our relationship with HomeState, a Texas kitchen in Southern California which sells breakfast tacos made exclusively with our liquid whole eggs. We have launched similar regional partnerships in all 4 of our U.S. sales regions, including Blue Plate Restaurant Company, a casual dining group concepts in the Minneapolis/St. Paul, Minnesota area; Cafe Patachou, a breakfast and lunch restaurant based in the Indianapolis, Indiana area; King David Tacos, which sells breakfast tacos made exclusively with our medium shell eggs at their locations and retail outlets in the New York City area; Pura Vida, a fresh all-day

22

concept in the Miami, Florida area; Hat Creek Burger Company, a fast-casual restaurant with locations across Texas; Tacodeli, which sells breakfast tacos made exclusively with our shell eggs across restaurant locations points of distribution, such as coffee shops and farmers' market stands, across Texas; and Moe's Broadway Bagel, an East Coast-style family-run bagel chain in the Denver/Boulder, Colorado area.

Expand Our Product Offerings

We intend to continue to strengthen our product offerings by investing in innovation in new and existing categories. We have a history of product introductions and intend to continue to innovate by introducing new products from time to time. Egg and egg-related products generated $78.1 million, or approximately 94%, of net revenue in the 13-week period ended June 26, 2022. Egg and egg-related products generated $150.2 million, or approximately 94%, of net revenue in the 26-week period ended June 26, 2022. We expect eggs will be our largest source of net revenue for the foreseeable future. We believe that investments in innovation will contribute to our long-term growth, including by reinforcing our efforts to increase household penetration. Our ability to successfully develop, market and sell new products will depend on a variety of factors, including the availability of capital to invest in innovation, as well as changing consumer preferences and demand for food products.

Key Components of Results of Operations

Net Revenue

We generate net revenue primarily from sales of our products, including eggs and butter to our customers, which include natural retailers, mainstream retailers and foodservice partners. We sell our products to customers on a purchase-order basis. We serve the majority of our natural channel customers and certain independent grocers and other customers through food distributors, which purchase, store, sell and deliver our products to these customers.

We periodically offer sales incentives to our customers, including rebates, temporary price reductions, off-invoice discounts, retailer advertisements, product coupons and other trade activities. We record a provision for sales incentives at the later of the date at which the related revenue is recognized or when the sales incentive is offered. At the end of each accounting period, we recognize a liability for an estimated promotional allowance reserve. We periodically provide credits or discounts to our customers in the event that products do not conform to customer expectations upon delivery or expire at a customer’s site. We treat these credits and discounts as a reduction of the sales price of the related transaction at the time of sale. We anticipate that these promotional activities, credits and discounts could impact our net revenue and that changes in such activities could impact period-over-period results.

Our shell eggs are sold to consumers at a premium price point, and when prices for commodity shell eggs fall relative to the price of our shell eggs, price-sensitive consumers may choose to purchase commodity shell eggs offered by our competitors instead of our eggs. As a result, low commodity shell egg prices may adversely affect our net revenue. Net revenue may also vary from period to period depending on the purchase orders we receive, the volume and mix of our products sold, and the channels through which our products are sold.

Selling, General and Administrative

Selling, general and administrative expenses consist primarily of broker and contractor fees for sales and marketing, and personnel costs for sales and marketing, finance, human resources and other administrative functions, consisting of salaries, benefits, bonuses, stock-based compensation expense and sales commissions. Selling, general and administrative expenses also include advertising and digital media costs, agency fees, travel and entertainment costs, and costs associated with consumer promotions, product samples, sales aids incurred to acquire new customers, retain existing customers and build our brand awareness, overhead costs for facilities, including associated depreciation and amortization expenses, and information technology-related expenses.

Shipping and Distribution

Shipping and distribution expenses consist primarily of costs related to third-party freight for our products. We expect shipping and distribution expenses to increase in absolute dollars in the medium-to-long term, as we continue to scale our business.

Results of Operations

The results of operations data for the 13-week and 26-week periods ended June 26, 2022 and June 27, 2021 have been derived from the unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

23

Comparison of the 13-Week Periods Ended June 26, 2022 and June 27, 2021

The following table sets forth our consolidated statement of operations data expressed as a percentage of net revenue for the quarters presented.

	13-Weeks Ended
	June 26, 2022						June 27, 2021
	Amount			% of Revenue			Amount			% of Revenue
	(dollars in thousands)
Net revenue	$	82,870			100	%	$	60,324			100	%
Cost of goods sold		57,931			70	%		38,391			64	%
Gross profit		24,939			30	%		21,933			36	%
Operating expenses:
Selling, general and administrative(1)		17,007			21	%		13,544			22	%
Shipping and distribution		7,211			9	%		5,374			9	%
Total operating expenses		24,218			29	%		18,918			31	%
Income from operations		721			1	%		3,015			5	%
Other income (expense), net:
Interest expense		(7	)		—			(13	)		—
Other income (expense), net		158			—			186			—
Total other income (expense), net		151			—			173			—
Net income before income taxes		872			1	%		3,188			5	%
Income tax provision (benefit)		680			1	%		(695	)		(1	)%
Net income		192			0	%		3,883			6	%
Less: Net loss attributable to noncontrolling    interests		(7	)		—			(24	)		—
Net income (loss) attributable to Vital Farms, Inc.    common stockholders	$	199			0	%	$	3,907			6	%

(1) Includes stock-based compensation expense of $1,633 and $1,141 for the periods 13-week periods ended June 26, 2022 and June 27, 2021, respectively.

Net Revenue

	13-Weeks Ended
	June 26, 2022		June 27, 2021		$ Change		% Change
	(in thousands)
Net revenue	$	82,870	$	60,324	$	22,546		37	%

The increase in net revenue of $22.5 million, or 37%, was primarily driven by volume-related increases of $18.3 million and price increases of $4.2 million. The volume favorability was primarily due to increasing volumes through our current distributors and new distribution with new and existing customers. Net revenue from sales through our retail channel was $80.1 million and $59.3 million for the 13-week periods ended June 26, 2022 and June 27, 2021, respectively.

Gross Profit and Gross Margin

	13-Weeks Ended
	June 26, 2022			June 27, 2021			$ Change		% Change
	(in thousands)
Gross profit	$	24,939		$	21,933		$	3,006		14	%
Gross margin		30	%		36	%

The increase in gross profit of $3.0 million, or 14%, was driven by higher net revenue generated during the period. The decrease in gross margin during the 13-weeks ended June 26, 2022 as compared to the 13-weeks ended June 27, 2021 was primarily driven by an increase in input costs across our shell egg business and butter business and transportation costs. Increased pricing on our organic

24

shell egg and butter businesses went into effect at the end of January 2022, along with additional pricing increases across the entire portfolio in May 2022, which partially offset the input cost headwinds.

Operating Expenses

Selling, General and Administrative

	13-Weeks Ended
	June 26, 2022			June 27, 2021			$ Change		% Change
	(in thousands)
Selling, general and administrative	$	17,007		$	13,544		$	3,463		26	%
Percentage of net revenue		21	%		22	%

The increase in selling, general and administrative expenses of $3.5 million, or 26% was primarily driven by:

• an increase of $2.7 million in employee-related costs, including stock-based compensation, driven by an overall increase in employee headcount to support our operations; and

• an increase of $0.7 million in brokerage-related expenses due to the expansion of the business.

Shipping and Distribution

	13-Weeks Ended
	June 26, 2022			June 27, 2021			$ Change		% Change
	(in thousands)
Shipping and distribution	$	7,211		$	5,374		$	1,837		34	%
Percentage of net revenue		9	%		9	%

The increase in shipping and distribution costs of $1.8 million, or 34%, was driven by higher sales volumes and freight rates in 2022. We are beginning to see freight rates stabilize due to a combination of steadying line haul rates and internal operational efficiency.

Other Income (Expense), Net 

	13-Weeks Ended
	June 26, 2022		June 27, 2021		$ Change			% Change
	(in thousands)
Other income (expense), net	$	151	$	173	$	(22	)		(13	%)
Percentage of net revenue		—		—

The decrease in other income (expense), net of $22, or 13%, was primarily driven by realized losses on available-for-sale debt securities that were originally purchased in October 2020.

Income Tax Provision (Benefit)

	13-Weeks Ended
	June 26, 2022		June 27, 2021			$ Change		% Change
	(in thousands)
Income tax provision (benefit)	$	680	$	(695	)	$	1,375		198	%

The change in the income tax provision (benefit) of $1.4 million was primarily driven by favorable tax benefits from stock option exercises in the prior year which did not recur during the 13-week period ended June 26, 2022.

25

Net Loss Attributable to Noncontrolling Interests

	13-Weeks Ended
	June 26, 2022			June 27, 2021			$ Change		% Change
	(in thousands)
Net loss attributable to noncontrolling interests	$	(7	)	$	(24	)	$	17		71	%

The decrease in net loss attributable to noncontrolling interests of $17, or 71%, was primarily driven by lower research and development costs in 2022.

Comparison of the 26-Week Periods Ended June 26, 2022 and June 27, 2021

The following table sets forth our consolidated statement of operations data expressed as a percentage of net revenue for the quarters presented.

	26-Weeks Ended
	June 26, 2022						June 27, 2021
	Amount			% of Revenue			Amount			% of Revenue
	(dollars in thousands)
Net revenue	$	159,929			100	%	$	118,869			100	%
Cost of goods sold		113,289			71	%		75,606			64	%
Gross profit		46,640			29	%		43,263			36	%
Operating expenses:
Selling, general and administrative(1)		34,632			22	%		26,726			22	%
Shipping and distribution		15,373			10	%		10,437			9	%
Total operating expenses		50,005			31	%		37,163			31	%
(Loss) income from operations		(3,365	)		(2	)%		6,100			5	%
Other income (expense), net:
Interest expense		(15	)		(0	)%		(31	)		—
Other income (expense), net		337			0	%		297			0
Total other income (expense), net		322			—			266			—
Net (loss) income before income taxes		(3,043	)		(2	)%		6,366			5	%
Income tax benefit		(1,697	)		(1	)%		(999	)		(1	)%
Net (loss) income		(1,346	)		(1	)%		7,365			6	%
Less: Net loss attributable to noncontrolling interests		(8	)		—			(34	)		—
Net (loss) income attributable to Vital Farms, Inc. common    stockholders	$	(1,338	)		(1	)%	$	7,399			6	%

(1) Includes stock-based compensation expense of $2,929 and $1,994 for the 26-weeks ended June 26, 2022 and June 27, 2021, respectively.

Net Revenue

	26-Weeks Ended
	June 26, 2022		June 27, 2021		$ Change		% Change
	(in thousands)
Net revenue	$	159,929	$	118,869	$	41,060		35	%

The increase in net revenue of $41.1 million, or 35%, was primarily driven by volume-related increases of $35.6 million and price increases of $5.5 million. The volume favorability was primarily due to increasing volumes through our current distributors and new distribution with new and existing customers. Net revenue from sales through our retail channel was $155.6 million and $117.0 million for the 26-week periods ended June 26, 2022 and June 27, 2021, respectively.

26

Gross Profit and Gross Margin

	26-Weeks Ended
	June 26, 2022			June 27, 2021			$ Change		% Change
	(in thousands)
Gross profit	$	46,640		$	43,263		$	3,377		8	%
Gross margin		29	%		36	%

The increase in gross profit of $3.4 million, or 8%, was drive by higher net revenue generated during the period. The decrease in gross margin during the 13-weeks ended June 26, 2022 as compared to the 13-weeks ended June 27, 2021 was primarily driven by an increase in input costs across our shell egg and butter business and transportation costs. Increased pricing on our organic shell egg and butter businesses went into effect at the end of January 2022, along with additional pricing increases across the entire portfolio in May 2022, which partially offset the input costs headwinds.

Operating Expenses

Selling, General and Administrative

	26-Weeks Ended
	June 26, 2022			June 27, 2021			$ Change		% Change
	(in thousands)
Selling, general and administrative	$	34,632		$	26,726		$	7,906		30	%
Percentage of net revenue		22	%		22	%

Selling, general, and administrative expenses increased to $34.7 million for the 26-week period ended June 26, 2022, compared to $26.7 million for the 26-week period ended June 27, 2021. The increase in selling, general and administrative expenses was primarily driven by:

• an increase of $5.3 million in employee-related costs, including stock-based compensation, driven by an overall increase in employee headcount to support our operations;

• an increase of $1.5 in brokerage-related expenses due to the expansion of the business; and,

• an increase of $1.2 million in exit fees and asset disposal related to the discontinuation of our egg-based breakfast bars and egg bite products.

Shipping and Distribution

	26-Weeks Ended
	June 26, 2022			June 27, 2021			$ Change		% Change
	(in thousands)
Shipping and distribution	$	15,373		$	10,437		$	4,936		47	%
Percentage of net revenue		10	%		9	%

The increase in shipping and distribution expense of $4.9 million, or 47%, was driven by higher sales volumes and freight rates. We are beginning to see freight rates stabilize due to a combination of steadying line haul rates and internal operational efficiency.

Other Income (Expense), Net 

	26-Weeks Ended
	June 26, 2022		June 27, 2021		$ Change		% Change
	(in thousands)
Other income (expense), net	$	322	$	266	$	56		21	%
Percentage of net revenue		—		—

27

The increase in other income (expense), net of $56, or 21%, was primarily driven higher interest income in the 26-week period ended June 27, 2021 from available-for-sale debt securities that were originally purchased in October 2020.

Income tax benefit

	26-Weeks Ended
	June 26, 2022			June 27, 2021			$ Change			% Change
	(in thousands)
Income tax benefit	$	(1,697	)	$	(999	)	$	(698	)		(70	)%

The change in the benefit for income taxes of $(0.7) million, or (70)%, was primarily driven by pre-tax losses incurred during the 26-week period ended June 26, 2022.

Net Loss Attributable to Noncontrolling Interests

	26-Weeks Ended
	June 26, 2022			June 27, 2021			$ Change		% Change
	(in thousands)
Net loss attributable to noncontrolling interests	$	(8	)	$	(34	)	$	26		76	%

The decrease in net loss attributable to noncontrolling interests of $26 or 76%, was primarily driven by lower research and development costs in 2022.

Liquidity and Capital Resources

Since inception, we have funded our operations with proceeds from sales of our capital stock, proceeds from borrowings and cash flows from the sale of our products. We had net income of $0.2 million and net loss of $1.3 million for the 13-week and 26-week periods ended June 26, 2022, respectively, and retained earnings of $1.6 million as of June 26, 2022. We completed our IPO on August 4, 2020, resulting in net proceeds to us of approximately $99.7 million, after deducting underwriting discounts, commissions and offering costs associated with the offering.

Funding and Material Cash Requirements

We expect that our cash and cash equivalents, together with cash provided by our operating activities and availability of borrowings under our existing Credit Facility, will be sufficient to fund our operating expenses for at least the next 12 months. We further believe that we will be able to fund potential operating expenses and cash obligations beyond the next 12 months, through a combination of existing cash and cash equivalents, cash provided by our operating activities and access to additional funds held as investment securities as well as available borrowing under our Credit Facility.

Our future capital requirements will depend on many factors, including our pace of new and existing customer growth, our investments in innovation, our investments in partnerships and unexplored channels and the costs associated with our expansion of Egg Central Station or future expansions of our production capacity. As of June 26, 2022, we expect to spend $25.8 million in total, on the expansion of Egg Central Station, including approximately $2.7 million that remains yet to be spent. In addition, we lease certain office facilities under operating lease arrangements that expire on various dates through fiscal year 2026. Under the terms of the leases, we are responsible for certain operating expenses, such as insurance, property taxes, and maintenance expenses. Future minimum lease payments under non-cancelable operating leases totaled $2.9 million as of June 26, 2022.

Credit Facility

We originally entered into our Credit Facility with PNC Bank, National Association, or PNC Bank, in October 2017. The Credit Facility initially included a $7.9 million term loan, a $15.0 million revolving line of credit and an equipment loan with a maximum borrowing capacity of $3.0 million.

Subsequently, terms of the Credit Facility were modified at various times between fiscal 2018 and fiscal 2021. These modifications (i) amended various definitions, (ii) waived a technical default in May 2020 which was triggered by exceeding the capital expenditure limit, (iii) increased borrowing capacity and (iv) extended the maturity date. The Ninth Amendment to the Credit Facility in April 2021 eliminated the term loan and equipment loan. The revolving line of credit matures in April 2024.  

28

The maximum borrowing capacity under the revolving line of credit is currently $20.0 million. Interest on borrowings under the revolving line of credit, as well as loan advances thereunder, accrues at a rate, at our election at the time of borrowing, equal to (i) LIBOR plus 2.00% or (ii) 1.00% plus the alternate base rate, as defined in the Credit Facility. In April 2020, all then-outstanding amounts under the Revolving Line of Credit were repaid at an effective rate of 4.5%.

The Credit Facility is secured by all of our assets (other than real property and certain other property excluded pursuant to the terms of the Credit Facility) and requires us to maintain three financial covenants: a fixed charge coverage ratio, a leverage ratio and a minimum tangible net worth requirement. The Credit Facility also contains various covenants relating to limitations on indebtedness, acquisitions, mergers, consolidations, the sale of properties and liens. As a result of the limitations contained in the Credit Facility, certain of the net assets on our consolidated balance sheet as of June 26, 2022 are restricted in use. The Credit Facility contains other customary covenants, representations and events of default.  

As of June 26, 2022, there was no outstanding balance under the Credit Facility and we were in compliance with all covenants under the Credit Facility.

Cash Flows

The following table summarizes our cash flows for the 26-week periods indicated:

	26-Weeks Ended
	June 26, 2022			June 27, 2021
	(in thousands)
Net cash (used in) provided by operating activities	$	(3,005	)	$	15,666
Net cash used in investing activities		(5,977	)		(9,056	)
Net cash provided by financing activities		98			1,195
Net (decrease) increase in cash and cash equivalents	$	(8,884	)	$	7,805

Operating Activities

Net cash used in operating activities was $3.0 million in the 26-week period ended June 26, 2022 and was primarily driven by a net loss of $1.3 million, a decrease in net working capital items of $6.1 million, non-cash items of depreciation and amortization of $2.3 million, non-cash stock-based compensation expense of $2.9 million and amortization of available-for-sale securities of $0.5 million offset by $1.9 million in deferred taxes.

Net cash provided by operating activities was $15.7 million in the 26-week period ended June 27, 2021 and was primarily driven by net income of $7.4 million, an increase in net working capital items of $5.1 million, non-cash items of depreciation and amortization of $1.6 million, non-cash stock-based compensation expense of $2.0 million and amortization of available-for-sale securities of $0.6 million offset by $1.2 million in deferred taxes.

Investing Activities

For the 26-week period ended June 26, 2022, net cash used in investing activities was $6.0 million, resulting primarily from $4.4 million of purchases of property, plant and equipment used in ongoing operations and $29.9 million in purchases of available-for-sale debt securities, offset by $28.3 million in maturities and call redemptions of available-for-sale debt securities.

For the 26-week period ended June 27, 2021, net cash used in investing activities was $9.1 million resulting from $7.8 million of purchases of property, plant and equipment used in ongoing operations, $27.5 million in purchases of available-for-sale securities, offset by $1.4 million and $24.8 million in sales and maturities and call redemptions of available-for-sale debt securities, respectively.

Financing Activities

For the 26-week period ended June 26, 2022, net cash provided by financing activities was $0.1 million, which primarily consisted of $0.4 million from the exercise of stock options, partially offset by $0.3 million of repayments of our finance lease obligations.

For the 26-week period ended June 27, 2021, net cash provided by financing activities was $1.2 million, which primarily consisted of $1.5 million from the exercise of stock options, partially offset by $0.2 million of repayments of our finance lease obligations.

29

Non-GAAP Financial Measures

Adjusted EBITDA

We report our financial results in accordance with GAAP. However, management believes that Adjusted EBITDA, a non-GAAP financial measure, provides investors with additional useful information in evaluating our performance.

We calculate Adjusted EBITDA as net (loss) income, adjusted to exclude:

• Depreciation and amortization,

• Stock-based compensation expense,

• Costs related to the discontinuation of our convenient breakfast product line,

• Benefit or provision for income taxes as applicable,

• Interest expense,

• Change in fair value of contingent consideration, and

• Interest income.

Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with GAAP. We believe that Adjusted EBITDA, when taken together with our financial results presented in accordance with GAAP, provides meaningful supplemental information regarding our operating performance and facilitates internal comparisons of our historical operating performance on a more consistent basis by excluding certain items that may not be indicative of our business, results of operations or outlook. In particular, we believe that the use of Adjusted EBITDA is helpful to our investors as it is a measure used by management in assessing the health of our business, determining incentive compensation and evaluating our operating performance, as well as for internal planning and forecasting purposes.

Adjusted EBITDA is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Some of the limitations of Adjusted EBITDA include the following:

• It does not properly reflect capital commitments to be paid in the future,

• Although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and Adjusted EBITDA does not reflect these capital expenditures,

• It does not consider the impact of stock-based compensation expense as such expenses in any specific period may not directly correlate to the underlying performance of our business operations and can vary significantly between periods as a result of the timing of grants of new stock-based awards,

• It does not reflect other non-operating expenses, including interest expense,

• It does not consider the impact of any contingent consideration liability valuation adjustments, and

• It does not reflect tax payments that may represent a reduction in cash available to us.

In addition, our use of Adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate Adjusted EBITDA in the same manner, limiting its usefulness as a comparative measure. Because of these limitations, when evaluating our performance, you should consider Adjusted EBITDA alongside other financial measures, including our net income or loss and other results stated in accordance with GAAP.

30

The following table presents a reconciliation of Adjusted EBITDA to Net (loss) income, the most directly comparable financial measure stated in accordance with GAAP, for the periods presented:

	13-Weeks Ended						26-Weeks Ended
	June 26, 2022			June 27, 2021			June 26, 2022			June 27, 2021
	(in thousands)
Net income (loss)	$	192		$	3,883		$	(1,346	)	$	7,365
Depreciation and amortization		1,339			835			2,287			1,620
Stock-based compensation expense		1,633			1,141			2,929			1,994
Costs related to our exit of the convenient breakfast product line		—			—			2,341			—
Income tax expense (benefit)		680			(695	)		(1,697	)		(999	)
Interest expense		7			13			15			31
Change in fair value of contingent consideration(1)		12			14			19			19
Interest income		(210	)		(89	)		(340	)		(186	)
Adjusted EBITDA	$	3,653		$	5,102		$	4,208		$	9,844

(1) Amount reflects the change in fair value of a contingent consideration liability in connection with our 2014 acquisition of certain assets of Heartland Eggs.

Seasonality

Demand for our products fluctuates in response to seasonal factors. Demand tends to increase with the start of the school year and is highest prior to holiday periods, particularly Thanksgiving, Christmas and Easter, and lowest during the summer months. As a result of these seasonal and quarterly fluctuations, comparisons of our sales and results of operations between different quarters within a single fiscal year are not necessarily meaningful comparisons.

Critical Accounting Estimates

The preparation of our unaudited condensed consolidated financial statements in conformity with GAAP requires us to make estimates and judgments that affect the amounts reported in the financial statements and related notes thereto. Critical accounting estimates are those estimates that, in accordance with GAAP, involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on our unaudited condensed consolidated financial statements. Management has determined that our most critical accounting estimates are those relating to revenue recognition and trade promotions, income taxes, and contingencies. Although we believe that the estimates we use are reasonable, due to the inherent uncertainty involved in making these estimates, actual results reported in future periods could differ materially from those estimates. For further discussion about our accounting policies, see “Summary of Significant Accounting Policies” in Note 2 to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

The significant accounting estimates used in preparation of the unaudited condensed consolidated financial statements are described in our audited consolidated financial statements as of and for the fiscal year ended December 26, 2021, and the notes thereto, which are included in our Annual Report on Form 10-K. Except as detailed in Note 2 to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q, there have been no material changes to our significant accounting policies or critical accounting estimates during the 26-week period ended June 26, 2022.

Recent Accounting Pronouncements

See the sections titled “Summary of Significant Accounting Policies—Recently Adopted Accounting Pronouncements” and “—Recently Issued Accounting Pronouncements Not Yet Adopted” in Note 2 to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for a discussion of recent accounting pronouncements.

31

Emerging Growth Company Status

In April 2012, the Jumpstart Our Business Startups Act of 2012, or JOBS Act, was enacted. Section 107 of the JOBS Act provides that an “emerging growth company” may take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. Therefore, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to use the extended transition period under the JOBS Act. Accordingly, our financial statements may not be comparable to the financial statements of public companies that comply with such new or revised accounting standards.

We may take advantage of these exemptions until December 31, 2025, or such earlier time that we are no longer an emerging growth company. We would cease to be an emerging growth company on the date that is the earliest of (1) the last day of the fiscal year in which we have total annual gross revenues of $1.07 billion or more; (2) December 31, 2025; (3) the date on which we have issued more than $1.0 billion in nonconvertible debt during the previous three years; or (4) the date on which we are deemed to be a large accelerated filer under the rules of the Securities and Exchange Commission. We may choose to take advantage of some but not all of these exemptions.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily the result of fluctuations in raw materials, ingredients, inflation and interest rates.

There have been no material changes in our exposure to market risk during the 13-week or 26-week periods ended June 26, 2022 from the information provided in Part II, Item 7A. “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures. 

We maintain “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (2) accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of June 26, 2022. Based upon the evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at a reasonable assurance level.

Changes in Internal Control over Financial Reporting. 

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

32

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. We are not currently a party to any material legal proceedings, and we are not aware of any pending or threatened legal proceeding against us that we believe could have an adverse effect on our business, operating results or financial condition.

Item 1A. Risk Factors.

Our operations and financial results are subject to various risks and uncertainties. The following is a description of the known factors that may materially affect our business, results of operations or financial condition.  You should carefully consider the following risk factors, as well as the other information in this Quarterly Report. If any of the following risks actually occurs, our business, results of operations and financial condition could be adversely affected. In this case, the trading price of our common stock would likely decline. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may adversely affect our business, results of operations and financial condition.

Summary of Selected Risks Associated with Our Business

Our business faces significant risks and uncertainties. If any of the following risks are realized, our business, financial condition and results of operations could be materially and adversely affected. These risks include, among others, the following:

• Our recent, rapid growth may not be indicative of our future growth, and if we continue to grow rapidly, we may not be able to effectively manage our growth or evaluate our future prospects. If we fail to effectively manage our future growth or evaluate our future prospects, our business could be adversely affected.

• We have incurred net losses in the past and we may not be able to maintain or increase our profitability in the future.

• We have only recently expanded our product offerings beyond shell eggs and butter, which makes it difficult to forecast our future results of operations.

• Sales of shell eggs constitute the vast majority of our revenue, and a reduction in these sales would have an adverse effect on our financial condition.  

• Failure to introduce successful new products or to successfully pursue growth by other means may adversely affect our ability to continue to grow.

• We are dependent on the market for shell eggs, and fluctuations in this market could adversely affect our business, financial condition and results of operations.

• Fluctuations in commodity prices and in the availability of feed grains could negatively impact our results of operations and financial condition.

• If we fail to effectively expand our processing, manufacturing and production capacity as we continue to grow and scale our business, our business and operating results and our brand reputation could be harmed.

• A substantial amount of our shell eggs are processed at our Egg Central Station, processing facility, in Springfield, Missouri. Any damage or disruption at this facility may harm our business.

• We have substantially completed the expansion of Egg Central Station; however, we may not be successful in adequately staffing the expanded facility to meet production needs and the expanded facility may not operate in accordance with our expectations. Furthermore, future expansions of our processing capacity may not provide us with the benefits we expect to receive.

• If we fail to effectively maintain or expand our network of family farms, our business, operating results and brand reputation could be harmed.

• Our future business, results of operations and financial condition may be adversely affected by reduced or limited availability of eggs, cream and other raw materials that meet our standards.

• We may not be able to compete successfully in our highly competitive market.

• We currently have a limited number of co-manufacturers. Loss of one or more of our co-manufacturers or our failure to timely identify and establish relationships with new co-manufacturers could harm our business and impede our growth.

• We could be adversely affected by a change in consumer preferences, perception and spending habits in the natural food industry generally and on animal-based products. In particular, any failure to develop or enrich our product offering or gain market acceptance of our new products could have a negative effect on our business.

• A limited number of distributors represent a substantial portion of our sales, and the loss of one or more distributor relationships that cannot be replaced in a timely manner may adversely affect our results of operations.

33

• We are dependent on hatcheries and pullet farms to supply our network of family farms with laying hens. Any disruption in that supply chain could materially and adversely affect our business, financial condition or results of operations.

• Consolidation of retain customers or the loss of a significant retail customer could negatively impact our sales and profitability.

• Increased transportation costs and failure by our transportation providers to pick up raw materials or deliver our products on time, in compliance with applicable governmental regulations or at all, has adversely impacted and is expected to continue to adversely impact our operating results.

• We source substantially all of our shell egg cartons from a sole source supplier, and any disruptions may impact our ability to sell our eggs.

• Because we rely on a limited number of third-party vendors to manufacture and store our products, we may not be able to maintain manufacturing and storage capacity at the times and with the capacities necessary to produce and store our products or meet the demand for our products.

• Our brand and reputation may be diminished due to real or perceived quality or food safety issues with our products, which could have an adverse effect on our business, reputation, operating results and financial condition.

• Demand for shell eggs is subject to seasonal fluctuations and can adversely impact our results of operations in certain quarters.

• Packaging costs are volatile and may rise significantly, which may negatively impact our profitability, and any reduced availability of packaging supplies may otherwise impact our business.

• If we fail to retain and motivate members of our management team or other key crew members, fail to attract and retain additional crew members or fail to maintain our company culture and focus on our purpose, our business may be harmed.

• Outbreaks of agricultural diseases, including avian influenza, the perception that outbreaks may occur or regulatory or market responses to outbreaks could reduce demand for our products and harm our business.

• The ongoing COVID-19 pandemic could have a material adverse impact on our business, results of operations and financial condition.

• Food safety and food-borne illness incidents or advertising or product mislabeling may materially and adversely affect our business by exposing us to lawsuits, product recalls or regulatory enforcement actions, increasing our operating costs and reducing demand for our product offerings.

• Our operations are subject to FDA and USDA federal regulation, as well as other federal, state and local regulations, and there is no assurance that we will be in compliance with all regulations.

• Our status as a public benefit corporation and a Certified B Corporation may not result in the benefits we anticipate, and as a public benefit corporation, our duty to balance a variety of interests may result in actions that do not maximize stockholder value.

Risks Related to Our Growth and Capital Requirements

Our recent, rapid growth may not be indicative of our future growth and, if we continue to grow rapidly, we may not be able to effectively manage our growth or evaluate our future prospects. If we fail to effectively manage our future growth or evaluate our future prospects, our business could be adversely affected.

We have grown rapidly since inception and anticipate further growth. For example, our net revenue increased from $60.3 million in the 13-week period ended June 27, 2021 to $82.9 million in 13-week period ended June 26, 2022, our net revenue increased from $118.9 million in the 26-week period ended June 27, 2021 to $159.9 million in the 26-week period ended June 26, 2022, and our net revenue increased from $214.3 million in fiscal 2020 to $260.9 million in fiscal 2021. This growth has placed significant demands on our management, financial, operational, technological and other resources. The anticipated growth and expansion of our business depends on a number of factors, including our ability to:

• increase awareness of our brand and successfully compete with other companies;

• price our products effectively so that we are able to attract new customers and consumers and expand sales to our existing customers and consumers;

• expand distribution to new points of sales with new and existing customers;

• continue to innovate and introduce new products;

• expand our supplier, co-manufacturing, co-packing, cold storage, processing and distribution capacities;

34

• invest in information technology systems and related process and procedures improvements; and

• maintain quality control over our product offerings.

Such growth and expansion of our business will place significant demands on our management and operations teams and require significant additional resources, financial and otherwise, to meet our needs, which may not be available in a cost-effective manner, or at all. We expect to continue to expend substantial resources on:

• our current and future processing facilities;

• our sales and marketing efforts to increase brand awareness, engage our existing and prospective customers, and drive sales of our products;

• product innovation and development; and

• general administration, including increased finance, legal and accounting expenses associated with being a public company.

These investments may not result in the growth of our business. Even if these investments do result in the growth of our business, if we do not effectively manage our growth, we may not be able to execute on our business plan, respond to competitive pressures, take advantage of market opportunities, satisfy customer requirements or maintain high-quality product offerings, any of which could adversely affect our business, financial condition and results of operations.

We have incurred net losses in the past and we may not be able to maintain or increase our profitability in the future.

For the 13-week period ended June 26, 2022 and June 27, 2021, we generated a net income of $0.2 million and $3.9 million, respectively. For the 26-week period ended June 26, 2022, we generated a net loss of $1.3 million, compared to the 26-week period ended June 27, 2021, where we generated net income of $7.4 million. We have also experienced net losses in prior fiscal years, including a net loss of $2.1 million in fiscal 2017. Our ability to maintain or increase our profitability is subject to various factors, many of which are beyond our control. As we expand our operations, we anticipate that our operating expenses and capital expenditures will increase substantially in the foreseeable future as we continue to invest to increase our household penetration, customer base, supplier network, marketing channels and product portfolio, expand and enhance our processing, manufacturing and distribution facilities as needed, and hire additional crew members. Our expansion efforts may prove more expensive than we anticipate (including as a result of increases in equipment prices or transportation costs, which may be due to actual or threatened disruptions in our supply chain relating to public health pandemics, such as COVID-19, trade wars, geopolitical tensions, such as the Russia-Ukraine war, inflation or other factors), and we may not succeed in increasing our net revenue and margins sufficiently to offset the anticipated higher expenses. We have incurred significant expenses in connection with investing in our egg processing facility, our co-manufacturing and co-packing relationships, and obtaining and storing raw materials, and we will continue to incur significant expenses in developing and marketing products. In addition, many of our expenses, including the costs associated with our existing and any future processing and manufacturing facilities, are fixed. We also expect to continue to incur significant additional legal, accounting and other expenses as a public company that we did not incur as a private company. If we fail to continue to grow our revenue at a greater rate than our costs and expenses, we may be unable to maintain or increase our profitability and may incur losses in the future.

We have only recently expanded our product offerings beyond shell eggs and butter, which makes it difficult to forecast our future results of operations.

We have only recently expanded our product offerings beyond shell eggs and butter. As a result of our limited experience managing multiple product lines, our ability to accurately forecast our future results of operations is limited and subject to a number of uncertainties, including our ability to plan for and model future growth. Our historical revenue growth should not be considered indicative of our future performance. Further, in future periods, our revenue growth could slow or our revenue could decline for a number of reasons, including slowing demand for our products, increasing competition, a decrease in the growth of our overall market, or our failure, for any reason, to continue to take advantage of growth opportunities. If our assumptions regarding these risks and uncertainties and our future revenue growth are incorrect or change, or if we do not address these risks successfully, our operating and financial results could differ materially from our expectations, and our business could suffer.

Sales of shell eggs constitute the vast majority of our net revenue, and a reduction in these sales would have an adverse effect on our financial condition.

Shell eggs accounted for approximately 92% and 90% of our net revenue in the 13-week periods ended June 26, 2022 and June 27, 2021, respectively. Shell eggs accounted for approximately 92% of our net revenue in each of the 26-week periods ended June 26, 2022 and June 27, 2021. Shell eggs are our flagship product and have been the focal point of our sales and marketing efforts, and we

35

believe that sales of shell eggs will continue to constitute a significant portion of our net revenue, net income and cash flow for the foreseeable future. We cannot be certain that we will be able to continue to expand sales, processing and distribution of shell eggs, or that consumer and customer demand for our other existing and future products will expand to allow such products to represent a larger percentage of our revenue than they do currently. Accordingly, any factor adversely affecting sales of our shell eggs could have an adverse effect on our business, financial condition and results of operations.

Failure to introduce successful new products or to successfully pursue growth by other means may adversely affect our ability to continue to grow.

One element of our growth strategy depends on our ability to develop and market new products that meet our standards for quality and appeal to consumer preferences. The success of our innovation and product development efforts is affected by our ability to anticipate changes in consumer preferences, the technical capability of our innovation staff in developing and testing product prototypes, our ability to comply with applicable governmental regulations, and the success of our management and sales and marketing teams in introducing and marketing new products. There can be no assurance that we will successfully develop and market new products that appeal to consumers. For example, in January 2022, we decided to discontinue our convenient breakfast offerings due primarily to financial performance, supply chain complexities and product shelf-life limitations. Any failure to successfully develop, market and launch future products may lead to decreased growth, sales and profitability.

Additionally, the development and introduction of new products requires substantial marketing expenditures, which we may be unable to recoup if the new products do not gain widespread market acceptance. If we are unsuccessful in meeting our objectives with respect to new or improved products, our business could be harmed.

Further risks are presented if we elect to pursue growth by means other than new product introductions, including acquisitions or investments in business or technologies that we believe could offer growth opportunities. The pursuit of such growth opportunities may divert the attention of management. Furthermore, it may cause us to incur various costs and expenses in identifying, investigating and pursuing such transactions, regardless of whether such opportunities are realized. Such acquisitions, transactions or investments may also result in potentially dilutive equity issuances, the incurrence of debt or contingent liabilities or challenges with integration, any of which could adversely affect our business, financial condition and results of operations.

We estimate market opportunity and forecast market growth that may prove to be inaccurate, and even if the market in which we compete achieves the forecasted growth, our business could fail to grow at similar rates, if at all.

Our estimates of market opportunity and growth forecasts included in this Quarterly Report on Form 10-Q are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate, particularly in light of the ongoing COVID-19 pandemic, geopolitical tensions and wars, inflation, rising interest rates, supply chain shortages, or other economic uncertainties. The variables that go into the calculation of our market opportunity are subject to change over time, and there is no guarantee that any particular number or percentage of customers covered by our market opportunity estimates will purchase our products at all or generate any particular level of revenue for us. Any expansion in our market depends on a number of factors, including the cost and perceived value associated with our products and those of our competitors. Even if the market in which we compete meets the size estimates and growth forecast, our business could fail to grow at the rate we anticipate, if at all. Our growth is subject to many factors, including our success in implementing our business strategy, which is subject to many risks and uncertainties. Accordingly, the forecasts of market growth included herein should not be taken as indicative of our future growth.

We may require additional financing to achieve our goals, and the failure to obtain this necessary capital when needed on acceptable terms, or at all, may force us to delay, limit, reduce or terminate our product manufacturing and development, and other operations.

We have funded our operations since inception primarily through equity financings and sales of our products. We have incurred and expect to continue to incur significant expenses related to the expansion of our egg packing capacity, including in connection with our expansion of Egg Central Station and the potential development of an additional egg packing center. We believe that we will continue to expend substantial resources for the foreseeable future as we consider additional markets we may choose to pursue and other growth opportunities such as new product introductions, acquisitions or investments. These expenditures are expected to include working capital, costs associated with research and development, manufacturing and supply, as well as marketing and selling existing and new products. In addition, other unanticipated costs may arise.

We expect that our existing cash will be sufficient to fund our planned operating expenses, capital expenditure requirements and debt service payments through at least the next 12 months. However, our operating plan may change because of factors currently unknown to us, and we may need to seek additional funds sooner than planned, through public or private equity or debt financings or other sources, such as strategic collaborations. We may also seek financing in connection with potential new product introductions or

36

acquisitions or investments in businesses or technologies that we believe could offer growth opportunities. Such financings may result in dilution to stockholders, imposition of debt covenants and repayment obligations, or other restrictions that may adversely affect our business. In addition, we may seek additional capital due to favorable market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans.

Risks Related to Our Business, Our Brand, Our Products and Our Industry

We are dependent on the market for shell eggs, and fluctuations in this market could adversely affect our business, financial condition and results of operations.

We contract with family farms to purchase all of their egg production for the duration of our contracts. We are contractually obligated to purchase these eggs irrespective of our ability to sell such eggs. Periodically in our industry, there has been an oversupply of eggs, which has caused egg prices to contract, sometimes substantially so, and as a result we have sold or donated our excess supply at reduced prices or no cost. If we are unable to sell such eggs upon commercially reasonable terms, or at all, our gross margins, business, financial condition and operating results may be adversely affected.

We also sell shell eggs to consumers at a premium price point, and when prices for commodity shell eggs fall relative to the price of our shell eggs, price-sensitive consumers may choose to purchase commodity shell eggs offered by our competitors at a greater velocity than, or instead of, our eggs. As a result, low commodity shell egg prices may adversely affect our business, financial condition and results of operations.

We also sell a small percentage of our shell eggs to wholesalers and egg breaking plants at commodity shell egg prices, which fluctuate widely and are outside our control. Small increases in production, or small decreases in demand, can have a large adverse effect on the prices at which these eggs are sold.

Fluctuations in commodity prices and in the availability of feed grains could negatively impact our results of operations and financial condition.

The price we pay to purchase shell eggs from farmers fluctuates based on pallet weight and is also indexed quarterly in arrears for changes in feed cost, which may cause our agreed-upon pricing under these contracts to fluctuate on a quarterly basis. Therefore, our results of operations and financial condition, including our gross margin and profitability, fluctuate based on the cost and supply of commodities, including corn, soybean meal and other feed ingredients.

Although feed ingredients are available from a number of sources, we have little, if any, control over the prices of these ingredients, which are affected by weather, speculators, export restrictions, various supply and demand factors, geopolitical tensions, inflation, transportation and storage costs, and agricultural and energy policies in the United States and internationally. We saw increasing prices for conventional and organic corn and soybean crops on a global basis in 2021 and early 2022, including increased prices resulting from the Russia-Ukraine war and measures taken in response thereto, inflation and supply chain shortages.

We may not be able to increase our product prices enough or in a timely manner to sufficiently offset increased commodity costs due to consumer price sensitivity or the pricing postures of our competitors and, in many cases, our retailers may not accept a price increase or may require price increases to occur after a specified period of time elapses. For example, we increased prices on certain of our products in January 2022 and May 2022. If we further increase prices to offset higher commodity prices or other costs, we could experience lower demand for our products, decreased ability to attract new customers and lower sales volumes. Over time, if we are unable to price our products to cover increased costs, unable to offset operating cost increases with continuous improvement savings or unsuccessful in any commodity-hedging program, then commodity price volatility or increases could adversely affect our business, financial condition and results of operations.

If we fail to effectively expand our processing, manufacturing and production capacity as we continue to grow and scale our business, our business and operating results and our brand reputation could be harmed.

While our current supply, processing and manufacturing capabilities are sufficient to meet our present business needs, we may need to expand these capabilities in the future as we continue to grow and scale our business. For example, we have substantially completed the expansion of Egg Central Station, our shell egg processing facility, to increase our capacity for the distribution of shell eggs. Additionally, we recently announced that we have begun the design and the site selection process for our next egg packing center. However, there is risk in our ability to effectively scale production and processing and effectively manage our supply chain requirements. We must accurately forecast demand for our products in order to ensure we have adequate processing and manufacturing capacity to effectively allocate product supply across our stock keeping units, or SKUs.

37

Our forecasts are based on multiple assumptions which may be inaccurate and affect our ability to obtain our own adequate processing and manufacturing capacities (or co-processing and co-manufacturing capacities) in order to meet the demand for our products, which could prevent us from meeting increased customer demand.

Our brand and our business could be harmed if we are unable to fulfill orders in a timely manner or at all. If we fail to meet demand for our products and, as a result, consumers who have previously purchased our products buy other brands or our retailers allocate shelf space to other brands, our business, financial condition and results of operations could be adversely affected.

On the other hand, if we overestimate our demand (in general or on a particular SKU) or overbuild our capacity relative to distribution, we may have significantly underutilized supply or other assets and may experience reduced margins. If we do not accurately align our processing and manufacturing capabilities with demand, our business, financial condition and results of operations could be adversely affected.

A substantial amount of our shell eggs are processed at Egg Central Station in Springfield, Missouri. Any damage or disruption at this facility may harm our business.

A substantial amount of our shell egg processing occurs at Egg Central Station, our shell egg processing facility in Springfield, Missouri. Any shutdown or period of reduced production at Egg Central Station, which may be caused by regulatory noncompliance or other issues, as well as other factors beyond our control, such as natural disaster, fire, power interruption, work stoppage, disease outbreaks or pandemics (such as COVID-19), equipment failure or delay in raw materials delivery, would significantly disrupt our ability to deliver our products in a timely manner, meet our contractual obligations and operate our business. Further, the processing equipment used for our shell eggs is costly to replace or repair, particularly because certain of our processing equipment is sourced internationally. We have seen pricing and capacity constraints related to internationally sourced equipment, and our equipment supply chains may be further disrupted in connection with pandemics, such as COVID-19, geopolitical tensions and wars (including the Russia-Ukraine war), inflation, trade wars or other factors. If any material amount of our machinery were damaged, we could be unable to predict when, if at all, we could replace or repair such machinery or find co-manufacturers with suitable alternative machinery, which could adversely affect our business, financial condition and operating results. We have property and business disruption insurance in place for Egg Central Station; however, such insurance coverage may not be sufficient to cover all of our potential losses and may not continue to be available to us on acceptable terms, or at all.

We have substantially completed the expansion of Egg Central Station; however, we may not be successful in adequately staffing the expanded facility to meet production needs and the expanded facility may not operate in accordance with our expectations. Furthermore, future expansions of our processing capacity may not provide us with the benefits we expect to receive.

In January 2019, we commenced design of an expansion of Egg Central Station, our shell egg processing facility, in order to address our rapid growth and increase our shell egg processing capacity. Constructing and operating at this expanded facility has required, and will continue to require, significant capital expenditures and the efforts and attention of our management and other personnel, which has and will continue to divert resources from our existing business or operations. In addition, we will need to hire and retain more crew members to operate the expanded facility. In Springfield, Missouri, where Egg Central Station is located, there is a tight labor market. If we are unable to hire, train and retain additional crew members due to the current labor market (or as a result of other labor disruptions, including due to the ongoing COVID-19 pandemic), our ability to fully realize the benefits of the expanded facility may be materially limited. Even if the expanded facility is brought up to full processing capacity, it may not provide us with all of the operational and financial benefits we expect to receive.

Additionally, we recently announced that we have begun the design and site selection process for our next egg packing center. If this process does not proceed as anticipated, or if the potential new egg packing center is not brought up to full processing capacity or if we are unable to hire, train and retain crew members to support an additional egg packing center, we may not be able to fully realize the potential benefits of such an expansion, and our business, financial condition and operating results could be adversely affected.

Increased transportation and freight costs or failure by our transportation providers to pick up raw materials or deliver our products on time, in compliance with applicable governmental regulations or at all, has adversely impact and is expected to continue to adversely impact our operating results.

We currently rely upon third-party transportation providers for a significant portion of our raw material transportation and product shipments. Our utilization of pickup and delivery services for shipments is subject to risks, including increases in fuel prices, chronic driver shortages, trucking capacity limitations due to general increases in freight demand, employee and contractor strikes or unavailability (including due to the ongoing COVID-19 pandemic) or inclement weather, any of which could increase our transportation and freight costs. For example, due in part to increased labor costs arising from the COVID-19 pandemic and rising fuel costs due to international tensions and wars, we have recently seen increased transportation and freight costs, and we expect that these elevated costs could remain in effect for the foreseeable future. Further increases in transportation and freight costs could have an adverse effect on our ability to increase or to maintain production on a profitable basis and could therefore adversely affect our

38

operating results. We may not be able to increase our product prices enough or in a timely manner to sufficiently offset increased transportation costs due to consumer price sensitivity or the pricing postures of our competitors and, in many cases, our retailers may not accept a price increase or may require price increases to occur after a specified period of time elapses. In addition, if we increase prices to offset higher transportation and freight costs, we could experience lower demand for our products, decreased ability to attract new customers and lower sales volumes.

Furthermore, noncompliance by our third-party transportation providers with applicable regulatory requirements may impact the ability of providers to provide delivery services that adequately meet our shipping needs. Due to increased costs or noncompliance by our transportation providers with applicable regulatory requirements, we may change shipping companies, and we could face logistical difficulties with any such change that could adversely affect deliveries. In addition, we could incur costs and expend resources in connection with such change. Moreover, we may not be able to obtain terms as favorable as those we receive from the third-party transportation providers that we currently use, which in turn would increase our costs and thereby adversely affect our operating results.

If we fail to effectively maintain or expand our network of family farms, our business, operating results and brand reputation could be harmed.

We source our eggs and cream for our products from our network of family farms, which is the foundation of our supply chain. If we are unable to maintain and expand this supply chain because of actions taken by farmers or other events outside of our control, we may be unable to timely supply distributors and customers with our products, which could lead to cancellation of purchase orders, damage to our commercial relationships and impairment of our brand. For example, we require our egg farmers to build and equip their farms to certain specifications, which requires a significant upfront capital investment, and any inability of farmers to obtain adequate financing on acceptable terms, including as a result of interest rate increases, would impair their ability to partner with us. If our relationship with these farmers is disrupted, we may not be able to fully recover our investments in birds and feed, which would negatively impact our operating results. There are a number of factors that could impair our relationship with farmers, many of which are outside of our control. For example, while we strive to operate our business in a manner that drives long-term and sustainable benefits for our stakeholders, including farmers, we may make strategic decisions that the farmers do not believe align with their interests or values, which could cause the farmers to terminate their relationships with us. Any failure to maintain or expand our network of family farms would adversely affect our business, financial condition and results of operations.  

Our future business, results of operations and financial condition may be adversely affected by reduced or limited availability of eggs, cream and other raw materials that meet our standards.

Our ability to ensure a continuing supply of eggs, cream and other raw materials for our products at competitive prices depends on many factors beyond our control. In particular, we rely on the farms that supply us with eggs and cream to implement controls and procedures to manage the risk of exposing animals to harmful diseases, but outbreaks may occur despite their efforts. An outbreak of disease could result in increased government restriction on the sale and distribution of our products, and negative publicity could impact customer and consumer perception of our products, even if an outbreak does not directly impact the animals from which we source our products. Our network of family farms for our shell eggs is in a geographic region we refer to as the Pasture Belt, which is a term we use that refers to the U.S. region where our eggs can be produced year-round. Our cream supply is located in Ohio and New York. The occurrence of a natural disaster in any of these regions could have a significant negative impact on us, the farmers and our supply chain. Additionally, the animals from which our products are sourced, the crops on which we rely for feed and the pastures on which these animals are raised, are vulnerable to adverse weather conditions and natural disasters, such as floods, droughts, frosts, earthquakes, hurricanes and pestilence. Disease, adverse weather conditions and natural disasters can adversely impact pasture quantity and quality, leading to reduced yields and quality, which in turn could reduce the available supply of, or increase the price of, our raw materials. If we raised prices for our products to account for this increase, we could experience decreased demand for our products and lower sales volumes, thereby adversely affecting our business, financial condition and results of operations.

We also compete with other food companies in the procurement of eggs and cream, and this competition may increase in the future if consumer demand increases for these items or products containing them or if competitors increasingly offer products in these market sectors. If supplies of eggs and cream that meet our quality standards are reduced or are in greater demand, we may not be able to obtain sufficient supply to meet our needs on favorable terms, or at all. For example, as a result of the ongoing COVID-19 pandemic, there have been recent disruptions in the U.S. cream supply, including increased freight costs for both collection and transport of cream ingredients to processing facilities. The cooperatives that we work with are under enormous financial pressures and the segregation of supply is an ongoing risk. We have worked with our co-manufacturers to mitigate these supply disruptions, but we expect that these supply disruptions will continue for the foreseeable future and that they may be further exacerbated by the ongoing effects of COVID-19, geopolitical tensions and wars, inflation or other economic uncertainties, each of which could impact our freight costs and our ability to fill customer orders in the future.

Our supply may also be affected by the number and size of farms that raise chickens and cows that meet our standards, changes in U.S. and global economic conditions and our ability to forecast our raw materials requirements. For example, in order to meet our standards, we require our poultry farms to invest in infrastructure at the outset of our relationship. The typical upfront investment for each of the farms is significant and many of the farmers seek financing assistance from local and regional banks as well as federal government loans from the U.S. Department of Agriculture, or USDA, Farm Service Agency. Changes in U.S. and global economic

39

conditions, interest rate increases or any U.S. government shutdown (including in connection with COVID-19) could significantly affect the loans available to farmers. Many of these farmers have alternative income opportunities and the relative financial performance of raising chickens and cows in accordance with our standards as compared to other potentially more profitable opportunities could affect their interest in working with us. Any of these factors could impact our ability to supply our products to distributors and customers and may adversely affect our business, financial condition and results of operations.

We may not be able to compete successfully in our highly competitive market.

We operate in a highly competitive environment across each of our product categories. We have numerous competitors of varying sizes, including producers of private-label products, as well as producers of other branded egg and butter products that compete for trade merchandising support and consumer dollars. Numerous brands and products compete for limited retailer shelf space, including in the refrigerated section, foodservice, and customers and consumers. In our market, competition is based on, among other things, product quality and taste, brand recognition and loyalty, product variety, product packaging and package design, shelf space, reputation, price, advertising, promotion and nutritional claims.

We compete with large egg companies such as Cal-Maine, Inc. and large international food companies such as Ornua Co-operative Limited (Kerrygold). We also compete directly with local and regional egg and dairy companies, as well as private-label specialty products processed by other egg and dairy companies. Each of these competitors may have substantially greater financial and other resources than us and some of whose products are well accepted in the marketplace today. They may also have lower operational costs, and as a result may be able to offer comparable or substitute products to customers at lower costs. This could put pressure on us to lower our prices, resulting in lower profitability or, in the alternative, cause us to lose market share if we fail to lower prices. Conversely, if we were to raise prices, including as a result of fluctuations in the shell egg market, increased commodity or raw material costs, increased packaging or transportation costs or otherwise, any resulting decline in consumer demand for our products may be exacerbated by the competitiveness of our market.

Generally, the food industry is dominated by multinational corporations with substantially greater resources and operations than we have. We cannot be certain that we will successfully compete with larger competitors that have greater financial, sales and technical resources. Conventional food companies may acquire our competitors or launch their own egg and butter products, and they may be able to use their resources and scale to respond to competitive pressures and changes in consumer preferences by introducing new products, reducing prices or increasing promotional activities, among other things. Retailers also market competitive products under their own private labels, which are generally sold at lower prices, and may change the merchandising of our products so they have less favorable placement. Competitive pressures or other factors could cause us to lose market share, which may require us to lower prices, increase marketing and advertising expenditures or increase the use of discounting or promotional campaigns, each of which would adversely affect our margins and could result in a decrease in our operating results and profitability.

Further, competitors with substantially greater operations and resources than we have may be less affected by the ongoing COVID-19 pandemic than we are. In connection with the pandemic, we have, at times, restricted employee travel, cancelled certain events with consumers, customers or partners, imposed operational safeguards at Egg Central Station and limited access to our headquarters. Although we are monitoring the situation, we cannot predict the ultimate extent to which the pandemic may disrupt our operations or if we are required to implement other changes, such as closure of our egg processing facility. Any significant disruption resulting from this or similar events on a large scale or over a prolonged period of time could cause significant delays and disruption to our business until we would be able to resume normal business operations or shift to other third-party vendors, negatively affecting our revenue and other financial results. A prolonged disruption of our business could also damage our reputation.

In addition, our ability to compete successfully in our market depends, in large part, on our ability to implement our growth strategy of expanding supply and distribution, improving placement of our products, attracting new consumers to our brand and introducing new products and product extensions. Our ability to implement this growth strategy depends, among other things, on our ability to:

• manage relationships with various suppliers, co-manufacturers, distributors, customers and other third parties, and expend time and effort to integrate new suppliers, co-manufacturers and customers into our fulfillment operations;

• secure placement in stores for our products;

• increase our brand recognition;

• expand and maintain brand loyalty;

• increase the number of consumer households purchasing our products; and

• develop new product lines and extensions.

Our sales and operating results will be adversely affected if we do not successfully implement our growth strategy or if we invest resources in a growth strategy that ultimately proves unsuccessful.

40

We currently have a limited number of co-manufacturers. Loss of one or more of our co-manufacturers or our failure to timely identify and establish relationships with new co-manufacturers could harm our business and impede our growth.

A significant amount of our revenue is derived from products manufactured at facilities owned and operated by our co-manufacturers. We currently rely on two co-manufacturers for hard-boiled eggs, one co-manufacturer for stick butter, one co-manufacturer for spreadable tub butter, one co-manufacturer for ghee and one co-manufacturer for liquid eggs. While we currently have written manufacturing contracts with our co-manufacturers for stick butter, spreadable tub butter, and one of our co-manufacturers for hard-boiled eggs, we do not currently have written manufacturing contracts with our other co-manufacturers. Due to the absence of written contracts with certain of our co-manufacturers, these co-manufacturers can generally seek to alter or terminate their relationships with us at any time, leaving us with periods during which we have limited or no ability to manufacture certain of our products.

In addition, due to the limited number of co-manufacturers, an interruption in, or the loss of operations at, one or more of our co-manufacturing facilities, which may be caused by work stoppages, regulatory issues or noncompliance, disease outbreaks or pandemics (such as COVID-19), war, terrorism, fire, earthquakes, flooding or other natural disasters, could delay, postpone or reduce production of some of our products, which could have an adverse effect on our business, financial condition and results of operations until such time as the interruption is resolved or an alternate source of production is secured, especially in times of low inventory.

We believe there are a limited number of competent, high-quality co-manufacturers in our industry that meet our geographical requirements and our strict quality and control standards, and should we seek to obtain additional or alternative co-manufacturing arrangements in the future, there can be no assurance that we would be able to do so on satisfactory terms, in a timely manner, or at all. Therefore, the loss of one or more co-manufacturers, any disruption or delay at a co-manufacturer or any failure to identify and engage co-manufacturers for new products and product extensions could delay, postpone or reduce production of our products, which could have an adverse effect on our business, financial condition and results of operations.

We could be adversely affected by a change in consumer preferences, perception and spending habits in the natural food industry generally and on animal-based products in particular, and failure to develop or enrich our product offerings or gain market acceptance of our new products could have a negative effect on our business.

We have positioned our brand to capitalize on growing consumer interest in natural, clean-label, traceable, ethically produced, great-tasting and nutritious foods. The market in which we operate is subject to changes in consumer preference, perception and spending habits. Our performance depends significantly on factors that may affect the level and pattern of consumer spending in the U.S. natural food industry market in which we operate. Such factors include consumer preference, consumer confidence, consumer income, consumer perception of the safety and quality of our products and shifts in the perceived value for our products relative to alternatives. Media coverage regarding the safety or quality of, or diet or health issues relating to, our products or the raw materials, ingredients or processes involved in their manufacturing may damage consumer confidence in our products. A general decline in the consumption of our products could occur at any time as a result of change in consumer preference, perception, confidence and spending habits, including an unwillingness to pay a premium or an inability to purchase our products due to financial hardship or increased price sensitivity, which may be exacerbated by the effects of the ongoing COVID-19 pandemic and general inflationary trends. For example, we and many of our customers face pressure from animal rights groups to require all companies that supply food products to operate their business in a manner that treats animals in conformity with certain standards developed or approved by these animal rights groups. If consumer preferences shift away from animal-based products for these reasons, because of a preference for plant-based products or otherwise, our business, financial condition and results of operations could be adversely affected.

The success of our products depends on a number of factors, including our ability to accurately anticipate changes in market demand and consumer preferences, our ability to differentiate the quality of our products from those of our competitors, and the effectiveness of our marketing and advertising campaigns for our products. We may not be successful in identifying trends in consumer preferences and developing products that respond to such trends in a timely manner. We also may not be able to effectively promote our products by our marketing and advertising campaigns and gain market acceptance. If our products fail to gain market acceptance, are restricted by regulatory requirements or have quality problems, we may not be able to fully recover costs and expenses incurred in our operation, and our business, financial condition or results of operations could be materially and adversely affected.

A limited number of distributors represent a substantial portion of our sales, and the loss of one or more distributor relationships that cannot be replaced in a timely manner may adversely affect our results of operations.

Our products are distributed through a broker-distributor-retailer network whereby brokers represent our products to distributors and retailers who in turn sell our products to consumers. We serve the majority of natural channel customers through food distributors, such as United Natural Foods, Inc., or UNFI, KeHE Distributors, LLC, or KeHE, and US Foods, Inc., or US Foods, which purchase, store, sell and deliver our products to retailers, including Whole Foods and Sprouts.

In the 13-weeks ended June 26, 2022 and June 27, 2021, UNFI (which was Whole Foods’ primary distributor other than from April 2020 to August 2021) accounted for approximately 32% and less than 10% of our net revenue, respectively, KeHE accounted for approximately 10%, and 10% of our net revenue, respectively, and US Foods (which was Whole Foods’ primary distributor from April 2020 to August 2021) accounted for 0% and 25% of our net revenue, respectively. In the 26-weeks ended June 26, 2022 and June 27, 2021, UNFI (which was Whole Foods’ primary distributor other than from April 2020 to August 2021) accounted for approximately 32% and less than 10% of our net revenue, respectively, KeHE accounted for approximately 10%, and 10% of our net revenue, respectively, and US Foods (which was Whole Foods’ primary distributor from April 2020 to August 2021) accounted for approximately 0% and 25% of our net revenue, respectively. In the 26-weeks ended June 26, 2022 and June 27, 2021, UNFI (which was Whole Foods’ primary distributor other than from April 2020 to August 2021) accounted for approximately 32% and less than 10% of our net revenue, respectively, KeHE accounted for approximately 10%, and 10% of our net

41

revenue, respectively, and US Foods (which was Whole Foods’ primary distributor from April 2020 to August 2021) accounted for less than 10% and approximately 25% of our net revenue, respectively. Since these distributors act as intermediaries between us and the retail grocers or foodservice providers, who generally select the distributors, we do not have short-term or long-term commitments or minimum purchase volumes in our contracts with distributors that ensure future sales of our products. These distributors are able to decide on the products carried, and they may limit the products available for retailers, such as Whole Foods and Sprouts, to purchase. We expect that most of our sales will be made through a core number of distributors for the foreseeable future. The loss of one or more of our significant distributor relationships that cannot be replaced in a timely manner (or at all), under similar terms and conditions, could adversely affect our business, financial condition and results of operations.

We are dependent on hatcheries and pullet farms to supply our network of family farms with laying hens. Any disruption in that supply chain could materially and adversely affect our business, financial condition or results of operations.

Under the terms of our contracts with our network of family farms, while we do not own laying hens, we are generally responsible for coordinating the acquisition and delivery of laying hens to the farmers. In order to meet these obligations, we place orders for chicks directly with hatcheries intended to supply a future year’s production of eggs at least a year in advance. Once the chicks are hatched, they are delivered to a network of pullet farms, who rear the chicks to approximately 16 to 18 weeks of age, at which time they begin laying eggs. The hens are then delivered directly from the pullet farms to our network of family farms, which then place the hens into egg production.

We currently work with a sole source supplier that contracts with a network of independent pullet farms. We do not have a long-term supply contract with this supplier, and if the supplier were to cease doing business with us for any reason, we may have a difficult time finding and contracting with alternate pullet farms in sufficient scale to meet our needs, if at all. Additionally, any disruption in these supply services for any reason, including agricultural disease such as avian influenza, natural disaster, fire, power interruption, work stoppage or other calamity, could have a material adverse effect on our business, financial condition and results of operations if we cannot replace these providers in a timely manner on acceptable terms or at all.

Consolidation of retail customers or the loss of a significant retail customer could negatively impact our sales and profitability.

Our retail customers include natural channel and mainstream channel stores, which have been undergoing a consolidation in recent years. This consolidation has produced larger, more sophisticated organizations with increased negotiating and buying power that are able to resist price increases, as well as operate with lower inventories, decrease the number of brands that they carry and increase their emphasis on private-label products, all of which could negatively impact our business. During the 13-week and 26-week periods ended June 26, 2022 and June 27, 2021, our largest direct retail customer, Kroger, accounted for approximately 12% and 11% of our net revenue, respectively.

With certain of our retail customers, like Whole Foods, we sell our products through distributors. We are not able to precisely attribute our net revenue to a specific retailer for products sold through distributors. We rely on third-party data to calculate the portion of retail sales attributable to retailers, but this data is inherently imprecise because it is based on gross sales generated by our products sold at retailers, without accounting for price concessions, promotional activities or chargebacks, and because it measures retail sales for only the portion of our retailers serviced through distributors. Based on this third-party data and internal analysis, Whole Foods accounted for approximately 24% and 27% of our retail sales in the 13-week periods ended June 26, 2022 and June 27, 2021, respectively and 25% and 27% for the 26-week periods then ended. The loss of Kroger, Whole Foods or any other large retail customer or the reduction of purchasing levels or the cancellation of any business from Kroger, Whole Foods or any other large retail customer for an extended length of time could negatively impact our sales and profitability.

A retailer may take actions that affect us for reasons that we cannot always anticipate or control, such as their financial condition, changes in their business strategy or operations, the introduction of competing products or the perceived quality of our products. Despite operating in different channel segments, our retailers sometimes compete for the same consumers. Because of actual or perceived conflicts resulting from this competition, retailers may take actions that negatively affect us. Consequently, our financial results may fluctuate significantly from period to period based on the actions of one or more significant retailers.

42

We source substantially all of our shell egg cartons from a sole source supplier, and any disruptions may impact our ability to sell our eggs.

We obtain substantially all of the packaging for our shell eggs from a sole-source supplier. Any disruption in the supply of our shell egg cartons, including as a result of interruptions to global shipping, could delay our production and hinder our ability to meet our commitments to customers. If we are unable to obtain a sufficient quantity of our packaging on commercially reasonable terms or in a timely manner, or if we are unable to obtain alternative sources, sales of our products could be delayed or we may be required to redesign our products. For example, in connection with increased demand for shell eggs in relation to the COVID-19 pandemic, the supplier of substantially all of our shell egg cartons began to prioritize packaging for core egg products (such as 12-count packages), and we separately experienced certain quality issues with our 18-count egg cartons. As a result of these events, and in order to otherwise meet demand for our products, we began using recycled plastic packaging for certain of our shell egg products. While this change in packaging did not materially impact our operations, there is no guarantee that we will not experience similar packaging issues in the future, or that any such packaging issues will not impact our ability to meet product demand for our shell eggs. Any of these events could result in lost sales, price increases, reduced gross margins or damage to our customer relationships, which would have a material adverse effect on our business, financial condition and results of operations.

Because we rely on a limited number of third-party vendors to manufacture and store our products, we may not be able to maintain manufacturing and storage capacity at the times and with the capacities necessary to produce and store our products or meet the demand for our products.

We rely on a limited number of co-manufacturers and cold storage providers. We currently rely on two co-manufacturers for hard-boiled eggs, one co-manufacturer for stick butter, one co-manufacturer for spreadable tub butter, one co-manufacturer for ghee, and one co-manufacturer for liquid eggs. Our financial performance depends in large part on our ability to obtain adequate co-manufacturing and cold storage facilities services in a timely manner. We are not assured of continued co-manufacturing and cold storage capacities. Certain of our co-manufacturers or our cold storage providers could discontinue or seek to alter their relationship with us. In addition, we are not assured of sufficient capacities of these providers commensurate with increased product demand.

Any disruption in the supply of our final products from these providers would have an adverse effect on our business if we cannot replace these providers in a timely manner or at all. For example, in December 2019, our co-manufacturer for hard-boiled eggs conducted a voluntary Class I recall of all hard-boiled eggs produced at its facility, including ours, due to a potential listeria contamination at the production facility. In connection with the recall, our co-manufacturer elected to permanently close the affected production facility and move all production to a different facility, which did not have sufficient capacity to meet product demand. As a result, we were unable to supply customers with hard-boiled eggs for a period of time in the first quarter of fiscal 2020. This disruption led to the loss of certain customer accounts for this product, the revenues from which were immaterial in the aggregate.

Our brand and reputation may be diminished due to real or perceived quality or food safety issues with our products, which could have an adverse effect on our business, reputation, operating results and financial condition.

We believe our consumers rely on us to provide them with high-quality products. Therefore, real or perceived quality or food safety concerns or failures to comply with applicable food regulations and requirements, whether or not ultimately based on fact and whether or not involving us (such as incidents involving our competitors), could cause negative publicity and reduced confidence in our company, brand or products, which could in turn harm our reputation and sales, and could adversely affect our business, financial condition and operating results.

Our products may be subject to contamination by foreign materials or disease-producing organisms or pathogens, such as salmonella and E. coli. These organisms and pathogens are found generally in the environment and there is a risk that one or more could be present in our products, either as a result of food processing or as an inherent risk based on the nature of our products. These organisms and pathogens also can be introduced to our products as a result of improper handling at the further-processing, foodservice or consumer level. These risks may be controlled, but may not be eliminated, by adherence to good manufacturing practices and finished product testing. Shipment of contaminated products, even if inadvertent, could result in a violation of law and lead to increased risk of exposure to product liability claims, product recalls and increased scrutiny by federal and state regulatory agencies, penalties and adverse publicity. In addition, products purchased from other producers, including co-manufacturers, could contain contaminants that we might inadvertently redistribute.

If our products become contaminated, or if there is a potential health risk associated with our products, we or our co-manufacturers might decide or need to recall a product. Any product recall could result in a loss of consumer confidence in our products and adversely affect our reputation with existing and potential customers. For example, in December 2019, our co-manufacturer for hard-boiled eggs conducted a voluntary Class I recall of all hard-boiled eggs produced at its facility, including ours, due to potential listeria contamination at the production facility. In connection with the recall, our co-manufacturer elected to permanently close the affected production facility and move all production to a different facility. As a result, we were unable to supply customers with hard-boiled eggs for a period of time in the first quarter of fiscal 2020, which led to the loss of certain customer accounts for this product, the revenues from which were immaterial in the aggregate.

43

We also have no control over our products once purchased by consumers. For example, consumers may store our products under conditions and for periods of time inconsistent with USDA, U.S. Food and Drug Administration, or FDA, and other governmental guidelines, which may adversely affect the quality and safety of our products.

If consumers do not perceive our products to be of high quality or safe, then the value of our brand would be diminished, and our business, results of operations and financial condition would be adversely affected. Any loss of confidence on the part of consumers in the quality and safety of our products would be difficult and costly to overcome. Any such adverse effect could be exacerbated by our market positioning as a socially conscious purveyor of high-quality products and may significantly reduce our brand value. Issues regarding the safety of any of our products, regardless of the cause, may have an adverse effect on our brand, reputation and operating results. Further, the growing use of social and digital media by us, our consumers and third parties increases the speed and extent that information or misinformation and opinions can be shared. Negative publicity about us, our brands or our products on social or digital media could seriously damage our brands and reputation. If we do not maintain the favorable perception of our brands, our business, financial condition and results of operations could be adversely affected.

Failure to leverage our brand value propositions to compete against private-label products, especially during an economic downturn, may adversely affect our profitability.

In many product categories, we compete not only with other widely advertised branded products, but also with private-label products that generally are sold at lower prices. Consumers are more likely to purchase our products if they believe that our products provide a higher quality and greater value than less expensive alternatives. If the difference in perceived value between our brands and private-label products narrows, or if there is a perception of such a narrowing, consumers may choose not to buy our products at prices that are profitable for us. We believe that in periods of economic uncertainty, particularly in periods of uncertainty driven by high inflation, consumers may purchase more lower-priced private-label or other economy brands. To the extent this occurs, we could experience a reduction in the sales volume of our higher margin products or a shift in our product mix to lower margin offerings. In addition, our foodservice product sales will be reduced if consumers reduce the amount of food that they consume away from home at our foodservice customers, whether as a result of restaurant closures or government-ordered quarantines, travel restrictions or other directives in connection with the COVID-19 pandemic or in times of economic uncertainty driven by inflation or other factors.

We must expend resources to maintain consumer awareness of our brand, build brand loyalty and generate interest in our products. Our marketing strategies and channels will evolve and our programs may or may not be successful.

In order to remain competitive and expand and keep shelf placement for our products, we may need to increase our marketing and advertising spending to maintain and increase consumer awareness, protect and grow our existing market share or promote new products, which could impact our operating results. Substantial advertising and promotional expenditures may be required to maintain or improve our brand’s market position or to introduce new products to the market, and participants in our industry are increasingly engaging with non-traditional media, including consumer outreach through social media and web-based channels, which may not prove successful.

An increase in our marketing and advertising efforts may not maintain our current reputation or lead to increased brand awareness. Further, social media platforms frequently change the algorithms that determine the ranking and display of results of a user’s search and may make other changes to the way results are displayed, or may increase the costs of such advertising, which can negatively affect the placement of our links and, therefore, reduce the number of visits to our website and social media channels or make such marketing cost prohibitive. In addition, social media platforms typically require compliance with their policies and procedures, which may be subject to change or new interpretation with limited ability to negotiate, which could negatively impact our marketing capabilities. If we are unable to maintain and promote a favorable perception of our brand and products on a cost-effective basis, our business, financial condition and results of operations could be adversely affected.

If we fail to develop and maintain our brand, our business could suffer.

We have developed a strong and trusted brand that has contributed significantly to the success of our business, and we believe our continued success depends on our ability to maintain and grow the value of the Vital Farms brand. Maintaining, promoting and positioning our brand and reputation will depend on, among other factors, the success of our product offerings, food safety, quality assurance, marketing and merchandising efforts, our continued focus on animal welfare, the environment and sustainability and our ability to provide a consistent, high-quality consumer and customer experience. Any negative publicity, regardless of its accuracy, could have an adverse effect on our business. Brand value is based on perceptions of subjective qualities, and any incident that erodes the loyalty of our consumers, customers, suppliers or co-manufacturers, including changes to our products or packaging, adverse publicity or a governmental investigation, litigation or regulatory enforcement action, could significantly reduce the value of our brand and significantly damage our business.

44

If we fail to cost-effectively acquire new consumers or retain our existing consumers, our business could be adversely affected.

Our success, and our ability to increase revenue and operate profitably, depends in part on our ability to cost-effectively acquire new consumers, retain existing consumers and keep existing consumers engaged so that they continue to purchase our products. While we intend to continue to invest significantly in sales and marketing to educate consumers about our brand, our values and our products, there is no assurance that these efforts will generate further demand for our products or expand our consumer base. Our ability to attract new consumers and retain our existing consumers will depend on the perceived value and quality of our products, consumers’ desire to purchase ethically produced products at a premium, offerings of our competitors, our ability to offer new and relevant products and the effectiveness of our marketing efforts, among other items. For example, because our shell eggs are sold to consumers at a premium price point, when prices for commodity shell eggs fall relative to the price of our shell eggs, we may be unable to entice price-sensitive consumers to try our products. We may also lose loyal consumers to our competitors if we are unable to meet consumer demand in a timely manner. If we are unable to cost-effectively acquire new consumers, retain existing consumers and keep existing consumers engaged, our business, financial condition and operating results would be adversely affected.

Our sales and profits are dependent upon our ability to expand existing customer relationships and acquire new customers.

Our business depends on our ability to increase our household penetration, to expand the number of products sold through existing retail customers, to grow within the foodservice channel and to strengthen our product offerings through innovation in both new and existing categories. Any strategies we employ to pursue this growth are subject to numerous factors outside of our control. For example, retailers continue to aggressively market their private-label products, which could reduce demand for our products. The expansion of our business also depends on our ability over the long term to obtain customers in additional distribution channels, such as convenience, drugstore, club, military and international markets. Any growth in distribution channels may also affect our existing customer relationships and present additional challenges, including related to pricing strategies. Additionally, we may need to increase or reallocate spending on marketing and promotional activities, such as rebates, temporary price reductions, off-invoice discounts, retailer advertisements, product coupons and other trade activities, and these expenditures are subject to risks, including related to consumer acceptance of our efforts. Our failure to obtain new customers, or expand our business with existing customers, could have a material adverse effect on our business, financial condition, results of operations and cash flows.

Demand for shell eggs is subject to seasonal fluctuations and can adversely impact our results of operations in certain quarters.

Demand for shell eggs fluctuates in response to seasonal factors. Shell egg demand tends to increase with the start of the school year and is highest prior to holiday periods, particularly Thanksgiving, Christmas and Easter, and the lowest during the summer months. As a result of these seasonal and quarterly fluctuations, comparisons of our sales and operating results between different quarters within a single fiscal year are not necessarily meaningful comparisons. If we are not correct in predicting our future shell egg demand, we may experience a supply and demand shell egg imbalance. This imbalance between supply and demand can adversely impact our results of operations at certain times of the year.

Packaging costs are volatile and may rise significantly, which may negatively impact our profitability, and any reduced availability of packaging supplies may otherwise impact our business.

We and our co-manufacturers purchase and use significant quantities of cardboard, glass, corrugated fiberboard, kraft paper, flexible plastic, flexible film and paperboard to package our products. Costs of packaging are volatile and can fluctuate due to conditions that are difficult to predict, including global competition for resources, weather conditions, consumer demand and changes in governmental trade. Volatility in the prices of supplies we and our co-manufacturers purchase could increase our cost of sales and reduce our profitability. Moreover, we may not be able to implement price increases for our products to cover any increased costs, and any price increases we do implement may result in lower consumer demand, decreased ability to attract new customers and lower sales volumes. Additionally, if the availability of certain packaging supplies is limited due to factors beyond our control (including as a result of the COVID-19 pandemic or disruptions to global supply chains), or if packaging supplies do not meet our standards, we may make changes to our product packaging, which could negatively impact the perception of our brand. For example, in connection with increased demand for shell eggs in relation to the COVID-19 pandemic, the supplier of substantially all of our shell egg cartons began to prioritize packaging for core egg products (such as 12-count packages), and we separately experienced certain quality issues with our 18-count egg cartons. As a result of these events, and in order to otherwise meet demand for our products, we began using recycled plastic packaging for certain of our shell egg products. If we are not successful in managing our packaging costs or the supply of packaging that meets our standards to use for our products, if we are unable to increase our prices to cover increased costs or if such price increases reduce our sales volumes, any of these factors could adversely affect our business, financial condition, and results of operations.

45

Our net revenue and earnings may fluctuate as a result of price actions, promotional activities and chargebacks.

Retailers may require price concessions that would negatively impact our margins and our profitability. Alternatively, we may increase our prices to offset commodity inflation and potentially impact our margins and volume.  

In addition, we periodically offer sales incentives through various programs to customers and consumers, including rebates, temporary price reductions, off-invoice discounts, retailer advertisements, product coupons and other trade activities.

Additionally, while we continue to work to optimize supply chain logistics, we are occasionally charged fees and/or fines by retailers for various delivery and order discrepancies. While we challenge and vet these charges, we may be subject to such charges that could be detrimental to our performance, particularly when combined with the effects of increased freight costs or the other risks outlined in this section. The cost associated with promotions and chargebacks is estimated and recorded as a reduction in net revenue. We anticipate that these price concessions, promotional activities and chargebacks could adversely impact our net revenue and that changes in such activities could adversely impact period-over-period results. If we are not correct in predicting the performance of promotions, or if we are not correct in estimating chargebacks, our business, financial condition and results of operations would be adversely affected.

If we fail to retain and motivate members of our management team or other key crew members, or fail to attract, train, develop and retain additional qualified crew members to support our operations, our business and future growth prospects would be harmed.

Our success and future growth depend largely upon the continued services of our executive officers as well as our other key crew members. These executives and key crew members have been primarily responsible for determining the strategic direction of our business and for executing our growth strategy and are integral to our brand, culture and the reputation we enjoy with suppliers, co-manufacturers, distributors, customers and consumers. From time to time, there may be changes in our executive management team or other key crew members resulting from the hiring or departure of these personnel. The loss of one or more of our executive officers, or the failure by our executive team to effectively work with our crew members and lead our company, could harm our business.

In addition, our success depends in part upon our ability to attract, train, develop and retain a sufficient number of crew members who understand and appreciate our culture and can represent our brand effectively and establish credibility with our business partners and consumers. If we are unable to win in a competitive market for top talent capable of meeting our business needs and expectations, our business and brand image may be impaired. For example, in Springfield, Missouri, where Egg Central Station is located, there is a tight labor market. As a result of this tight labor market, we may be unable to attract and retain crew members with the skills we require, particularly given the need for additional crew members due to our expansion of Egg Central Station. Any failure to meet our staffing needs or any material increase in turnover rates of our crew members may adversely affect our business, financial condition and results of operations.

If we cannot maintain our company culture or focus on our purpose as we grow, our success and our business and competitive position may be harmed.

We believe our culture and our purpose have been key contributors to our success to date and that the critical nature of the platform that we provide promotes a sense of greater purpose and fulfillment in our crew members. Any failure to preserve our culture or focus on our purpose could negatively affect our ability to retain and recruit personnel, which is critical to our growth, and to effectively focus on and pursue our corporate objectives. As we grow and develop the infrastructure of a public company, we may find it difficult to maintain these important values. We may also have difficulty preserving our company culture as a large portion of our existing and newly hired workforce are working remotely on a permanent basis. If we fail to maintain our company culture or focus on our purpose, our business and competitive position may be harmed.

Our operations are geographically consolidated. A major tornado or other natural disaster within the region in which we operate could seriously disrupt our entire business.

Egg Central Station, our shell egg processing facility, is located in Springfield, Missouri. This facility and our network of family farms supporting our shell egg business are concentrated in the Midwestern portion of the Pasture Belt. The cream for our butter is sourced from two separate and distinct geographical areas, one area in the Midwest and one area in the Northeast. This supply encompasses a total of approximately 68 farms. Butter is manufactured in close proximity to the Midwest farm supply. The impact of natural disasters such as tornadoes, drought or flood within these areas is difficult to predict, particularly given the potential of climate change to increase the frequency and intensity of such natural disasters, but a natural disaster could seriously disrupt our entire business. Our insurance may not adequately cover our losses and expenses in the event of a natural disaster. As a result, natural disasters within these areas could lead to substantial losses.

46

Outbreaks of agricultural diseases, including avian influenza, the perception that outbreaks may occur or regulatory or market responses to outbreaks could reduce demand for our products and harm our business.

Our business activities are subject to a variety of agricultural risks, including pests and diseases such as avian influenza, which can materially and adversely affect the quality and quantity of products, including shell eggs, that we distribute.  While we are confident in the controls and procedures we maintain to reduce the risk to our farms and production facilities of disease, including with respect to the recent avian influenza outbreaks in the United States, if a substantial portion of our farms or production facilities were affected by an outbreak of disease such as avian influenza, this could have a material and adverse effect on our business, financial condition and results of operations.  Even if our farms and production facilities were not directly impacted by avian disease, we may nevertheless be negatively affected by resulting governmental restrictions on our operations and the sale and distribution of our products, as well as negative publicity and impacted consumer perceptions for our industry. For example, certain states in which our family farms are located have recommended or required during the 26-week period ended June 26, 2022, that farms keep hens indoors to help limit exposure to avian influenza. Prolonged requirements to keep our hens indoors could adversely impact consumer perception of our egg products in comparison to those of our competitors, which could have a negative effect on our business, financial condition and operating results.

Our inability to maintain our GFSI and SQF Select Site certifications may negatively affect our reputation.

The Safe Quality Food Institute administers the SQF Program, which is a third-party auditing program that examines and certifies food producers with respect to certain aspects of the producer’s business, including food safety, quality control and social, environmental and occupational health and safety management systems. The SQF Select Site certification is one of a number of available SQF certifications and involves both auditing for food safety issues and unannounced inspections by SQF personnel on an annual basis.

The Global Food Safety Initiative, or GFSI, is a private organization established and managed by an international trade association, The Consumer Goods Forum. GFSI operates a benchmarking scheme whereby certification bodies, such as the SQF Program, are “recognized” as meeting certain criteria maintained by GFSI. GFSI itself does not certify or accredit entities in the food industry.

SQF Select Site certification and the GFSI recognition of the SQF Program do not themselves have any independent legal significance and do not necessarily signal regulatory compliance. As a practice matter, however, certain retailers, including some of our largest customers, require SQF certification or certification by another GFSI-recognized program as a condition for doing business. Loss of SQF Select Site certification could impair our ability to do business with these customers, which could materially and adversely affect our business, financial condition and operating results.

Risks Related to Socioeconomic, Political and Environmental Factors

The COVID-19 pandemic could have a material adverse impact on our business, results of operations and financial condition.

In connection with the COVID-19 pandemic, governments have implemented significant measures, including closures, quarantines, travel restrictions and other social distancing directives, intended to control the spread of the virus. Companies have also taken precautions, such as requiring employees to work remotely, imposing travel restrictions and temporarily closing businesses. Certain of these restrictions were reinstated at various points during 2021 as a response to the emergence of new variants or increased rates of infection. To the extent that any such restrictions remain in place, additional prevention and mitigation measures are implemented in the future, or there is uncertainty about the effectiveness of these or any other measures to contain or treat COVID-19, there is likely to be an adverse impact on global economic conditions and consumer confidence and spending, which could materially and adversely affect our supply chain as well as the demand for our products. While at this time we are working to manage and mitigate potential disruptions to our supply chain, and we have not experienced decreases in demand or material financial impacts as compared to prior periods, the fluid nature of the COVID-19 pandemic and uncertainties regarding the related economic impact may result in sustained market turmoil, which could also negatively impact our business, financial condition and cash flows.

The impact of COVID-19 on any of our suppliers, co-manufacturers, distributors or transportation or logistics providers may negatively affect the price and availability of our raw materials and impact our supply chain. If the disruptions caused by COVID-19, including interruptions to global shipping that may impact our and our suppliers’ ability to access equipment and other materials, continue for an extended period of time, our ability to meet the demands of our customers or to expand as planned may be materially impacted. The COVID-19 vaccination rate in the State of Missouri currently is currently lower than the national rate, and the reported rates of infection and hospitalization due to COVID-19 in Greene County, Missouri, where our Egg Central Station shell egg processing facility is located, rose at certain points during the 26-week period ended June 26, 2022. If we are forced to scale back hours of operation or close this facility in response to the pandemic, or if the effects of COVID-19 or related mitigation measures make it difficult to adequately staff the facility to meet the demands of its expansion, our business, financial condition and results of operations would be materially and adversely affected.

47

In addition, any health and safety concerns and/or demands on agency resources related to the COVID-19 pandemic that prevent the FDA or USDA from conducting their regular regulatory activities could significantly impact the ability of these agencies to regulate our products, which could have a material adverse effect on our business.

The extent of COVID-19’s effect on our operational and financial performance will depend on future developments, including the duration, spread and intensity of the pandemic, the emergence of new variants and the adoption and effectiveness of vaccination programs and other actions intended to mitigate the effects of the pandemic, all of which are uncertain and difficult to predict considering the rapidly evolving landscape. As a result, it is not currently possible to ascertain the overall impact of COVID-19 on our business. However, if the pandemic continues to persist as a severe worldwide health crisis, the disease could have a material adverse effect on our business, financial condition results of operations and cash flows, and may also have the effect of heightening many of the other risks described in this “Risk Factors” section.

A U.S. federal government shutdown could have a material adverse impact on our results of operations and financial condition.

The partial shutdown of the U.S. federal government that began in late 2018 and continued into 2019 adversely impacted many of our family farmers’ ability to access capital, as these farmers receive funding through farm loan programs of the USDA Farm Service Agency. The partial shutdown also impacted our ability to receive governmental approvals for products and labeling of new products. Another U.S. federal government shutdown of similar or greater duration could similarly impact our business, which could have a material adverse effect on our results of operations and financial condition.

Disruptions in the worldwide economy may adversely affect our business, results of operations and financial condition.

Adverse and uncertain economic conditions, including uncertainty related to inflation, market volatility, the ongoing COVID-19 pandemic, or geopolitical tensions and wars, including the Russia-Ukraine war, may impact distributor, retailer, foodservice and consumer demand for our products. In addition, our ability to manage normal commercial relationships with our suppliers, co-manufacturers, distributors, retailers, foodservice consumers and creditors may suffer. Consumers may shift purchases to lower-priced or other perceived value offerings during economic downturns. In particular, consumers may reduce the amount of our egg products that they purchase where there are more affordable products, including caged, cage-free and free-range egg and egg product offerings, which generally have lower retail prices than our eggs. In addition, our products are sold to consumers at a premium price point, and in an economic downturn, consumers may choose to purchase private-label or commodity products rather than our products because they are generally less expensive. Further, our foodservice product sales will be reduced if consumers reduce the amount of food they consume away from home at our foodservice customers, whether in connection with the ongoing COVID-19 pandemic, or in other times of economic uncertainty. Distributors and customers may become more conservative in response to these conditions and seek to reduce their inventories. Our results of operations depend upon, among other things, our ability to maintain and increase sales volume with our existing distributors, retailer and foodservice customers, our ability to attract new consumers, the financial condition of our consumers and our ability to provide products that appeal to consumers at the right price. Prolonged unfavorable economic conditions may have an adverse effect on our sales and profitability.

Disruptions in international trade, including disruptions due to the ongoing COVID-19 pandemic and Russia-Ukraine war, may have a material adverse impact on us, our suppliers and our network of farms, including our ability to expand our operations as planned.

The global COVID-19 pandemic and the Russia-Ukraine war have disrupted international trade, resulting in increased shipping costs and delays in the import and export of goods to and from the United States and other countries. Specifically, the increased demand for international shipping has resulted in shortages of shipping containers and delays at international ports. We, our suppliers and our network of family farms are dependent on the import of equipment and other supplies from Europe and other locations.  To the extent that disruptions to global shipping, including disruptions due to COVID-19 pandemic or geopolitical tensions or wars, such as the Russia-Ukraine war, negatively impact our, our suppliers’ and our network of farms’ ability to access necessary goods, we may not be able to expand our operations as planned, and our business, financial condition and results of operations would be materially and adversely affected.

We are subject to risks related to heightened stakeholder focus on sustainability and corporate social responsibility.

Our business faces increasing scrutiny related to environmental, social and governance issues, including sustainable development, product packaging, renewable resources, environmental stewardship, supply chain management, climate change, diversity and inclusion, workplace conduct, human rights, philanthropy and support for local communities. If we fail to meet applicable standards or expectations with respect to these issues, including the expectations we establish for our own business, our reputation and brand image could be damaged, and our business, financial condition and results of operations could be adversely impacted.

48

Implementation of our environmental and sustainability initiatives, including in connection with our annual sustainability report, may require certain financial expenditures and employee resources, and if we are unable to meet our environmental, social and governance goals, this could have a material adverse effect on our reputation and brand and negatively impact our relationship with our investors, crew members, customers and consumers.

Climate change, or legal, regulatory or market efforts to address climate change, may negatively affect our business and operations.

There is growing concern that carbon dioxide and other greenhouse gases emissions may have an adverse impact on global temperatures, weather conditions, and the frequency and severity of natural disasters. If climate change has a negative effect on agricultural productivity, we may be subject to decreased availability or less favorable pricing for certain raw materials that are necessary for our products, including corn, soybean meal and other feed ingredients. We may further be subject to unpredictable water availability due to the impact of climate change, and the lack of available water may adversely affect our business and operations.

Additionally, extreme weather and natural disasters exacerbated by climate change may impact our business. The family farms in our network are all geographically located in a region that provides an environment conducive to year-round raising of chickens. However, if climate change has a negative effect on the year-round habitability of this region for chickens, we may be subject to decreased availability or less favorable pricing for our eggs. We may also incur increased transportation, storage and processing costs if we are unable to source products within a certain distance from Egg Central Station and co-manufacturing facilities due to the effects of climate change.

Governmental and market concern about climate change and its effects may result in additional legal or regulatory requirements to reduce or mitigate the effects of greenhouse gases or water usage. Such laws or regulations, to the extent applicable to us or our suppliers, co-manufacturers or service providers, may result in significant increases to our costs of operation, particularly the supply chain and distribution costs associated with our products.

Risks Related to Legal and Government Regulation

Food safety and food-borne illness incidents or advertising or product mislabeling may materially and adversely affect our business by exposing us to lawsuits, product recalls or regulatory enforcement actions, increasing our operating costs and reducing demand for our product offerings.

Selling food for human consumption involves inherent legal and other risks, and there is increasing governmental scrutiny of and public awareness regarding food safety. Illness, injury or death related to allergens, food-borne illnesses, foreign material contamination or other food safety incidents caused by our products, or involving our suppliers, could result in the disruption or discontinuance of sales of these products or our relationships with such suppliers, or otherwise result in increased operating costs, regulatory enforcement actions or harm to our reputation. For example, in December 2019, our co-manufacturer for hard-boiled eggs conducted a voluntary Class I recall of all hard-boiled eggs produced at its facility, including ours, due to a potential listeria contamination at the production facility. Our co-manufacturer elected to permanently close the affected production facility and move all production to a different facility, which did not have sufficient capacity to meet product demand. As a result, we were unable to supply customers with hard-boiled eggs for a period of time in the first quarter of fiscal 2020.

Shipment of adulterated or misbranded products, even if inadvertent, can result in criminal or civil liability. Such incidents could also expose us to product liability, negligence or other lawsuits, including consumer class action lawsuits. Any claims brought against us may exceed or be outside the scope of our existing or future insurance policy coverage or limits. Any judgment against us that is more than our policy limits or not covered by our policies or not subject to insurance would have to be paid from our cash reserves, which would reduce our capital resources.

The occurrence of food-borne illnesses or other food safety incidents could also adversely affect the price and availability of affected raw materials, resulting in higher costs, disruptions in supply and a reduction in our sales. Furthermore, any instances of food contamination or regulatory noncompliance, whether or not caused by our actions, could compel us, our suppliers, our distributors or our customers, depending on the circumstances, to conduct a recall in accordance with FDA or USDA regulations and policies, and comparable state laws. Food recalls could result in significant losses due to their costs, the destruction of product inventory, lost sales due to the unavailability of the product for a period of time and potential loss of existing distributors or customers and a potential negative impact on our ability to attract new customers due to negative consumer experiences or because of an adverse impact on our brand and reputation. The costs of a recall could be outside the scope of our existing or future insurance policy coverage or limits.

In addition, food companies have been subject to targeted, large-scale tampering as well as to opportunistic, individual product tampering, and we, like any food company, could be a target for product tampering. Forms of tampering could include the introduction of foreign material, chemical contaminants and pathological organisms into food products, as well as product substitution. Governmental regulations require companies like us to analyze, prepare and implement mitigation strategies specifically to address tampering designed to inflict widespread public health harm. If we do not adequately address the possibility, or any actual instance, of product tampering, we could face possible seizure or recall of our products and the imposition of civil or criminal sanctions, which could adversely affect our business, financial condition and operating results.

49

Our operations are subject to FDA and USDA federal regulation and state regulation, and there is no assurance that we will be in compliance with all regulations.

Our operations are subject to extensive regulation by the FDA, the USDA and other federal, state and local authorities. With respect to eggs in particular, the FDA and the USDA split jurisdiction depending on the type of product involved. While the FDA has primary responsibility for the regulation of shell eggs, the USDA has primary responsibility for the regulation of dried, frozen or liquid eggs and other “egg products,” subject to certain exceptions. Specifically, our shell eggs, butter, hard-boiled eggs, ghee, and convenient breakfast products are subject to the requirements of the Federal Food, Drug, and Cosmetic Act, as amended, or the FDCA, and regulations promulgated thereunder by the FDA. This comprehensive regulatory program governs, among other things, the manufacturing, composition and ingredients, packaging, labeling and safety of most food products. The FDA requires that facilities that manufacture food products comply with a range of requirements, including hazard analysis and preventative controls regulations, current good manufacturing practices, or cGMPs, and supplier verification requirements. Our shell egg operations are further subject to FDA regulatory requirements governing the production, storage and transportation of shell eggs for the control of salmonella. FDA-inspected processing facilities are subject to periodic and “for cause” inspection by federal, state and local authorities. In addition, certain of our products, such as our liquid whole egg and certain of our convenient breakfast products, are subject to regulation by the USDA, including facility registration, inspection, manufacturing and labeling requirements. We do not control the manufacturing processes of, and rely upon, our co-manufacturers for compliance with cGMPs and other regulatory requirements for the manufacturing of our products that is conducted by our co-manufacturers. If we or our co-manufacturers cannot successfully manufacture products that conform to our specifications and the strict regulatory requirements of the FDA, the USDA or others, we or they may be subject to adverse inspectional findings or enforcement actions, which could materially impact our ability to market our products, result in our co-manufacturers’ inability to continue manufacturing for us, result in a recall of our products that have already been distributed and result in damage to our brand and reputation. For example, in December 2019, our co-manufacturer for hard-boiled eggs conducted a voluntary Class I recall of all hard-boiled eggs produced at its facility, including ours, due to a potential listeria contamination at the production facility. We rely upon our co-manufacturers to maintain adequate quality control, quality assurance and qualified personnel. If the FDA, the USDA or another regulatory authority determines that we or these co-manufacturers have not complied with the applicable regulatory requirements, our business may be adversely impacted.

Our liquid whole eggs are subject to the requirements of the Egg Products Inspection Act, or EPIA, and regulations promulgated thereunder by the USDA. The USDA has comprehensive regulations in place that apply to establishments that break, dry and process shell eggs into liquid egg products. This regulatory scheme governs the manufacturing, processing, pasteurizations, packaging, labeling and safety of egg products. Under the EPIA and USDA regulations, establishments that manufacture egg products must comply with the USDA’s requirements for sanitation, temperature control, pasteurization and labeling. In addition, in September 2020, the USDA announced that it had finalized its Egg Products Inspection Rule. Pursuant to the regulatory requirements established by this rule, we anticipate that our co-manufacturers’ liquid whole egg establishment will be required to implement Hazard Analysis and Critical Control Point plans within two years after publication of the final rule in the Federal Register and will further be required to implement Sanitary Standard Operating Procedures within one year after publication in the Federal Register. Certain of our egg bite products that contain bacon and ham are also subject to USDA regulation, pursuant to the Federal Meat Inspection Act, or FMIA. The FMIA and USDA regulations establish registration, inspection, recordkeeping, labeling and other requirements governing certain products that contain meat, including our products. We do not control the manufacturing processes of, and rely upon, our co-manufacturers for compliance with USDA regulations for the manufacturing of our liquid whole egg, egg bite and breakfast bar products, which is conducted by our co-manufacturers. If we or our co-manufacturers cannot successfully manufacture products that conform to our specifications and the strict regulatory requirements of the USDA or others, we or they may be subject to adverse inspectional findings or enforcement actions, which could materially impact our ability to market our products, could result in our co-manufacturers’ inability to continue manufacturing for us, or could result in a recall of our product that has already been distributed. In addition, we rely upon our co-manufacturers to maintain adequate quality control, quality assurance and qualified personnel. If the USDA or a comparable foreign regulatory authority determines that we or these co-manufacturers have not complied with the applicable regulatory requirements, our business may be materially impacted.

In addition to regulation pursuant to the FDCA, EPIA and FMIA, some of our products are subject to the Agricultural Marketing Act of 1946, or the AMA. The AMA governs voluntary grade claims that appear on some of our products and are administered by the USDA Agricultural Marketing Service, or AMS. For instance, our shell eggs, including those handled by our co-manufacturers, are graded for quality by USDA AMS grading personnel. We do not control the processes in place on our contract farms or with our co-manufacturers (which can affect the assigned grade), and rely upon both to provide us quality, fresh products that meet our stringent quality standards. If we, or our network of family farms and co-manufacturers, cannot successfully manufacture products that confirm with our quality specifications or meet appropriate grading standards under the AMA, we may have difficulty marketing our products or may be required to source our products from other farms and co-manufacturers.

Our products that are labeled as “organic” are subject to the requirements of the Organic Foods Production Act, or OFPA, and the USDA’s National Organic Program, or NOP, regulations. The OFPA is a comprehensive regulatory scheme that mandates certain practices and prohibits other practices pertaining to the raising of animals and handling and processing of food products. We, and our network of family farms and co-manufacturers, contract with NOP-accredited certifying agents to ensure that our organic products are produced in compliance with the OFPA and NOP regulations. We do not control the farms where our products are raised and rely on

50

the farms for compliance with the on-farm requirements of the OFPA and NOP regulations. Similarly, we do not control the manufacturing processes of, and we rely upon, our co-manufacturers for compliance with requirements of the OFPA and NOP regulations with respect to organic products handled and manufactured by our co-manufacturers. If we, the farms or the co-manufacturers cannot successfully raise and manufacture products that meet the strict regulatory requirements of the OFPA and the NOP, we or they may be subject to adverse inspectional findings or enforcement actions, which could materially impact our ability to market our products as “organic,” could result in the farms or co-manufacturers’ inability to continue to raise farm products or manufacture food for us, or we, the farms, or the co-manufacturer could lose the right to market products as “organic,” and subject us, the farms, or co-manufacturers to civil monetary penalties. If the USDA or a comparable foreign regulatory authority determines that we or these co-manufacturers have not complied with the applicable regulatory requirements, our business may be materially impacted.

We are also subject to state and local regulations, including product requirements, labeling requirements and import restrictions. For example, the State of Iowa requires that grocery stores which participate in the Special Supplement Nutrition Program for Women, Infants, and Children, and which sell eggs produced by chickens advertised as being housed in cage-free, free-range or enriched colony cage environments, also sell “conventional” eggs produced by chickens that are not so advertised. That regulation impacted the space allocation for non-caged eggs on the shelves of retailers in Iowa and their willingness to carry our eggs. In addition, one or more states could pass regulations that establish requirements that our products would not satisfy. If our products fail to meet such individual state standards or are restricted from being imported into a state by regulatory requirements, our business, financial condition or results of operations could be materially and adversely affected.

We seek to comply with applicable regulations through a combination of employing internal experience and expert personnel to ensure quality assurance compliance (i.e., assuring that our products are not adulterated or misbranded) and contracting with third-party laboratories that conduct analyses of products to ensure compliance with nutrition labeling requirements and to identify any potential contaminants before distribution. Failure by us, the farms or the co-manufacturers to comply with applicable laws and regulations or maintain permits, licenses or registrations relating to our or our co-manufacturers’ operations could subject us to civil remedies or penalties, including fines, injunctions, recalls or seizures, warning letters, restrictions on the marketing or manufacturing of products, or refusals to permit the import or export of products, as well as potential criminal sanctions, which could result in increased operating costs resulting in a material effect on our operating results and business. See the section titled “—Government Regulation” in Part I, Item 1, “Business,” of our Annual Report on Form 10-K for further information on the regulations to which we are subject.

Changes in existing laws or regulations, or the adoption of new laws or regulations may increase our costs and otherwise adversely affect our business, results of operations and financial condition.

The manufacture and marketing of food products is highly regulated. We, our suppliers and our co-manufacturers are subject to a variety of laws and regulations. These laws and regulations apply to many aspects of our business, including the manufacture, packaging, labeling, distribution, advertising, sale, quality and safety of our products, as well as the health and safety of our crew members and the protection of the environment.

In the United States, we are subject to regulation by various government agencies, including the FDA, the USDA, the Federal Trade Commission, or FTC, the Occupational Safety and Health Administration, or OSHA, and the Environmental Protection Agency, or EPA, as well as various state and local agencies. We are also regulated outside the United States by various international regulatory bodies. In addition, we are subject to certain standards, such as GFSI standards and review by voluntary organizations, such as the Council of Better Business Bureaus’ National Advertising Division. We could incur costs, including fines, penalties and third-party claims, because of any violations of, or liabilities under, such requirements, including any competitor or consumer challenges relating to compliance with such requirements. For example, in connection with the marketing and advertisement of our products, we could be the target of claims relating to false or deceptive advertising, including under the auspices of the FTC and the consumer protection statutes of some states.

The regulatory environment in which we operate could change significantly and adversely in the future. Any change in manufacturing, labeling or packaging requirements for our products may lead to an increase in costs or interruptions in production, either of which could adversely affect our operations and financial condition. New or revised government laws and regulations could result in additional compliance costs and, in the event of non-compliance, civil remedies, including fines, injunctions, withdrawals, recalls or seizures and confiscations, as well as potential criminal sanctions, any of which may adversely affect our business, financial condition and results of operations.

51

Failure by our network of family farms, suppliers of raw materials or co-manufacturers to comply with food safety, environmental or other laws and regulations, or with the specifications and requirements of our products, may disrupt our supply of products and adversely affect our business.

If any of our family farms, suppliers or co-manufacturers fail to comply with food safety, environmental, health and safety or other laws and regulations, or face allegations of non-compliance, their operations may be disrupted and our reputation could be harmed. Additionally, the farms and co-manufacturers are required to maintain the quality of our products and to comply with our standards and specifications. In the event of actual or alleged non-compliance, we might be forced to find alternative farms, suppliers or co-manufacturers and we may be subject to lawsuits and/or regulatory enforcement actions related to such non-compliance by the farms, suppliers and co-manufacturers. As a result, our supply of eggs and other raw materials or finished inventory could be disrupted or our costs could increase, which would adversely affect our business, results of operations and financial condition. The failure of any partner farmer or co-manufacturer to produce products that conform to our standards could adversely affect our reputation in the marketplace and result in product recalls, product liability claims, government or third-party actions and economic loss. For example, in December 2019, our co-manufacturer for hard-boiled eggs conducted a voluntary Class I recall of all hard-boiled eggs produced at its facility, including ours, due to a potential listeria contamination at the production facility. Additionally, actions we may take to mitigate the impact of any disruption or potential disruption in our supply of eggs and other raw materials or finished inventory, including increasing inventory in anticipation of a potential supply or production interruption, may adversely affect our business, financial condition and results of operations.

We are subject to stringent environmental regulation and potentially subject to environmental litigation, proceedings and investigations.

Our business operations and ownership and past and present operation of real property are subject to stringent federal, state, and local environmental laws and regulations pertaining to the discharge of materials into the environment and natural resources. Violation of these laws and regulations could lead to substantial liabilities, fines and penalties or to capital expenditures related to pollution control equipment that could have a material adverse effect on our business. We could also experience in the future significant opposition from third parties with respect to our business, including environmental non-governmental organizations, neighborhood groups and municipalities. Additionally, new matters or sites may be identified in the future, including in connection with the potential expansion of our egg packing capacity, that will require additional environmental investigation, assessment, or expenditures, which could cause additional capital expenditures. Future discovery of contamination of property underlying or in the vicinity of our present, or future, properties or facilities and/or waste disposal sites could require us to incur additional expenses, delays to our business and to our proposed construction. The occurrence of any of these events, the implementation of new laws and regulations, or stricter interpretation of existing laws or regulations, could adversely affect our business, financial condition and results of operations.

Legal claims, government investigations or other regulatory enforcement actions could subject us to civil and criminal penalties.

We operate in a highly regulated environment with constantly evolving legal and regulatory frameworks. Consequently, we are subject to a heightened risk of legal claims, government investigations or other regulatory enforcement actions. Although we have implemented policies and procedures designed to ensure compliance with existing laws and regulations, there can be no assurance that our crew members, consultants, independent contractors, suppliers, co-manufacturers or distributors will not violate our policies and procedures. Moreover, a failure to maintain effective control processes could lead to violations, unintentional or otherwise, of laws and regulations. Legal claims, government investigations or regulatory enforcement actions arising out of our failure or alleged failure to comply with applicable laws and regulations could subject us to civil and criminal penalties that could materially and adversely affect our product sales, reputation, financial condition and operating results. In addition, the costs and other effects of defending potential and pending litigation and administrative actions against us may be difficult to determine and could adversely affect our financial condition and operating results.

Litigation or legal proceedings could expose us to significant liabilities and have a negative impact on our reputation or business.

From time to time, we may be party to various claims and litigation proceedings. We evaluate these claims and litigation proceedings to assess the likelihood of unfavorable outcomes and to estimate, if possible, the amount of potential losses. Based on these assessments and estimates, we may establish reserves, as appropriate. These assessments and estimates are based on the information available to management at the time and involve a significant amount of management judgment. Actual outcomes or losses may differ materially from our assessments and estimates. We are not currently party to any material litigation.

Even when not merited, the defense of these lawsuits may divert our management’s attention, and we may incur significant expenses in defending these lawsuits. The results of litigation and other legal proceedings are inherently uncertain, and adverse judgments or settlements in some of these legal disputes may result in adverse monetary damages, penalties or injunctive relief against us, which could have a material adverse effect on our financial position, cash flows or results of operations. Any claims or litigation, even if fully indemnified or insured, could damage our reputation and make it more difficult to compete effectively or to obtain adequate insurance in the future.

52

Furthermore, while we maintain insurance for certain potential liabilities, such insurance does not cover all types and amounts of potential liabilities and is subject to various exclusions and caps on amounts recoverable. Even if we believe a claim is covered by insurance, insurers may dispute our entitlement to recovery for a variety of potential reasons, which may affect the timing and, if the insurers prevail, the amount of our recovery.

Risks Related to Our Status as a Certified B Corporation and Public Benefit Corporation

Our status as a public benefit corporation and a Certified B Corporation may not result in the benefits that we anticipate.

We have elected to be classified as a public benefit corporation under Delaware law. As a public benefit corporation, we are required to balance the financial interests of our stockholders with the best interests of those stakeholders materially affected by our conduct, including particularly those affected by the specific benefit purposes set forth in our amended and restated certificate of incorporation. In addition, there is no assurance that the expected positive impact from being a public benefit corporation will be realized. Accordingly, being a public benefit corporation and complying with our related obligations could negatively impact our ability to provide the highest possible return to our stockholders.

As a public benefit corporation, we are required to disclose to stockholders a report at least biennially on our overall public benefit performance and on our assessment of our success in achieving our specific public benefit purpose, which we may disclose through our annual report and proxy statement for our annual meeting of stockholders made available to our stockholders each year. If we are not timely or are unable to provide this report, or if the report is not viewed favorably by parties doing business with us or regulators or others reviewing our credentials, our reputation and status as a public benefit corporation may be harmed.

While not required by Delaware law or the terms of our certificate of incorporation, we have elected to have our social and environmental performance, accountability and transparency assessed against the proprietary criteria established by B Lab, an independent non-profit organization. As a result of this assessment, we have been designated as a “Certified B Corporation,” which refers to companies that are certified as meeting certain levels of social and environmental performance, accountability and transparency. The standards for Certified B Corporation certification are B Lab and may change over time, and our continued certification is at the sole discretion of B Lab. To maintain our certification, we are required to update our assessment and verify our updated score with B Lab every three years. We were most recently recertified as a Certified B Corporation in January 2022. Our reputation could be harmed if we lose our status as a Certified B Corporation, whether by our choice or by our failure to continue to meet the certification requirements, if that failure or change were to create a perception that we are more focused on financial performance and are no longer as committed to the values shared by Certified B Corporations. Likewise, our reputation could be harmed if our publicly reported Certified B Corporation score declines.

As a public benefit corporation, our duty to balance a variety of interests may result in actions that do not maximize stockholder value.

As a public benefit corporation, our board of directors has a duty to balance (i) the pecuniary interest of our stockholders, (ii) the best interests of those materially affected by our conduct and (iii) specific public benefits identified in our amended and restated certificate of incorporation. While we believe our public benefit designation and obligation will benefit our stockholders, in balancing these interests our board of directors may take actions that do not maximize stockholder value. Any benefits to stockholders resulting from our public benefit purposes may not materialize within the timeframe we expect or at all and may have negative effects. For example:

• we may choose to revise our policies in ways that we believe will be beneficial to stakeholders other than our stockholders, including farmers, suppliers, crew members and local communities, even though the changes may be costly;

• we may take actions, such as building state-of-the-art facilities with technology and quality control mechanisms that exceed the requirements of USDA and the FDA, even though these actions may be more costly than other alternatives;

• we may be influenced to pursue programs and services to demonstrate our commitment to the communities to which we serve and bringing ethical food to the table, even though there is no immediate return to our stockholders; or

• in responding to a possible proposal to acquire the company, our board of directors may be influenced by the interests of stakeholders other than our stockholders, including farmers, suppliers, crew members and local communities, whose interests may be different from the interests of our stockholders.

We may be unable or slow to realize the benefits we expect from actions taken to benefit our stakeholders, including farmers, suppliers, crew members and local communities, which could adversely affect our business, financial condition and results of operations, which in turn could cause our stock price to decline.

53

As a public benefit corporation, we may be subject to increased derivative litigation concerning our duty to balance stockholder and public benefit interests, the occurrence of which may have an adverse impact on our financial condition and results of operations.

As a Delaware public benefit corporation, our stockholders (if they, individually or collectively, own at least 2% of our outstanding capital stock or shares having at least $2 million in market value (whichever is less)) are entitled to file a derivative lawsuit claiming that our directors failed to balance stockholder and public benefit interests. This potential liability does not exist for traditional corporations. Therefore, we may be subject to the possibility of increased derivative litigation, which would require the attention of management and, as a result, may adversely impact management’s ability to effectively execute our strategy. Any such derivative litigation may be costly and have an adverse impact on our financial condition and results of operations.

Risks Related to Being a Public Company

If we fail to maintain an effective system of internal control over financial reporting in the future, we may not be able to accurately report our financial condition, results of operations or cash flows, which may adversely affect investor confidence in us and, as a result, the value of our common stock.

The Sarbanes-Oxley Act requires, among other things, that we maintain effective internal controls for financial reporting and disclosure controls and procedures. We are required, under Section 404 of the Sarbanes-Oxley Act, or Section 404, to furnish a report by management on, among other things, the effectiveness of our internal control over financial reporting. This assessment must include disclosure of any material weaknesses identified by our management in our internal control over financial reporting. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting that results in more than a reasonable possibility that a material misstatement of annual or interim financial statements will not be prevented or detected on a timely basis. Section 404 also generally requires an attestation from our independent registered public accounting firm on the effectiveness of our internal control over financial reporting. However, for as long as we remain an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012, or JOBS Act, we intend to take advantage of the exemption permitting us not to comply with the independent registered public accounting firm attestation requirement.

Our compliance with Section 404 will require that we continue to incur substantial expense and expend significant management efforts. We may not be able to complete our evaluation, testing and any required remediation in a timely fashion. During the evaluation and testing process, if we identify one or more material weaknesses in our internal control over financial reporting, we will be unable to assert that our internal control over financial reporting is effective. We cannot assure you that there will not be material weaknesses or significant deficiencies in our internal control over financial reporting in the future. Any failure to maintain internal control over financial reporting could severely inhibit our ability to accurately report our financial condition, results of operations or cash flows. If we are unable to conclude that our internal control over financial reporting is effective, or if our independent registered public accounting firm determines we have a material weakness or significant deficiency in our internal control over financial reporting once that firm conducts its Section 404 reviews, we could lose investor confidence in the accuracy and completeness of our financial reports, the market price of our common stock could decline, and we could be subject to sanctions or investigations by The Nasdaq Stock Market LLC, or Nasdaq, the SEC or other regulatory authorities. Failure to remedy any material weakness in our internal control over financial reporting, or to implement or maintain other effective control systems required of public companies, could also restrict our future access to the capital markets.

We are an “emerging growth company,” and we cannot be certain if the reduced reporting and disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors.

We are an “emerging growth company,” as defined in the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including the auditor attestation requirements of Section 404, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Pursuant to Section 107 of the JOBS Act, as an emerging growth company, we have elected to use the extended transition period for complying with new or revised accounting standards until those standards would otherwise apply to private companies. As a result, our consolidated financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective dates for new or revised accounting standards that are applicable to public companies, which may make our common stock less attractive to investors. In addition, if we cease to be an emerging growth company, we will no longer be able to use the extended transition period for complying with new or revised accounting standards.

We will remain an emerging growth company until the earliest of: (1) December 28, 2025; (2) the last day of the first fiscal year in which our annual gross revenue is $1.07 billion or more; (3) the date on which we have, during the previous rolling three-year period, issued more than $1 billion in non-convertible debt securities; and (4) the last day of the fiscal year in which the market value of our common stock held by non-affiliates exceeded $700 million as of the last business day of the second fiscal quarter of such fiscal year.

54

We cannot predict if investors will find our common stock less attractive if we choose to rely on these exemptions. For example, if we do not adopt a new or revised accounting standard, our future results of operations may not be as comparable to the results of operations of certain other companies in our industry that adopted such standards. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock, and our stock price may be more volatile.

We have incurred and will continue to incur increased costs as a result of operating as a public company, and our management will be required to devote substantial time to compliance with our public company responsibilities and corporate governance practices.

As a public company, we have incurred and will continue to incur significant finance, legal, accounting, and other expenses, including director and officer liability insurance. We expect that these expenses will increase further after we are no longer an “emerging growth company.” The Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the listing requirements of Nasdaq and other applicable securities rules and regulations impose various requirements on public companies. Our management and other personnel devote a substantial amount of time toward compliance with these requirements. Moreover, these rules and regulations have increased and will continue to increase our legal and financial compliance costs and time commitments.

Risks Related to Information Technology and Intellectual Property

We rely on information technology systems and any inadequacy, failure, interruption or security breaches of those systems may harm our ability to effectively operate our business.

We are dependent on various information technology systems, including, but not limited to, networks, applications and outsourced services in connection with the operation of our business. A failure of our information technology systems to perform as we anticipate could disrupt our business and result in transaction errors, processing inefficiencies and loss of sales, causing our business to suffer. In addition, while we have not experienced a material information security breach in the last three years, our information technology systems may be vulnerable to damage or interruption from circumstances beyond our control, including fire, natural disasters, systems failures, viruses and security breaches. Any such damage or interruption could have an adverse effect on our business.

A cybersecurity incident or other technology disruptions could negatively impact our business and our relationships with customers and consumers.

We use computers in substantially all aspects of our business operations. We also use mobile devices, social networking and other online activities to connect with our crew members, suppliers, co-manufacturers, distributors, customers and consumers. Such uses give rise to cybersecurity risks, including security breaches, espionage, system disruption, theft and inadvertent release of information. Cybersecurity incidents are increasing in their frequency, sophistication and intensity, with third-party phishing and social engineering attacks in particular increasing in connection with the COVID-19 pandemic. Our business involves sensitive information and intellectual property, including customers’, distributors’ and suppliers’ information, private information about crew members and financial and strategic information about us and our business partners. Further, as we pursue new initiatives that improve our operations and cost structure, we also intend to expand and improve our information technologies, resulting in a larger technological presence and corresponding exposure to cybersecurity risk. If we fail to assess and identify cybersecurity risks associated with new initiatives, we may become increasingly vulnerable to such risks.

In 2021, we launched an online ordering platform, and in connection with this platform, our third-party service providers may collect, store, process, and use personal and payment information and other customer and consumer data. Any breach of our data security or that of our service providers could result in an unauthorized release or transfer of information or the loss of valuable business data or cause a disruption in our business. Any such breach could result in harm to our brand and exposure to losses, litigation or regulatory proceedings.

While we have implemented measures to prevent security breaches and cyber incidents, our preventative measures and incident response efforts may not be entirely effective. The theft, destruction, loss, misappropriation or release of sensitive information or intellectual property, or interference with our information technology systems or the technology systems of third parties on which we rely, could result in business disruption, negative publicity, brand damage, violation of privacy laws, loss of customers and distributors, potential liability and competitive disadvantage all of which could have an adverse effect on our business, financial condition or results of operations.

Such risks may be heightened by the fact that a large portion of our existing and newly hired crew members are working remotely on a permanent basis. Technologies and security systems in place at our crew members’ homes may be less secure than those used in a physical office, and while we have implemented controls and safeguards to help protect our systems as our crew members work from home, we may nevertheless be subject to increased cybersecurity risk, which could expose us to risks of data or financial loss, resulting in an adverse impact on our business, financial condition or results of operations.

55

The loss of any registered trademark or other intellectual property could enable other companies to compete more effectively with us.

We utilize intellectual property in our business. Our trademarks are valuable assets that reinforce our brand and consumers’ favorable perception of our products. We have invested a significant amount of money in establishing and promoting our trademarked brands. We also rely on unpatented proprietary expertise and copyright protection to develop and maintain our competitive position. Our continued success depends, to a significant degree, upon our ability to protect and preserve our intellectual property, including our trademarks and copyrights.

We rely on confidentiality agreements and trademark and copyright law to protect our intellectual property rights. Our confidentiality agreements with our crew members and certain of our consultants, contract employees, suppliers and independent contractors, including some of our co-manufacturers who use our formulations to manufacture our products, generally require that all information made known to them be kept strictly confidential. Further, some of our formulations have been developed by or with our suppliers and co-manufacturers. As a result, we may not be able to prevent others from using similar formulations.

We cannot be certain that the steps we have taken to protect our intellectual property rights are adequate, that our intellectual property rights can be successfully defended and asserted in the future or that third parties will not infringe upon or misappropriate any such rights. In addition, our trademark rights and related registrations may be challenged in the future and could be canceled or narrowed. Failure to protect our trademark rights could prevent us in the future from challenging third parties who use names and logos similar to our trademarks, which may in turn cause consumer confusion or negatively affect consumers’ perception of our brand and products. Moreover, intellectual property disputes and proceedings and infringement claims may result in a significant distraction for management and significant expense, which may not be recoverable regardless of whether we are successful. Such proceedings may be protracted with no certainty of success, and an adverse outcome could subject us to liabilities, force us to cease use of certain trademarks or other intellectual property or force us to enter into licenses with others. Any one of these occurrences may have an adverse effect on our business, financial condition and results of operations.

Risks Related to Ownership of Our Common Stock and Other General Risks

Our stock price may be volatile, and the value of our common stock may decline.

The market price of our common stock may be highly volatile and may fluctuate or decline substantially as a result of a variety of factors, some of which are beyond our control, including:

• actual or anticipated fluctuations in our financial condition or results of operations;

• variance in our financial performance from expectations of securities analysts;

• changes in our projected operating and financial results;

• announcements by us or our competitors of significant business developments, acquisitions or new offerings;

• announcements or concerns regarding real or perceived quality or health issues with our products or similar products of our competitors;

• adoption of new regulations applicable to the food industry or the expectations concerning future regulatory developments;

• our involvement in litigation;

• sales of our common stock by us or our stockholders, as well as the anticipation of lock-up releases;

• changes in senior management or key personnel;

• the trading volume of our common stock; and

• changes in the anticipated future size and growth rate of our market.

Broad market and industry fluctuations, as well as general economic, political, regulatory and market conditions, may also negatively impact the market price of our common stock, particularly in light of uncertainties surrounding inflation, geopolitical tensions, and the ongoing COVID-19 pandemic and related impacts.

An active public market for our common stock may not develop or be sustained.

Prior to the closing of our IPO on August 4, 2020, no public market for our common stock existed. An active public trading market for our common stock may not continue to develop or, if further developed, may not be sustained. The lack of an active market

56

may impair your ability to sell your shares at the time you wish to sell them or at a price that you consider reasonable. The lack of an active market may also reduce the fair value of your shares. An inactive market may also impair our ability to raise capital to continue to fund operations by selling shares and may impair our ability to acquire other companies by using our shares as consideration.

Insiders have substantial control over us and will be able to influence corporate matters.

Based on the number of shares outstanding as of June 26, 2022, our directors, and officers hold, in the aggregate, approximately 27% of our outstanding capital stock. As a result, these stockholders are able to exercise significant influence over all matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions, such as a merger or other sale of our company or its assets. This concentration of ownership could limit stockholders’ ability to influence corporate matters, including, but not limited to, delaying or preventing a third party from acquiring control over us.

Sales of our common stock in the public market could cause the market price of our common stock to decline.

Sales of a substantial number of shares of our common stock in the public market, or the perception that these sales might occur, could depress the market price of our common stock and could impair our ability to raise capital through the sale of additional equity securities. Many of our existing equity holders have substantial unrecognized gains on the value of the equity they hold, and therefore they may take steps to sell their shares or otherwise secure the unrecognized gains on those shares. We are unable to predict the timing of or the effect that such sales may have on the prevailing market price of our common stock.

In addition, as of June 26, 2022, there were 5,226,124 shares of common stock issuable upon the exercise of outstanding stock options or subject to vesting of outstanding restricted stock awards. We have registered all of the shares of common stock issuable upon exercise of outstanding stock options, vesting of outstanding restricted stock awards or other equity incentives we may grant in the future, for public resale under the Securities Act of 1933, as amended, or the Securities Act. The shares of common stock will become eligible for sale in the public market to the extent such options are exercised, subject to the lock-up agreements described above and compliance with applicable securities laws.

Further, based on shares outstanding as of June 26, 2022, holders of approximately 13.4 million shares of our capital stock and certain shares that may be issued in the future upon exercise or vesting of outstanding equity awards, have rights, subject to some conditions, to require us to file registration statements covering the sale of their shares or to include their shares in registration statements that we may file for ourselves or other stockholders.

Our issuance of additional capital stock in connection with financings, acquisitions, investments, our equity incentive plans or otherwise will dilute all other stockholders.

We expect to issue additional capital stock in the future that will result in dilution to all other stockholders. We expect to grant equity awards to employees, directors and consultants under our equity incentive plans. We may also raise capital through equity financings in the future. As part of our business strategy, we may acquire or make investments in companies and issue equity securities to pay for any such acquisition or investment. Any such issuances of additional capital stock may cause stockholders to experience significant dilution of their ownership interests and the per share value of our common stock to decline.

If securities or industry analysts do not publish research or publish unfavorable or inaccurate research about our business, the market price and trading volume of our common stock could decline.

The market price and trading volume of our common stock is heavily influenced by the way analysts interpret our financial information and other disclosures. We do not have control over these analysts. If few securities analysts commence coverage of us, or if industry analysts cease coverage of us, our stock price would be negatively affected. If securities or industry analysts do not publish research or reports about our business, downgrade our common stock, or publish negative reports about our business, our stock price would likely decline. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, demand for our common stock could decrease, which might cause our stock price to decline and could decrease the trading volume of our common stock.

We do not intend to pay dividends for the foreseeable future.

While we have previously paid cash dividends on our capital stock, we do not intend to pay any cash dividends in the foreseeable future. Any determination to pay dividends in the future will be at the discretion of our board of directors. Accordingly, you may need to rely on sales of our common stock after price appreciation, which may never occur, as the only way to realize any future gains on your investment.

57

We may be subject to significant liability that is not covered by insurance.

Although we believe that the extent of our insurance coverage is consistent with industry practice, any claim under our insurance policies may be subject to certain exceptions, may not be honored fully, in a timely manner, or at all, and we may not have purchased sufficient insurance to cover all losses incurred. If we were to incur substantial liabilities or if our business operations were interrupted for a substantial period of time, we could incur costs and suffer losses. Such inventory and business interruption losses may not be covered by our insurance policies. Any significant uninsured liability may require us to pay substantial amounts, which would adversely affect our cash position and results of operations. Additionally, in the future, insurance coverage may not be available to us at commercially acceptable premiums, or at all.

Increases in interest rates could adversely affect our business.

Our business and operating results could be harmed by factors such as the availability, terms of and cost of capital and increases in interest rates. These changes could cause our cost of doing business to increase and limit our ability to pursue growth opportunities. Disruptions and volatility in the global financial markets may lead to a contraction in credit availability impacting our ability to finance our operations. A significant reduction in cash flows from operations or the availability of credit could materially and adversely affect our ability to achieve planned growth and operating results.  

Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of our company more difficult, limit attempts by our stockholders to replace or remove our current management and limit the market price of our common stock.

Provisions in our amended and restated certificate of incorporation and amended and restated bylaws, and provisions of Delaware law applicable to us as a public benefit corporation, may have the effect of delaying or preventing a change of control or changes in our management. Our amended and restated certificate of incorporation and amended and restated bylaws include provisions that:

• authorize our board of directors to issue, without further action by the stockholders, shares of undesignated preferred stock that may be senior to our common stock with terms, rights and preferences determined by our board of directors;

• require that any action to be taken by our stockholders be effected at a duly called annual or special meeting and not by written consent;

• specify that special meetings of our stockholders can be called only by our board of directors, the chairperson of our board of directors, or our chief executive officer;

• establish an advance notice procedure for stockholder proposals to be brought before an annual meeting, including proposed nominations of persons for election to our board of directors;

• establish that our board of directors is divided into three classes, with each class serving three-year staggered terms;

• prohibit cumulative voting in the election of directors;

• provide that our directors may be removed for cause only upon the vote of at least 66 2/3% of our outstanding shares of voting stock; and

• provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even though less than a quorum.

These provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management. In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the General Corporation Law of the State of Delaware, or DGCL, which generally, subject to certain exceptions, prohibits a Delaware corporation from engaging in any of a broad range of business combinations with any “interested” stockholder for a period of three years following the date on which the stockholder became an “interested” stockholder.

Also, as a public benefit corporation, our board of directors is required by the DCGL to manage or direct our business and affairs in a manner that balances the pecuniary interests of our stockholders, the best interests of those materially affected by our conduct, and the specific public benefits identified in our certificate of incorporation. Additionally, pursuant to our amended and restated certificate of incorporation, a vote of at least 66 2/3% of our outstanding shares of voting stock is required for matters directly or indirectly amending or removing our public benefit purpose, or to effect a merger or consolidation involving stock consideration with an entity that is not a public benefit corporation with an identical public benefit to ours. These provisions may make it more difficult for another party to obtain control of us without maintaining our public benefit corporation status and purpose. Any of the foregoing provisions could limit the price that investors might be willing to pay in the future for shares of our common stock, and they could deter potential acquirers of our company, thereby reducing the likelihood that you would receive a premium for your shares of our common stock in an acquisition.

58

Our amended and restated certificate of incorporation designates the Court of Chancery of the State of Delaware and, with respect to certain matters, the federal district courts of the United States of America as the exclusive forums for substantially all disputes between us and our stockholders, which could restrict our stockholders’ ability to choose the judicial forum for disputes with us or our directors, officers, or employees.

Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware (or, if and only if the Court of Chancery of the State of Delaware lacks subject matter jurisdiction, any state court located within the State of Delaware or, if and only if all such state courts lack subject matter jurisdiction, the federal district court for the District of Delaware) is the exclusive forum for the following types of actions or proceedings under Delaware statutory or common law: any derivative action or proceeding brought on our behalf; any action asserting a breach of a fiduciary duty; any action asserting a claim against us arising pursuant to the DGCL, our amended and restated certificate of incorporation or our amended and restated bylaws; any action as to which the DCGL confers jurisdiction to the court of Chancery of the State of Delaware; or any action asserting a claim against us that is governed by the internal affairs doctrine. The provisions would not apply to suits brought to enforce a duty or liability created by the Exchange Act of 1934, as amended, or the Exchange Act, or any other claim for which federal courts have exclusive jurisdiction.

Furthermore, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our amended and restated certificate of incorporation provides that the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act.

These choice of forum provisions may limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage lawsuits against us and our directors, officers and other employees. While Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring such a claim arising under the Securities Act against us and our directors, officers or other employees in a venue other than in the federal district courts of the United States of America. In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our amended and restated certificate of incorporation. This may require further significant additional costs associated with resolving the dispute in other jurisdictions, and there can be no assurance that the provisions will be enforced by a court in those other jurisdictions, any of which could seriously harm our business.

59

Item 2. Unregistered Sale of Equity Securities and Use of Proceeds

Recent Sales of Unregistered Equity Securities

None.

Use of Proceeds

Use of Proceeds from the IPO

On August 4, 2020, we completed our IPO, from which we received net proceeds of approximately $99.7 million, after deducting underwriting discounts and commissions of $7.8 million and offering expenses of $3.4 million. The offer and sale of the shares in our IPO were registered under the Securities Act on Registration Statement on Form S-1 (Registration No. 333-239772), which was declared effective on July 30, 2020.

There has been no material change in the planned use of proceeds from our IPO as described in the prospectus that formed a part of the Registration Statement. We invested the funds received in cash equivalents, other marketable securities and investments in accordance with our investment policy.  As of June 26, 2022, we have used an aggregate of $32.2 million of the IPO proceeds, including $7.3 million to pay off our term loan, $1.9 million to pay off our equipment loan in 2020 and $23 million for the expansion of Egg Central Station.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

60

Item 6. Exhibits.

Exhibit Number	Description
3.1	Amended and Restated Certificate of Incorporation, as currently in effect (incorporated herein by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K (File No. 001-39411), filed with the SEC on August 4, 2020).
3.2	Amended and Restated Bylaws, as currently in effect (incorporated herein by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K (File No. 001-39411), filed with the SEC on August 4, 2020).
10.1+	Second Amended and Restated Employment Agreement between the Company and Russell Diez-Canseco, dated April 1, 2022. (incorporated herein by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q (File No. 001-39411), filed with the SEC on May 5, 2022).
10.2+	Second Amended and Restated Employment Agreement between the Company and Jason Dale, dated April 1, 2022. (incorporated herein by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q (File No. 001-39411), filed with the SEC on May 5, 2022).
10.3+	Change in Control Severance Plan, effective March 31, 2022, and form of Participation Agreement, (incorporated herein by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q (File No. 001-39411), filed with the SEC on May 5, 2022).
31.1	Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	Inline XBRL Instance Document
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover page interactive data file (formatted as Inline XBRL and contained in Exhibit 101)

+ Indicates a management contract or compensatory plan.

* Furnished herewith and not deemed to be “filed” for purposes of Section 18 of the Exchange Act, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.

61

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Vital Farms, Inc.
Dated: August 4, 2022	By:	/s/ Russell Diez-Canseco
		Russell Diez-Canseco
		President and Chief Executive Officer (Principal Executive Officer)
Dated: August 4, 2022	By:	/s/ Bo Meissner
		Bo Meissner
		Chief Financial Officer (Principal Financial Officer)

62

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Russel Diez-Canseco, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Vital Farms, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;  

(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 4, 2022	By:	/s/ Russell Diez-Canseco
		Russell Diez-Canseco
		President and Chief Executive Officer (Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Bo Meissner, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Vital Farms, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;  

(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 4, 2022	By:	/s/ Bo Meissner
		Bo Meissner
		Chief Financial Officer (Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350),Russell Diez-Canseco, President and Chief Executive Officer of Vital Farms, Inc. (the “Company”), and Bo Meissner, Chief Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:

1. The Company’s Quarterly Report on Form 10-Q for the period ended June 26, 2022, to which this Certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and

2. The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:  August 4, 2022

IN WITNESS WHEREOF, the undersigned have set their hands hereto as of the 4th day of August, 2022.

/s/ Russell Diez-Canseco	/s/ Bo Meissner
Russell Diez-Canseco	Bo Meissner
President and Chief Executive Officer (Principal Executive Officer)	Chief Financial Officer (Principal Financial Officer)

This certification accompanies the Quarterly Report on Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Vital Farms, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Quarterly Report on Form 10-Q), irrespective of any general incorporation language contained in such filing. 

XML

Document and Entity Information - shares	6 Months Ended
	Jun. 26, 2022	Aug. 01, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 26, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-26
Entity Registrant Name	Vital Farms, Inc.
Entity Central Index Key	0001579733
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Security 12b Title	Common Stock, par value $0.0001 per share
Trading Symbol	VITL
Security Exchange Name	NASDAQ
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-39411
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-0496985
Entity Address, Address Line One	3601 South Congress Avenue
Entity Address, Address Line Two	Suite C100
Entity Address, City or Town	Austin
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	78704
City Area Code	877
Local Phone Number	455-3063
Entity Common Stock, Shares Outstanding		40,680,033

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 26, 2022	Dec. 26, 2021
Current assets:
Cash and cash equivalents	$ 22,082	$ 30,966
Investment securities, available-for-sale	68,257	68,621
Accounts receivable, net	31,110	26,938
Inventories	19,100	10,945
Prepaid expenses and other current assets	2,797	3,817
Total current assets	143,346	141,287
Property, plant and equipment, net	47,887	44,608
Operating lease right-of-use assets	2,578
Goodwill	3,858	3,858
Other assets	2,511	189
Total assets	200,180	189,942
Current liabilities:
Accounts payable	25,258	22,520
Accrued liabilities	19,145	15,143
Operating lease liabilities	1,425
Finance lease liabilities	88	327
Income taxes payable	112
Total current liabilities	46,028	37,990
Operating lease liabilities, non-current	1,377
Other liabilities	210	192
Total liabilities	47,615	38,182
Commitments and contingencies (Note 15)
Stockholders’ equity:
Common stock, $0.0001 par value per share, 310,000,000 shares authorized as of June 26, 2022 and December 26, 2021; 40,679,414 and 40,493,969 shares issued and outstanding as of June 26, 2022 and December 26, 2021, respectively	5	5
Additional paid-in capital	152,317	149,000
Retained earnings	1,571	2,746
Accumulated other comprehensive loss	(1,447)	(281)
Total stockholders’ equity attributable to Vital Farms, Inc. stockholders	152,446	151,470
Noncontrolling interests	(56)	115
Total stockholders’ equity	152,390	151,585
Total liabilities, redeemable noncontrolling interest, and stockholders’ equity	200,180	189,942
Variable Interest Entity, Primary Beneficiary
Current liabilities:
Redeemable noncontrolling interest	$ 175	$ 175

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 26, 2022	Dec. 26, 2021
Statement Of Financial Position [Abstract]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	310,000,000	310,000,000
Common stock, shares issued	40,679,414	40,493,969
Common stock, shares outstanding	40,679,414	40,493,969

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2022	Jun. 27, 2021	Jun. 26, 2022	Jun. 27, 2021
Income Statement [Abstract]
Net revenue	$ 82,870	$ 60,324	$ 159,929	$ 118,869
Cost of goods sold	57,931	38,391	113,289	75,606
Gross profit	24,939	21,933	46,640	43,263
Operating expenses:
Selling, general and administrative	17,007	13,544	34,632	26,726
Shipping and distribution	7,211	5,374	15,373	10,437
Total operating expenses	24,218	18,918	50,005	37,163
Income (loss) from operations	721	3,015	(3,365)	6,100
Other income (expense), net:
Interest expense	(7)	(13)	(15)	(31)
Other income (expense), net	158	186	337	297
Total other income (expense), net	151	173	322	266
Net income (loss) before income taxes	872	3,188	(3,043)	6,366
Income tax provision (benefit)	680	(695)	(1,697)	(999)
Net income (loss)	192	3,883	(1,346)	7,365
Less: Net loss attributable to noncontrolling interests	(7)	(24)	(8)	(34)
Net income (loss) attributable to Vital Farms, Inc. common stockholders	$ 199	$ 3,907	$ (1,338)	$ 7,399
Net income (loss) per share attributable to Vital Farms, Inc. stockholders:
Basic:	$ 0.00	$ 0.10	$ (0.03)	$ 0.19
Diluted:	$ 0.00	$ 0.09	$ (0.03)	$ 0.17
Weighted average common shares outstanding:
Basic:	40,628,416	40,000,136	40,580,598	39,767,127
Diluted:	42,694,767	43,375,668	40,580,598	43,444,101

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2022	Jun. 27, 2021	Jun. 26, 2022	Jun. 27, 2021
Statement Of Income And Comprehensive Income [Abstract]
Net income (loss)	$ 192	$ 3,883	$ (1,346)	$ 7,365
Other comprehensive loss
Unrealized holding loss on available-for-sale securities, net of deferred tax benefit of $118 and $7 for the 13-weeks ended June 26, 2022 and June 27, 2021, respectively and $361 and $14 for the 26-weeks ended June 26, 2022 and June 27, 2022, respectively	(383)	(26)	(1,166)	(48)
Total comprehensive (loss) income	$ (191)	$ 3,857	$ (2,512)	$ 7,317

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2022	Jun. 27, 2021	Jun. 26, 2022	Jun. 27, 2021
Statement Of Income And Comprehensive Income [Abstract]
Unrealized holding loss on available-for-sale securities, tax	$ 118	$ 7	$ 361	$ 14

XML

CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTEREST AND STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Variable Interest Entity, Primary Beneficiary	Redeemable Noncontrolling Interest Variable Interest Entity, Primary Beneficiary	Common Stock	Treasury Stock	Additional Paid-In Capital	Retained Earnings (Deficit)	Accumulated Other Comprehensive Loss	Total Stockholders' Equity Attributable to Vital Farms, Inc. Stockholders	Noncontrolling Interests
Beginning balance at Dec. 27, 2020	$ 142,211			$ 5	$ (16,276)	$ 144,311	$ 14,039	$ (31)	$ 142,048	$ 163
Beginning balance at Dec. 27, 2020			$ 175
Beginning balance, shares at Dec. 27, 2020				44,938,958	(5,494,918)
Exercise of stock options	525					525			525
Exercise of stock options, Shares				300,266
Stock-based compensation expense	853					853			853
Net loss attributable to non- controlling interests - stockholders	(11)									(11)
Other comprehensive loss, net	(22)							(22)	(22)
Net income (loss) attributable to Vital Farms, Inc. stockholders	3,491						3,491		3,491
Ending balance at Mar. 28, 2021	147,047			$ 5	$ (16,276)	145,689	17,530	(53)	146,895	152
Ending balance at Mar. 28, 2021			175
Ending balance, shares at Mar. 28, 2021				45,239,224	(5,494,918)
Beginning balance at Dec. 27, 2020	142,211			$ 5	$ (16,276)	144,311	14,039	(31)	142,048	163
Beginning balance at Dec. 27, 2020			175
Beginning balance, shares at Dec. 27, 2020				44,938,958	(5,494,918)
Net loss attributable to non- controlling interests - stockholders	(34)
Net income (loss) attributable to Vital Farms, Inc. stockholders	7,399
Ending balance at Jun. 27, 2021	153,023			$ 5	$ (16,276)	147,808	21,437	(79)	152,895	128
Ending balance at Jun. 27, 2021			175
Ending balance, shares at Jun. 27, 2021				45,648,146	(5,494,918)
Beginning balance at Mar. 28, 2021	147,047			$ 5	$ (16,276)	145,689	17,530	(53)	146,895	152
Beginning balance at Mar. 28, 2021			175
Beginning balance, shares at Mar. 28, 2021				45,239,224	(5,494,918)
Exercise of stock options	978					978			978
Exercise of stock options, Shares				393,922
Vested restricted stock, Shares				15,000
Stock-based compensation expense	1,141					1,141			1,141
Net loss attributable to non- controlling interests - stockholders	(24)									(24)
Other comprehensive loss, net	(26)							(26)	(26)
Net income (loss) attributable to Vital Farms, Inc. stockholders	3,907						3,907		3,907
Ending balance at Jun. 27, 2021	153,023			$ 5	$ (16,276)	147,808	21,437	(79)	152,895	128
Ending balance at Jun. 27, 2021			175
Ending balance, shares at Jun. 27, 2021				45,648,146	(5,494,918)
Beginning balance at Dec. 26, 2021	151,585			$ 5		149,000	2,746	(281)	151,470	115
Beginning balance at Dec. 26, 2021		$ 175	175
Beginning balance, shares at Dec. 26, 2021				40,493,969
Exercise of stock options	254					254			254
Exercise of stock options, Shares				102,328
Stock-based compensation expense	1,296					1,296			1,296
Net loss attributable to non- controlling interests - stockholders	(2)						162		162	(164)
Other comprehensive loss, net	(783)							(783)	(783)
Net income (loss) attributable to Vital Farms, Inc. stockholders	(1,536)						(1,536)		(1,536)
Ending balance at Mar. 27, 2022	150,814			$ 5		150,550	1,372	(1,064)	150,863	(49)
Ending balance at Mar. 27, 2022			175
Ending balance, shares at Mar. 27, 2022				40,596,297
Beginning balance at Dec. 26, 2021	$ 151,585			$ 5		149,000	2,746	(281)	151,470	115
Beginning balance at Dec. 26, 2021		175	175
Beginning balance, shares at Dec. 26, 2021				40,493,969
Exercise of stock options, Shares	130,894
Net loss attributable to non- controlling interests - stockholders	$ (8)
Net income (loss) attributable to Vital Farms, Inc. stockholders	(1,338)
Ending balance at Jun. 26, 2022	152,390			$ 5		152,317	1,571	(1,447)	152,446	(56)
Ending balance at Jun. 26, 2022		175	175
Ending balance, shares at Jun. 26, 2022				40,679,414
Beginning balance at Mar. 27, 2022	150,814			$ 5		150,550	1,372	(1,064)	150,863	(49)
Beginning balance at Mar. 27, 2022			175
Beginning balance, shares at Mar. 27, 2022				40,596,297
Exercise of stock options	143					143			143
Exercise of stock options, Shares				35,573
Vesting of restricted stock units	(9)					(9)			(9)
Vested restricted stock, Shares				47,544
Stock-based compensation expense	1,633					1,633			1,633
Net loss attributable to non- controlling interests - stockholders	(7)									(7)
Other comprehensive loss, net	(383)							(383)	(383)
Net income (loss) attributable to Vital Farms, Inc. stockholders	199						199		199
Ending balance at Jun. 26, 2022	$ 152,390			$ 5		$ 152,317	$ 1,571	$ (1,447)	$ 152,446	$ (56)
Ending balance at Jun. 26, 2022		$ 175	$ 175
Ending balance, shares at Jun. 26, 2022				40,679,414

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 26, 2022	Jun. 27, 2021
Cash flows from operating activities:
Net (loss) income	$ (1,346)	$ 7,365
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation and amortization	2,287	1,620
Amortization of right-of-use assets	829
Amortization of available-for-sale debt securities	541	626
Stock-based compensation expense	2,929	1,994
Deferred taxes	(1,927)	(1,184)
Other	(260)	125
Changes in operating assets and liabilities:
Accounts receivable	(4,186)	2,864
Inventories	(7,784)	(1,052)
Prepaid expenses and other current assets	892	2,052
Deposits and other assets	38	96
Income taxes payable	112	185
Accounts payable	2,738	361
Accrued liabilities	2,867	614
Operating lease liabilities	(735)
Net cash (used in) provided by operating activities	(3,005)	15,666
Cash flows from investing activities:
Purchases of property, plant and equipment	(4,417)	(7,811)
Purchases of available-for-sale debt securities	(29,944)	(27,493)
Sales of available-for sale debt securities		1,436
Maturities and call redemptions of available-for-sale debt securities	28,334	24,812
Proceeds from the sale of property, plant and equipment	50
Net cash used in investing activities	(5,977)	(9,056)
Cash flows from financing activities:
Payment of contingent consideration	(38)	(75)
Principal payments under finance lease obligations	(252)	(233)
Proceeds from exercise of stock options	388	1,503
Net cash provided by financing activities	98	1,195
Net (decrease) increase in cash and cash equivalents	(8,884)	7,805
Cash and cash equivalents at beginning of the period	30,966	29,544
Cash and cash equivalents at end of the period	22,082	37,349
Supplemental disclosure of cash flow information:
Cash paid for interest	15	32
Cash paid for income taxes	68	4
Supplemental disclosure of non-cash investing and financing activities:
Purchases of property, plant and equipment included in accounts payable and accrued liabilities	$ 1,398	$ 51

XML

Nature of the Business and Basis of Presentation

6 Months Ended

Jun. 26, 2022

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Nature of the Business and Basis of Presentation

Note 1. Nature of the Business and Basis of Presentation

Vital Farms, Inc. (the “Company”, “we”, “us” or “our”) was incorporated in Delaware on June 6, 2013 and is headquartered in Austin, Texas. Vital Farms packages, markets and distributes shell eggs, butter and other products. These products are sold under the trade names Vital Farms and RedHill Farms, primarily to retail and foodservice channels in the United States.

The accompanying unaudited condensed consolidated financial statements as of June 26, 2022 and for the 13-week and 26-week periods ended June 26, 2022 and June 27, 2021 have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial statements. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto on our Annual Report on Form 10-K for the fiscal year ended December 26, 2021 (“Annual Report on Form 10-K”).

In the opinion of management, the included disclosures are adequate, and the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary for a fair presentation of our consolidated financial position as of June 26, 2022, consolidated results of operations for the 13-week and 26-week periods ended June 26, 2022 and June 27, 2021, and consolidated cash flows for the 26-week periods ended June 26, 2022 and June 27, 2021. Such adjustments are of a normal and recurring nature and certain reclassifications of previously reported amounts have been made to conform to the current year presentation. The condensed consolidated results of operations for the 13-week and 26-week periods ended June 26, 2022 are not necessarily indicative of the consolidated results of operations that may be expected for the fiscal year ending December 25, 2022.

Fiscal Year: The Company’s fiscal year ends on the last Sunday in December and contains either 52 or 53 weeks. In a 52-week fiscal year, each of the Company’s fiscal quarters consist of 13 weeks. The additional week in a 53-week fiscal year is added to the fourth quarter, making such quarter consist of 14 weeks. Therefore, the financial results of certain 53-week fiscal years, and the associated 14-week quarters, will not be exactly comparable to the prior and subsequent 52-week fiscal years and the associated 13-week quarters. The quarters ended June 26, 2022 and June 27, 2021 both contain operating results for 13 weeks.

Impact of COVID-19 Pandemic: Due to the ongoing COVID-19 pandemic, the Company has implemented business continuity plans designed to address and mitigate the impact of the COVID-19 pandemic on the Company’s business. The Company does not currently anticipate that the COVID-19 pandemic will have a material impact on the timelines for the Company’s product development and expansion efforts. However, the extent to which the COVID-19 pandemic impacts the Company’s business, product development and expansion efforts, corporate development objectives and the value of and market for the Company’s common stock will depend on future developments that are highly uncertain and cannot be predicted with confidence at this time, such as the ultimate duration of the pandemic, travel restrictions, quarantines, social distancing and business closure requirements in the United States, and the effectiveness of actions taken globally to contain and treat the disease, including the effectiveness of vaccines. The global economic slowdown, the overall disruption of global supply chains and distribution systems and the other risks and uncertainties associated with the pandemic could have a material adverse effect on the Company’s business, financial condition, results of operations and growth prospects.  

XML

Summary of Significant Accounting Policies

6 Months Ended

Jun. 26, 2022

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2. Summary of Significant Accounting Policies

The significant accounting policies and estimates used in preparation of the unaudited condensed consolidated financial statements are described in the Company’s audited consolidated financial statements as of and for the fiscal year ended December 26, 2021, and the notes thereto, which are included in our Annual Report on Form 10-K. Other than the adoption of the new accounting pronouncements as further described below, there have been no material changes to the Company’s significant accounting policies during the 26-week period ended June 26, 2022.  

Recently Adopted Accounting Pronouncements: The new accounting pronouncements recently adopted by the Company are described in the Company’s audited consolidated financial statements as of and for the fiscal year ended December 26, 2021, and the notes thereto, which are included in our Annual Report on Form 10-K. Except as described below, there have been no new accounting pronouncements adopted by the Company during the 26-week period ended June 26, 2022.

In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”) and also issued subsequent amendments to the initial guidance, ASU 2017-13, ASU 2018-01, ASU 2018-10, ASU 2018-11, ASU 2018-20, ASU 2019-01, ASU 2019-10, ASU 2020-02, and ASU 2020-05 (collectively, “Topic 842”). The guidance in Topic 842 supersedes the leasing guidance in Topic 840, Leases. Under the new guidance, lessees are required to recognize lease assets and lease liabilities on the balance sheet for all leases with terms longer than twelve months. Leases are classified as either finance or operating, with classification affecting the pattern of expense recognition in the unaudited condensed consolidated statement of operations. An entity may adopt the guidance either (1) retrospectively to each prior reporting period presented in the financial statements with a cumulative-effect adjustment recognized at the beginning of the earliest comparative period presented or (2) retrospectively at the beginning of the period of adoption through a cumulative-effect adjustment. The Company adopted Topic 842 as of the beginning of the period of adoption, December 27, 2021, and has not applied the new standard to comparative periods presented.

To reduce the burden of adoption and ongoing compliance with Topic 842, a number of practical expedients and policy elections are available under the new guidance. The Company elected the "package of practical expedients" permitted under the transition guidance, which among other things, did not require reassessment of whether contracts entered into prior to adoption are or contain leases, and allowed carryforward of the historical lease classification for existing leases. The Company has not elected to adopt the “hindsight” practical expedient, and therefore will measure the right-of-use (“ROU”) assets and lease liabilities using the remaining portion of the lease term at adoption on December 27, 2021.  

The Company made an accounting policy election under Topic 842 not to recognize ROU assets and lease liabilities for leases with a term of twelve months or less.  For all other leases, the Company recognizes ROU assets and lease liabilities based on the present value of lease payments over the lease term at the commencement date of the lease (or December 27, 2021 for existing leases upon the adoption of Topic 842). The Company’s recognized ROU assets also include any initial direct costs incurred and lease payments made at or before the commencement date, which are reduced by any lease incentives.

Future lease payments may include fixed rent escalation clauses or payments that depend on an index (such as the Consumer Price Index measured by the U.S. Bureau of Labor Statistics). Subsequent index changes and other periodic market-rate adjustments to base rent are recorded as variable lease expense during the period in which they are incurred. Residual value guarantees or payments for terminating the lease are included in the lease payments only when it is probable they will be incurred.

The Company has made an accounting policy election to account for lease and non-lease components in its contracts as a single lease component for all asset classes. The non-lease components typically represent additional services transferred to the Company, such as common area maintenance for real estate, which are variable in nature and recorded in variable lease expense in the period incurred.  

As an emerging growth company, the Company uses its lease-specific collateralized incremental borrowing rate to determine the present value of lease payments at lease commencement or upon the adoption of Topic 842. The adoption of the new lease standard had an immaterial impact on our consolidated net earnings and consolidated cash flows and did not result in a cumulative-effect adjustment to the opening balance of retained earnings. The adoption of Topic 842 as of December 27, 2021, resulted in the recording of right-of-use assets and lease liabilities of $4.1 million and $3.8 million, respectively.

Recently Issued Accounting Pronouncements Not Yet Adopted: In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”) and also issued subsequent amendments to the initial guidance, ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-10, ASU 2019-11, ASU 2020-02, and ASU 2020-03 (collectively, “Topic 326”), to introduce a new impairment model for recognizing credit losses on financial instruments based on an estimate of current expected credit losses. Topic 326 requires financial assets measured at amortized cost to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amounts. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances. 

The Company expects to adopt Topic 326 on December 26, 2022. Although the Company is currently evaluating the impact of its pending adoption of Topic 326, the Company does not expect it to have a material impact on its consolidated financial statements.

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which intends to simplify the guidance by removing certain exceptions to the general principles and clarifying or amending existing guidance. ASU 2019-12 is effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. The Company expects to adopt ASU 2019-12 on December 26, 2022. Although the Company is currently evaluating the impact of the adoption of ASU 2019-12, the Company does not expect it to have a material impact on its consolidated financial statements.

XML

Investment Securities

6 Months Ended

Jun. 26, 2022

Investments Debt And Equity Securities [Abstract]

Investment Securities

Note 3. Investment Securities

The following table summarizes the Company’s available-for-sale investment securities as of June 26, 2022:

	Amortized Cost		Unrealized Losses			Fair Value
U.S. Corporate Bonds and U.S. Dollar    Denominated Foreign Bonds	$	67,685	$	(1,866	)	$	65,819
Commercial Paper		1,293		—			1,293
U.S. Treasury		1,176		(31	)		1,145
Total	$	70,154	$	(1,897	)	$	68,257

The following table summarizes the Company’s available-for-sale investment securities as of December 26, 2021:

	Amortized Cost		Unrealized Losses			Fair Value
U.S. Corporate Bonds and U.S. Dollar    Denominated Foreign Bonds	$	64,816	$	(364	)	$	64,452
Commercial Paper		2,999		—			2,999
U.S. Treasury		1,177		(7	)		1,170
Total	$	68,992	$	(371	)	$	68,621

The securities incurred unrealized losses of $501 and $1,527, and related tax benefits of $118 and $361 for the 13-week and 26-weeks ended June 26, 2022. The unrealized losses in our U.S. corporate bond portfolio consist of losses on 97 diversified issuances with credit ratings ranging from BBB to AAA. There are no individual bonds with unrealized losses exceeding $82 and only four issuances have been in a loss position greater than 12 months with aggregate unrealized losses of $190.  

The decline in fair value has resulted primarily from rising interest rates over the last 12 months and the Company does not believe there has been any significant decline in the creditworthiness of the issuers. The Company also does not believe it is likely that the bonds will be called early given the current interest rate environment and it does not have current liquidity needs that would necessitate a sale of the investments prior to maturity. Therefore, the Company has not recorded an allowance for credit losses on the investment securities as of June 26, 2022.

Actual maturities may differ from contractual maturities because some borrowers have the right to call or prepay obligations with or without call or prepayment penalties. Contractual maturities of investment securities as of June 26, 2022 are as follows:

	Amortized Cost		Fair Value
Due within one year	$	17,070	$	16,826
Due in 1-5 years		53,084		51,431
Total available-for-sale	$	70,154	$	68,257

The following tables present information about the Company’s financial assets measured at fair value on a recurring basis for the periods presented:

	Fair Value Measurements as of June 26, 2022, Using:
	Level 1		Level 2		Level 3		Total
Assets:
U.S. Corporate Bonds and U.S. Dollar    Denominated Foreign Bonds	$	—	$	65,819	$	—	$	65,819
Commercial Paper		—		1,293		—		1,293
Money Market		12,002		—		—		12,002
U.S. Treasury		—		1,145		—		1,145
Total assets measured at fair value	$	12,002	$	68,257	$	—	$	80,259

	Fair Value Measurements as of December 26, 2021, Using:
	Level 1		Level 2		Level 3		Total
Assets:
U.S. Corporate Bonds and U.S. Dollar    Denominated Foreign Bonds	$	—	$	64,452	$	—	$	64,452
Commercial Paper		—		2,999		—		2,999
Money Market		20,101		—		—		20,101
U.S. Treasury		—		1,170		—		1,170
Total assets measured at fair value	$	20,101	$	68,621	$	—	$	88,722

XML

Revenue Recognition

6 Months Ended

Jun. 26, 2022

Revenue From Contract With Customer [Abstract]

Revenue Recognition

Note 4. Revenue Recognition

The following table summarizes the Company’s net revenue by primary product for the periods presented:

	13-Weeks Ended				26-Weeks Ended
	June 26, 2022		June 27, 2021		June 26, 2022		June  27, 2021
Net Revenue:
Egg and egg-related products	$	78,107	$	56,339	$	150,228	$	110,768
Butter and butter-related products		4,763		3,984		9,701		8,101
Net Revenue	$	82,870	$	60,324	$	159,929	$	118,869

Net revenue is primarily generated from the sale of eggs and butter. The Company’s product offerings include shell eggs, hard-boiled eggs, liquid whole eggs, butter (including stick butter and spreadable tub butter) and ghee. The Company’s previous convenient breakfast product line (including egg bites and egg-based breakfast bars) was discontinued in 2022.

As of June 26, 2022 and December 26, 2021, the Company had customers that individually represented 10% or more of the Company’s accounts receivable, net, and during the 13-week and 26-week periods ended June 26, 2022 and June 27, 2021, the Company had customers that individually exceeded 10% or more of the Company’s net revenue. The percentage of net revenue from these significant customers during the 13-week and 26-week periods ended June 26, 2022 and June 27, 2021 is as follows:

	Net Revenue for the 13-Weeks Ended June 26, 2022	Net Revenue for the 13-Weeks Ended June 27, 2021	Net Revenue for the 26-Weeks Ended June 26, 2022	Net Revenue for the 26-Weeks Ended June 27, 2021
Customer A	32%	*	33%	*
Customer B	*	25%	*	25%
Customer C	10%	10%	*	11%
Customer D	13%	11%	12%	11%

*Revenue was less than 10%.

The increase in net revenue for Customer A for the 13-week and 26-week periods ended June 26, 2022 compared to the 13- week and 26-week periods ended June 27, 2021 is due to a shift in the Company’s distribution channels away from Customer B during the year ended December 26, 2021. The slight increase in net revenue for Customer D for the 13-week and 26-week periods ended June 26, 2022 compared to the 13-week and 26-week periods ended June 27, 2021 is due to new distribution gains in the current period.

The percentage of accounts receivable, net due from these significant customers as of June 26, 2022 and December 26, 2021 is as follows:

	Accounts Receivable, Net as of June 26, 2022	Accounts Receivable, Net as of December 26, 2021
Customer A	23%	19%
Customer B	*	*
Customer C	*	*
Customer D	13%	13%

*Accounts receivable was less than 10%.

XML

Accounts Receivable

6 Months Ended

Jun. 26, 2022

Receivables [Abstract]

Accounts Receivable

Note 5. Accounts Receivable

Accounts receivable, net, were $31,110 and $26,938 as of June 26, 2022 and December 26, 2021, respectively.

As of June 26, 2022 and December 26, 2021, the Company recorded an allowance for doubtful accounts of $282 and $269, respectively. Changes in the allowance for doubtful accounts were as follows:

	Allowance for doubtful accounts
As of December 26, 2021	$	(269	)
Provisions Charged to Operating Results		(68	)
Account Write-off and Recoveries		—
As of March 27, 2022	$	(337	)
Provisions Released to Operating Results		24
Account Write-off and Recoveries		31
As of June 26, 2022	$	(282	)

XML

Inventories

6 Months Ended

Jun. 26, 2022

Inventory Disclosure [Abstract]

Inventories

Note 6. Inventories

Inventory consisted of the following as of the periods presented:

	June 26, 2022			December 26, 2021
Eggs and egg-related products	$	8,795		$	5,850
Butter and butter-related products		4,182			2,359
Packaging		3,829			2,166
Pullets		1,708			267
Other		642			731
Reserve for inventory obsolescence		(56	)		(428	)
	$	19,100		$	10,945

On a periodic basis, the Company compares the amount of inventory on hand with its latest forecasted requirements to determine whether provisions for excess or obsolete inventory reserves are required.

XML

Property, Plant and Equipment

6 Months Ended

Jun. 26, 2022

Property Plant And Equipment [Abstract]

Property, Plant and Equipment

Note 7. Property, Plant and Equipment

Property, plant and equipment consisted of the following as of the periods presented:

	June 26, 2022			December 26, 2021
Land	$	552		$	525
Land improvements		835			—
Buildings and improvements		28,407			14,214
Vehicles		689			695
Machinery and equipment		22,832			15,523
Leasehold improvements		918			830
Furniture and fixtures		678			503
Construction in progress		2,379			21,164
		57,290			53,454
Less: Accumulated depreciation and amortization		(9,403	)		(8,846	)
Property, plant and equipment, net	$	47,887		$	44,608

As of June 26, 2022 and December 26, 2021, machinery and equipment leased under finance leases and included in property, plant and equipment, net in the unaudited condensed consolidated balance sheets was $745 and $876, respectively.

During the 13-week periods ended June 26, 2022 and June 27, 2021, depreciation and amortization of property, plant and equipment was approximately $1,339 and $835, respectively. During the 26-week periods ended June 26, 2022 and June 27, 2021, depreciation and amortization of property, plant and equipment was approximately $2,287 and $1,620, respectively.

During the 13-week period ended June 26, 2022, $21.9 million of construction in progress, related to our expansion of Egg Central Station, was put into service across various property, plant and equipment categories.

XML

Leases

6 Months Ended

Jun. 26, 2022

Leases [Abstract]

Leases

Note 8. Leases

The Company determines if an arrangement is or contains a lease at inception, which is the date on which the terms of the contract are agreed to and the agreement creates enforceable rights and obligations. Under Topic 842, a contract is or contains a lease when (i) explicitly or implicitly identified assets have been deployed in the contract and (ii) the customer obtains substantially all of the economic benefits from the use of that underlying asset and directs how and for what purpose the asset is used during the term of the contract. The Company also considers whether its service arrangements include the right to control the use of an asset.

The Company leases office facilities, warehouses and office equipment under lease agreements with initial terms approximating one to five years.  In addition, substantially all the Company’s long-term supply contracts with farms contain components that meet the definition of embedded leases within the scope of Topic 842, Leases. These arrangements convey to the Company the right to control implicitly identified property, plant and equipment as it takes substantially all the utility generated by these assets over the term of the arrangements at a variable price. The initial term of these supply agreements ranges from one to seven years. As total purchase commitments contained in these arrangements are variable, the amounts attributable to the lease components are contingent rentals; there are no minimum lease payments associated with these long-term supply contracts.

As the classification and timing of recognition of costs attributable to the eggs and embedded cost of the lease rentals are identical, the Company does not allocate the total purchase cost of eggs between the cost of the eggs and the embedded cost of the lease rentals or distinguish between them in its accounting records. The Company records the total purchase cost of eggs, which includes costs associated with the eggs and the corresponding cost of embedded lease rentals from the same arrangement, into inventory. These costs are expensed to cost of goods sold when the associated eggs are sold to customers and are also reported as part of our variable lease cost.  For the 13-week and 26-week periods ended June 26, 2022, these costs totaled $32.1 and $62.3 million, respectively.

Our office lease for our corporate headquarters facility in Austin, Texas includes an option to renew, generally at our sole discretion, with renewal terms that can extend the lease term up to five years. In addition, certain leases contain termination options, where the rights to terminate are held by the Company, the lessor, or both parties. These options to extend or terminate a lease are included in the lease terms when it is reasonably certain that the Company will exercise that option. As of June 26, 2022, it is not reasonably certain that the Company will exercise the right to extend its office lease and therefore, the Company has not included the extended term in the calculation of its ROU assets or liabilities. The Company’s leases do not contain any material restrictive covenants or residual value guarantees.

Operating lease cost is recognized on a straight-line basis over the lease term and is classified within cost of goods sold and selling, general and administrative cost in the unaudited condensed consolidated statement of operations for the 13-week and 26-week periods ended June 26, 2022. 

Finance lease cost is recognized as amortization expense for the ROU assets and interest expense associated with the finance lease liabilities. Amortization expense associated with our finance leases during the 13-week and 26-week periods ended June 26, 2022 was $79 and $157, respectively, and is recorded within cost of goods sold and selling, general and administrative costs in the unaudited condensed consolidated statement of operations. 

The components of lease cost for the 13-week period and 26-week period ended June 26, 2022 are below:

	13-Weeks Ended		26-Weeks Ended
	June 26, 2022		June 26, 2022
Operating lease cost	$	361	$	722
Finance lease cost - amortization of right-of-use assets		79		157
Finance lease cost - interest on lease liabilities		2		5
Short-term lease cost		11		14
Variable lease cost		32,814		63,415
Total lease cost	$	33,267	$	64,313

Supplemental cash flow information related to leases is as follows:

Cash paid for amounts included in measurement of lease liabilities:

	13-Weeks Ended		26-Weeks Ended
	June 26, 2022		June 26, 2022
Operating cash outflows - payments on operating leases	$	368	$	735
Operating cash outflows - interest payments on finance leases		2		5
Financing cash outflows - principal payments on finance leases		121		247

Right-of-use assets obtained in exchange for new lease obligations:

	As of June 26, 2022
Operating leases	$	—
Finance leases		26

Supplemental balance sheet information related to leases is as follows:

	As of June 26, 2022
Operating Leases
Operating lease right-of-use assets	$	2,578
Operating lease liabilities		1,425
Operating lease liabilities, non-current		1,377
Total operating lease liabilities	$	2,802
Finance Leases
Property, plant and equipment, net	$	745
Finance lease liabilities		88
Other liabilities		19
Total finance leases	$	107

	As of June 26, 2022
	Operating Leases			Finance Leases
Weighted-average remaining lease term (years)		2.48			1.16
Weighted-average discount rate		3.28	%		4.44	%

Future undiscounted cash flows are as follows:

	As of June 26, 2022
	Operating Leases			Finance Leases
Remainder of 2022	$	742		$	85
2023		1,254			6
2024		471			6
2025		338			6
2026		115			6
Thereafter		—			—
Total lease payments		2,920			109
Less imputed interest		(118	)		(2	)
Total present value of lease liabilities	$	2,802		$	107

XML

Accrued Liabilities

6 Months Ended

Jun. 26, 2022

Payables And Accruals [Abstract]

Accrued Liabilities

Note 9. Accrued Liabilities

Accrued liabilities consisted of the following as of the periods presented:

	June 26, 2022		December 26, 2021
Accrued promotions and customer deductions	$	5,883	$	3,599
Accrued distribution fees and freight		4,204		3,875
Accrued employee related costs		4,011		3,039
Accrued purchases of inventory		934		1,197
Accrued marketing and broker commissions		1,138		769
Accrued property, plant and equipment		1,398		1,258
Accrued contract termination costs		70		—
Other		1,507		1,406
Accrued liabilities	$	19,145	$	15,143

XML

Product Exit Costs

6 Months Ended

Jun. 26, 2022

Restructuring And Related Activities [Abstract]

Product Exit Costs

Note 10. Product Exit Costs

During the 26-week period ended June 26, 2022, the Company made the determination to exit its convenient breakfast product category due to ongoing losses incurred and a shift in Company focus to product categories that are core to its operations.  Charges incurred in connection with these product exits are expected to be paid or settled by the end of the 13-week period ending September 25, 2022.  Due to the relatively short term over which the charges will ultimately be settled, the Company believes the actual charges as shown below approximate fair value.

The following table summarizes the activity related to the exit of the Company’s convenient breakfast products:

		For the 26-weeks period ended June 26, 2022
Description	Statement of Operations Classification	Charges Incurred		Amounts Paid or Settled			Ending Liability Balance
Contract terminations	Selling, general and administrative	$	1,126		(1,056	)	$	70
Inventory obsolescence	Cost of goods sold		749		(723	)		26
Customer allowances	Net revenue		146		(111	)		35
Asset write-downs	Cost of goods sold		119		—			119
Co-manufacturer charges	Cost of goods sold		135		(135	)		—
Asset disposals	Selling, general and administrative		66		(66	)		—
Total		$	2,341	$	(2,091	)	$	250

XML

Common Stock

6 Months Ended

Jun. 26, 2022

Equity [Abstract]

Common Stock

Note 11. Common Stock

Common Stock: As of June 26, 2022, the Company’s amended and restated certificate of incorporation authorized the Company to issue 310,000,000 shares of common stock, par value $0.0001 per share, of which 40,679,414 shares were issued and outstanding.

The voting, dividend and liquidation rights of the holders of the Company’s common stock are subject to and qualified by the rights, powers and preferences of the holders of the preferred stock. Each share of the Company’s common stock is entitled to one vote on all matters submitted to a vote of the Company’s stockholders. Holders of the Company’s common stock are entitled to receive dividends as may be declared by the Company’s board of directors, if any, subject to the preferential dividend rights of preferred stock. No cash dividends had been declared or paid during the periods presented.

As of each balance sheet date, the Company had reserved shares of common stock for issuance in connection with the following:

	June 26, 2022		December 26, 2021
Options to purchase common stock		4,712,898		4,927,033
Restricted stock units		513,226		107,867
Shares available for grant under the 2020 Equity Incentive Plan    and 2020 Employee Stock Purchase Plan		11,503,717		9,993,187
Total		16,729,841		15,028,087

Treasury Stock: In August 2021, the Company retired an aggregate of 5,494,918 shares of its common stock held in treasury. Upon retirement, the shares were redesignated as authorized but unissued shares of the Company’s common stock.

XML

Stock-Based Compensation

6 Months Ended

Jun. 26, 2022

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Stock-Based Compensation

Note 12. Stock-Based Compensation

During the 13-week periods ended June 26, 2022 and June 27, 2021, the Company recognized stock-based compensation expense of $1,633 and $1,141, respectively. The Company measures compensation expense for all stock-based awards based on the estimated fair values on the date of the grant. The Company records stock-based compensation expense in selling, general and administrative expenses and cost of goods sold. During the 13-week periods ended June 26, 2022 and June 27, 2021, stock-based compensation expense of $62 and $38, respectively, was recognized in cost of goods sold.

During the 26-week periods ended June 26, 2022 and June 27, 2021, the Company recognized stock-based compensation expense of $2,929 and $1,994, respectively. During the 26-week periods ended June 26, 2022 and June 27, 2021 $91 and $60 of stock-based compensation expense was recognized in cost of goods sold, respectively.

As of June 26, 2022, total unrecognized stock-based compensation expense related to unvested stock options and the Company’s restricted stock units (“RSU”) was $13,469, which is expected to be recognized over a weighted-average period of 2.36 years.

Stock Option Activity

The following table summarizes the Company’s stock option activity since December 26, 2021:

	Number of Options			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value
Outstanding as of December 26, 2021		4,927,033		$	9.25			$	50,561,622
Granted		132,654		$	12.89
Exercised		(130,894	)	$	3.04			$	1,304,528
Cancelled		(215,895	)	$	11.69			$	1,026,027
Outstanding as of June 26, 2022		4,712,898		$	9.41		6.1	$	17,381,476
Options exercisable as of June 26, 2022		2,661,079		$	5.81		4.8	$	13,663,597
Options vested and expected to vest as of June 26, 2022		4,708,857		$	9.42		6.1	$	17,361,548

The fair value of shares vested during the 13-week periods ended June 26, 2022 and June 27, 2021 was $1,251 and $608, respectively. The fair value of shares vested during the 26-week periods ended June 26, 2022 and June 27, 2021 was $2,209 and $912, respectively.

Restricted Stock Unit Activity

The following table summarizes the RSU activity since December 26, 2021:

	Number of RSUs			Weighted- Average Exercise Price
Unvested as of December 26, 2021		107,867		$	27.53
Granted		491,698			12.37
Vested		(51,350	)		27.93
Forfeited		(34,989	)		15.47
Unvested as of June 26, 2022		513,226		$	13.79

2020 Equity Incentive Plan: In July 2020, the Company’s board of directors adopted its 2020 Equity Incentive Plan (“2020 Incentive Plan”), which was subsequently approved by its stockholders and became effective on July 30, 2020. Initially, the maximum number of the Company’s common stock that may be issued under the 2020 Incentive Plan was 8,595,871 shares. The 2020 Incentive Plan provides that the number of shares reserved and available for issuance under the 2020 Incentive Plan will automatically increase each January 1, beginning on January 1, 2021 and ending on (and including) January 1, 2030, by an amount equal to 4% of the outstanding number of shares of common stock on the immediately preceding December 31 or such lesser number of shares as determined by the Company’s board of directors. As of June 26, 2022, 9,811,345 shares were available for future grants of the Company’s common stock, which includes 1,619,758 shares of stock that were automatically added to the available reserve on January 1, 2022. Awards issued under the 2020 Incentive Plan generally have a three-year ratable vesting period beginning on the date of grant.

Employee Stock Purchase Plan: In July 2020, the Company’s board of directors adopted the 2020 Employee Stock Purchase Plan (“2020 ESPP”), which was subsequently approved by the Company’s stockholders and became effective on July 30, 2020. The 2020 ESPP authorizes the initial issuance of up to 900,000 shares of the Company’s common stock to eligible employees of the Company or, as designated by the Company’s board of directors, employees of a related company. The 2020 ESPP provides that the number of shares reserved and available for issuance under the 2020 ESPP will automatically increase each January 1, beginning on January 1, 2021 and ending on (and including) January 1, 2030, by an amount equal to the lesser of (i) 1% of the outstanding number of shares of common stock on the immediately preceding December 31 and (ii) 900,000, or such lesser number of shares as determined by the Company’s board of directors. As of June 26, 2022, 1,692,372 shares of the Company’s common stock were available for future issuance, which includes 404,939 shares of common stock that were automatically added to the available reserve on January 1, 2022. In November 2021, the Company’s board of directors authorized an offering period commencing on March 1, 2022 and ending on May 15, 2022.  The Company’s board of directors has subsequently authorized additional six-month offering periods, with the most recent beginning on May 16, 2022.

XML

Income Taxes

6 Months Ended

Jun. 26, 2022

Income Tax Disclosure [Abstract]

Income Taxes

Note 13. Income Taxes

The Company’s effective tax rate for the 13-week periods ended June 26, 2022 and June 27, 2021 was approximately 78% and (22)%, respectively. The Company’s effective tax rate for the 26-week periods ended June 26, 2022 and June 27, 2021 was approximately 55% and (16)%, respectively. In the 13-week and 26-week periods ended June 26, 2022, the estimated annual effective tax rate was driven by permanent differences related to incentive stock options and the impact of compensation deduction limitations under Internal Revenue Code section 162(m). Tax expense has increased during these periods as a result of the impact of amended federal tax returns and increasing pre-tax income during the 13-weeks ended June 26, 2022.

For interim periods, our income tax expense and resulting effective tax rate are based upon an estimated annual effective tax rate adjusted for the effects of items required to be treated as discrete to the period, including changes in tax laws, changes in estimated exposures for uncertain tax positions, and other items.

XML

Net Income Per Share

6 Months Ended

Jun. 26, 2022

Earnings Per Share [Abstract]

Net Income Per Share

Note 14. Net Income Per Share

Basic and diluted net income per share attributable to Vital Farms, Inc. common stockholders were calculated as follows:

	13-Weeks Ended
	June 26, 2022			June 27, 2021
Numerator:
Net income	$	192		$	3,883
Less: Net loss attributable to noncontrolling    interests		(7	)		(24	)
Net income attributable to Vital Farms, Inc.    stockholders’ — basic and diluted	$	199		$	3,907
Denominator:
Weighted average common shares outstanding    — basic		40,628,416			40,000,136
Weighted average effect of potentially dilutive    securities:
Effect of potentially dilutive stock options		2,048,653			3,375,052
Effect of potentially dilutive restricted stock units		17,698			480
Effect of potentially dilutive common stock    warrants		—			—
Effect of potentially dilutive redeemable    convertible preferred stock		—			—
Weighted average common shares outstanding    — diluted		42,694,767			43,375,668
Net income per share attributable to Vital Farms,    Inc. stockholders
Basic	$	0.00		$	0.10
Diluted	$	0.00		$	0.09

For the 13-week periods ended June 26, 2022 and June 27, 2021, options to purchase 109,494 and 196,640 shares of common stock were excluded from the computation of diluted net income per share attributable to Vital Farms, Inc. common stockholders because including them would have been antidilutive.

	26-Weeks Ended
	June 26, 2022			June 27, 2021
Numerator:
Net (loss) income	$	(1,346	)	$	7,365
Less: Net loss attributable to noncontrolling    interests		(8	)		(34	)
Net (loss) income attributable to Vital Farms, Inc.    stockholders’ — basic and diluted	$	(1,338	)	$	7,399
Denominator:
Weighted average common shares outstanding    — basic		40,580,598			39,767,127
Weighted average effect of potentially dilutive    securities:
Effect of potentially dilutive stock options		—			3,676,494
Effect of potentially dilutive restricted stock units		—			480
Effect of potentially dilutive common stock    warrants		—			—
Effect of potentially dilutive redeemable    convertible preferred stock		—			—
Weighted average common shares outstanding    — diluted		40,580,598			43,444,101
Net (loss) income per share attributable to Vital Farms,    Inc. stockholders
Basic	$	(0.03	)	$	0.19
Diluted	$	(0.03	)	$	0.17

For the 26-week periods ended June 26, 2022 and June 27, 2021, options to purchase 61,707 and 112,644 shares of common stock were excluded from the computation of diluted net income per share attributable to Vital Farms, Inc. common stockholders because including them would have been antidilutive.

XML

Commitments and Contingencies

6 Months Ended

Jun. 26, 2022

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 15. Commitments and Contingencies

Supplier Contracts: The Company purchases its egg inventories under long-term supply contracts with farms. Purchase commitments contained in these arrangements are variable depending on the quantity of eggs produced by the farms. Accordingly, there are no estimable future purchase commitments associated with these supplier contracts and there are no minimum payments associated with these long-term supply contracts. The Company records the total cost of eggs into inventory and they are expensed to cost of goods sold when the associated eggs are sold to customers.

Indemnification Agreements: In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of its board of directors and its executive officers that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. As of June 26, 2022, the Company has not incurred any material costs as a result of such indemnifications.

Litigation: The Company is subject to various claims and contingencies which are in the scope of ordinary and routine litigation incidental to its business, including those related to regulation, litigation, business transactions, employee-related matters and taxes, among others. When the Company becomes aware of a claim or potential claim, the likelihood of any loss or exposure is assessed. If it is probable that a loss will result and the amount of the loss can be reasonably estimated, the Company records a liability for the loss. The liability recorded includes probable and estimable legal costs incurred to date and future legal costs to the point in the legal matter where the Company believes a conclusion to the matter will be reached. If the loss is not probable or the amount of the loss cannot be reasonably estimated, the Company discloses the claim if the likelihood of a potential loss is reasonably possible.

XML

Related Party Transactions

6 Months Ended

Jun. 26, 2022

Related Party Transactions [Abstract]

Related Party Transactions

Note 16. Related Party Transactions

Ovabrite, Inc.: Ovabrite is a related party because its founders are stockholders of the Company, with the majority stockholder in Ovabrite also serving as the Company’s executive chairman and member of the Company’s board of directors. Since Ovabrite’s incorporation in November 2016, the Company has been deemed to have had a variable interest in Ovabrite, and Ovabrite is deemed to have been a VIE, of which the Company is the primary beneficiary. Accordingly, the Company has consolidated the results of Ovabrite since November 2016. All significant intercompany transactions between the Company and Ovabrite have been eliminated in consolidation. The Ovabrite entity is immaterial as of the 26-weeks ended June 26, 2022.

Sandpebble Builders Preconstruction, Inc.: The Company utilizes Sandpebble Builders Preconstruction, Inc. (“Sandpebble”) for project management and related services associated with the construction and expansion of Egg Central Station. The owner and principal of Sandpebble is the father of an executive of the Company. In connection with the services described above, the Company paid Sandpebble $250 and $326 during the 13-week periods ended June 26, 2022 and June 27, 2021, respectively and $371 and $625 during the 26-week period ended June 26, 2022 and June 27, 2021, respectively. Amounts paid to Sandpebble are included in property, plant and equipment, net, accounts payable and accrued liabilities in the unaudited condensed consolidated balance sheets.

XML

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 26, 2022

Accounting Policies [Abstract]

Recently Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements: The new accounting pronouncements recently adopted by the Company are described in the Company’s audited consolidated financial statements as of and for the fiscal year ended December 26, 2021, and the notes thereto, which are included in our Annual Report on Form 10-K. Except as described below, there have been no new accounting pronouncements adopted by the Company during the 26-week period ended June 26, 2022.

In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”) and also issued subsequent amendments to the initial guidance, ASU 2017-13, ASU 2018-01, ASU 2018-10, ASU 2018-11, ASU 2018-20, ASU 2019-01, ASU 2019-10, ASU 2020-02, and ASU 2020-05 (collectively, “Topic 842”). The guidance in Topic 842 supersedes the leasing guidance in Topic 840, Leases. Under the new guidance, lessees are required to recognize lease assets and lease liabilities on the balance sheet for all leases with terms longer than twelve months. Leases are classified as either finance or operating, with classification affecting the pattern of expense recognition in the unaudited condensed consolidated statement of operations. An entity may adopt the guidance either (1) retrospectively to each prior reporting period presented in the financial statements with a cumulative-effect adjustment recognized at the beginning of the earliest comparative period presented or (2) retrospectively at the beginning of the period of adoption through a cumulative-effect adjustment. The Company adopted Topic 842 as of the beginning of the period of adoption, December 27, 2021, and has not applied the new standard to comparative periods presented.

To reduce the burden of adoption and ongoing compliance with Topic 842, a number of practical expedients and policy elections are available under the new guidance. The Company elected the "package of practical expedients" permitted under the transition guidance, which among other things, did not require reassessment of whether contracts entered into prior to adoption are or contain leases, and allowed carryforward of the historical lease classification for existing leases. The Company has not elected to adopt the “hindsight” practical expedient, and therefore will measure the right-of-use (“ROU”) assets and lease liabilities using the remaining portion of the lease term at adoption on December 27, 2021.  

The Company made an accounting policy election under Topic 842 not to recognize ROU assets and lease liabilities for leases with a term of twelve months or less.  For all other leases, the Company recognizes ROU assets and lease liabilities based on the present value of lease payments over the lease term at the commencement date of the lease (or December 27, 2021 for existing leases upon the adoption of Topic 842). The Company’s recognized ROU assets also include any initial direct costs incurred and lease payments made at or before the commencement date, which are reduced by any lease incentives.

Future lease payments may include fixed rent escalation clauses or payments that depend on an index (such as the Consumer Price Index measured by the U.S. Bureau of Labor Statistics). Subsequent index changes and other periodic market-rate adjustments to base rent are recorded as variable lease expense during the period in which they are incurred. Residual value guarantees or payments for terminating the lease are included in the lease payments only when it is probable they will be incurred.

The Company has made an accounting policy election to account for lease and non-lease components in its contracts as a single lease component for all asset classes. The non-lease components typically represent additional services transferred to the Company, such as common area maintenance for real estate, which are variable in nature and recorded in variable lease expense in the period incurred.  

As an emerging growth company, the Company uses its lease-specific collateralized incremental borrowing rate to determine the present value of lease payments at lease commencement or upon the adoption of Topic 842. The adoption of the new lease standard had an immaterial impact on our consolidated net earnings and consolidated cash flows and did not result in a cumulative-effect adjustment to the opening balance of retained earnings. The adoption of Topic 842 as of December 27, 2021, resulted in the recording of right-of-use assets and lease liabilities of $4.1 million and $3.8 million, respectively.

XML

Investment Securities (Tables)

6 Months Ended

Jun. 26, 2022

Investments Debt And Equity Securities [Abstract]

Summary of Available-for-sale Investment Securities

The following table summarizes the Company’s available-for-sale investment securities as of June 26, 2022:

	Amortized Cost		Unrealized Losses			Fair Value
U.S. Corporate Bonds and U.S. Dollar    Denominated Foreign Bonds	$	67,685	$	(1,866	)	$	65,819
Commercial Paper		1,293		—			1,293
U.S. Treasury		1,176		(31	)		1,145
Total	$	70,154	$	(1,897	)	$	68,257

The following table summarizes the Company’s available-for-sale investment securities as of December 26, 2021:

	Amortized Cost		Unrealized Losses			Fair Value
U.S. Corporate Bonds and U.S. Dollar    Denominated Foreign Bonds	$	64,816	$	(364	)	$	64,452
Commercial Paper		2,999		—			2,999
U.S. Treasury		1,177		(7	)		1,170
Total	$	68,992	$	(371	)	$	68,621

Summary of Contractual Maturities of Investment Securities

Contractual maturities of investment securities as of June 26, 2022 are as follows:

	Amortized Cost		Fair Value
Due within one year	$	17,070	$	16,826
Due in 1-5 years		53,084		51,431
Total available-for-sale	$	70,154	$	68,257

Schedule of Financial Assets Measured at Fair Value

The following tables present information about the Company’s financial assets measured at fair value on a recurring basis for the periods presented:

	Fair Value Measurements as of June 26, 2022, Using:
	Level 1		Level 2		Level 3		Total
Assets:
U.S. Corporate Bonds and U.S. Dollar    Denominated Foreign Bonds	$	—	$	65,819	$	—	$	65,819
Commercial Paper		—		1,293		—		1,293
Money Market		12,002		—		—		12,002
U.S. Treasury		—		1,145		—		1,145
Total assets measured at fair value	$	12,002	$	68,257	$	—	$	80,259

	Fair Value Measurements as of December 26, 2021, Using:
	Level 1		Level 2		Level 3		Total
Assets:
U.S. Corporate Bonds and U.S. Dollar    Denominated Foreign Bonds	$	—	$	64,452	$	—	$	64,452
Commercial Paper		—		2,999		—		2,999
Money Market		20,101		—		—		20,101
U.S. Treasury		—		1,170		—		1,170
Total assets measured at fair value	$	20,101	$	68,621	$	—	$	88,722

XML

Revenue Recognition (Tables)

6 Months Ended

Jun. 26, 2022

Revenue From Contract With Customer [Abstract]

Summary of Net Revenue by Primary Product

The following table summarizes the Company’s net revenue by primary product for the periods presented:

	13-Weeks Ended				26-Weeks Ended
	June 26, 2022		June 27, 2021		June 26, 2022		June  27, 2021
Net Revenue:
Egg and egg-related products	$	78,107	$	56,339	$	150,228	$	110,768
Butter and butter-related products		4,763		3,984		9,701		8,101
Net Revenue	$	82,870	$	60,324	$	159,929	$	118,869

Summary of Percentage of Net Revenue and Accounts Receivable, Net Due from Significant Customers

The percentage of net revenue from these significant customers during the 13-week and 26-week periods ended June 26, 2022 and June 27, 2021 is as follows:

	Net Revenue for the 13-Weeks Ended June 26, 2022	Net Revenue for the 13-Weeks Ended June 27, 2021	Net Revenue for the 26-Weeks Ended June 26, 2022	Net Revenue for the 26-Weeks Ended June 27, 2021
Customer A	32%	*	33%	*
Customer B	*	25%	*	25%
Customer C	10%	10%	*	11%
Customer D	13%	11%	12%	11%

*Revenue was less than 10%.

The percentage of accounts receivable, net due from these significant customers as of June 26, 2022 and December 26, 2021 is as follows:

	Accounts Receivable, Net as of June 26, 2022	Accounts Receivable, Net as of December 26, 2021
Customer A	23%	19%
Customer B	*	*
Customer C	*	*
Customer D	13%	13%

*Accounts receivable was less than 10%.

XML

Accounts Receivable (Tables)

6 Months Ended

Jun. 26, 2022

Receivables [Abstract]

Schedule of Changes in Allowance for Doubtful Accounts Receivable

Changes in the allowance for doubtful accounts were as follows:

	Allowance for doubtful accounts
As of December 26, 2021	$	(269	)
Provisions Charged to Operating Results		(68	)
Account Write-off and Recoveries		—
As of March 27, 2022	$	(337	)
Provisions Released to Operating Results		24
Account Write-off and Recoveries		31
As of June 26, 2022	$	(282	)

XML

Inventories (Tables)

6 Months Ended

Jun. 26, 2022

Inventory Disclosure [Abstract]

Schedule of Inventory

Inventory consisted of the following as of the periods presented:

	June 26, 2022			December 26, 2021
Eggs and egg-related products	$	8,795		$	5,850
Butter and butter-related products		4,182			2,359
Packaging		3,829			2,166
Pullets		1,708			267
Other		642			731
Reserve for inventory obsolescence		(56	)		(428	)
	$	19,100		$	10,945

XML

Property, Plant and Equipment (Tables)

6 Months Ended

Jun. 26, 2022

Property Plant And Equipment [Abstract]

Schedule of Property, Plant and Equipment

Property, plant and equipment consisted of the following as of the periods presented:

	June 26, 2022			December 26, 2021
Land	$	552		$	525
Land improvements		835			—
Buildings and improvements		28,407			14,214
Vehicles		689			695
Machinery and equipment		22,832			15,523
Leasehold improvements		918			830
Furniture and fixtures		678			503
Construction in progress		2,379			21,164
		57,290			53,454
Less: Accumulated depreciation and amortization		(9,403	)		(8,846	)
Property, plant and equipment, net	$	47,887		$	44,608

XML

Leases (Tables)

6 Months Ended

Jun. 26, 2022

Leases [Abstract]

Schedule of Components of Lease Cost

The components of lease cost for the 13-week period and 26-week period ended June 26, 2022 are below:

	13-Weeks Ended		26-Weeks Ended
	June 26, 2022		June 26, 2022
Operating lease cost	$	361	$	722
Finance lease cost - amortization of right-of-use assets		79		157
Finance lease cost - interest on lease liabilities		2		5
Short-term lease cost		11		14
Variable lease cost		32,814		63,415
Total lease cost	$	33,267	$	64,313

Summary of Cash Flow Information related to Leases

Supplemental cash flow information related to leases is as follows:

Cash paid for amounts included in measurement of lease liabilities:

	13-Weeks Ended		26-Weeks Ended
	June 26, 2022		June 26, 2022
Operating cash outflows - payments on operating leases	$	368	$	735
Operating cash outflows - interest payments on finance leases		2		5
Financing cash outflows - principal payments on finance leases		121		247

Right-of-use assets obtained in exchange for new lease obligations:

	As of June 26, 2022
Operating leases	$	—
Finance leases		26

Summary of Supplemental Balance Sheet Information Related to Leases

Supplemental balance sheet information related to leases is as follows:

	As of June 26, 2022
Operating Leases
Operating lease right-of-use assets	$	2,578
Operating lease liabilities		1,425
Operating lease liabilities, non-current		1,377
Total operating lease liabilities	$	2,802
Finance Leases
Property, plant and equipment, net	$	745
Finance lease liabilities		88
Other liabilities		19
Total finance leases	$	107

	As of June 26, 2022
	Operating Leases			Finance Leases
Weighted-average remaining lease term (years)		2.48			1.16
Weighted-average discount rate		3.28	%		4.44	%

Summary of Operating and Finance Leases Future Undiscounted Cash Flows

Future undiscounted cash flows are as follows:

	As of June 26, 2022
	Operating Leases			Finance Leases
Remainder of 2022	$	742		$	85
2023		1,254			6
2024		471			6
2025		338			6
2026		115			6
Thereafter		—			—
Total lease payments		2,920			109
Less imputed interest		(118	)		(2	)
Total present value of lease liabilities	$	2,802		$	107

XML

Accrued Liabilities (Tables)

6 Months Ended

Jun. 26, 2022

Payables And Accruals [Abstract]

Schedule of Accrued Liabilities

Accrued liabilities consisted of the following as of the periods presented:

	June 26, 2022		December 26, 2021
Accrued promotions and customer deductions	$	5,883	$	3,599
Accrued distribution fees and freight		4,204		3,875
Accrued employee related costs		4,011		3,039
Accrued purchases of inventory		934		1,197
Accrued marketing and broker commissions		1,138		769
Accrued property, plant and equipment		1,398		1,258
Accrued contract termination costs		70		—
Other		1,507		1,406
Accrued liabilities	$	19,145	$	15,143

XML

Product Exit Costs (Tables)

6 Months Ended

Jun. 26, 2022

Restructuring And Related Activities [Abstract]

Summary of Activity Related to Exit of Breakfast Products

The following table summarizes the activity related to the exit of the Company’s convenient breakfast products:

		For the 26-weeks period ended June 26, 2022
Description	Statement of Operations Classification	Charges Incurred		Amounts Paid or Settled			Ending Liability Balance
Contract terminations	Selling, general and administrative	$	1,126		(1,056	)	$	70
Inventory obsolescence	Cost of goods sold		749		(723	)		26
Customer allowances	Net revenue		146		(111	)		35
Asset write-downs	Cost of goods sold		119		—			119
Co-manufacturer charges	Cost of goods sold		135		(135	)		—
Asset disposals	Selling, general and administrative		66		(66	)		—
Total		$	2,341	$	(2,091	)	$	250

XML

Common Stock (Tables)

6 Months Ended

Jun. 26, 2022

Equity [Abstract]

Schedule of Reserved Shares of Common Stock for Issuance

As of each balance sheet date, the Company had reserved shares of common stock for issuance in connection with the following:

	June 26, 2022		December 26, 2021
Options to purchase common stock		4,712,898		4,927,033
Restricted stock units		513,226		107,867
Shares available for grant under the 2020 Equity Incentive Plan    and 2020 Employee Stock Purchase Plan		11,503,717		9,993,187
Total		16,729,841		15,028,087

XML

Stock-Based Compensation (Tables)

6 Months Ended

Jun. 26, 2022

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity since December 26, 2021:

	Number of Options			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value
Outstanding as of December 26, 2021		4,927,033		$	9.25			$	50,561,622
Granted		132,654		$	12.89
Exercised		(130,894	)	$	3.04			$	1,304,528
Cancelled		(215,895	)	$	11.69			$	1,026,027
Outstanding as of June 26, 2022		4,712,898		$	9.41		6.1	$	17,381,476
Options exercisable as of June 26, 2022		2,661,079		$	5.81		4.8	$	13,663,597
Options vested and expected to vest as of June 26, 2022		4,708,857		$	9.42		6.1	$	17,361,548

Summary of Restricted Stock Unit Activity

The following table summarizes the RSU activity since December 26, 2021:

	Number of RSUs			Weighted- Average Exercise Price
Unvested as of December 26, 2021		107,867		$	27.53
Granted		491,698			12.37
Vested		(51,350	)		27.93
Forfeited		(34,989	)		15.47
Unvested as of June 26, 2022		513,226		$	13.79

XML

Net Income Per Share (Tables)

6 Months Ended

Jun. 26, 2022

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Net Income Per Share

Basic and diluted net income per share attributable to Vital Farms, Inc. common stockholders were calculated as follows:

	13-Weeks Ended
	June 26, 2022			June 27, 2021
Numerator:
Net income	$	192		$	3,883
Less: Net loss attributable to noncontrolling    interests		(7	)		(24	)
Net income attributable to Vital Farms, Inc.    stockholders’ — basic and diluted	$	199		$	3,907
Denominator:
Weighted average common shares outstanding    — basic		40,628,416			40,000,136
Weighted average effect of potentially dilutive    securities:
Effect of potentially dilutive stock options		2,048,653			3,375,052
Effect of potentially dilutive restricted stock units		17,698			480
Effect of potentially dilutive common stock    warrants		—			—
Effect of potentially dilutive redeemable    convertible preferred stock		—			—
Weighted average common shares outstanding    — diluted		42,694,767			43,375,668
Net income per share attributable to Vital Farms,    Inc. stockholders
Basic	$	0.00		$	0.10
Diluted	$	0.00		$	0.09

	26-Weeks Ended
	June 26, 2022			June 27, 2021
Numerator:
Net (loss) income	$	(1,346	)	$	7,365
Less: Net loss attributable to noncontrolling    interests		(8	)		(34	)
Net (loss) income attributable to Vital Farms, Inc.    stockholders’ — basic and diluted	$	(1,338	)	$	7,399
Denominator:
Weighted average common shares outstanding    — basic		40,580,598			39,767,127
Weighted average effect of potentially dilutive    securities:
Effect of potentially dilutive stock options		—			3,676,494
Effect of potentially dilutive restricted stock units		—			480
Effect of potentially dilutive common stock    warrants		—			—
Effect of potentially dilutive redeemable    convertible preferred stock		—			—
Weighted average common shares outstanding    — diluted		40,580,598			43,444,101
Net (loss) income per share attributable to Vital Farms,    Inc. stockholders
Basic	$	(0.03	)	$	0.19
Diluted	$	(0.03	)	$	0.17

XML

Nature of the Business and Basis of Presentation - Additional Information (Details)	6 Months Ended
	Jun. 26, 2022
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Date of incorporation	Jun. 06, 2013

XML

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Thousands	Jun. 26, 2022	Dec. 27, 2021
Summary of Significant Accounting Policies [Line Items]
Right-of-use asset	$ 2,578
Lease liability	$ 2,802
ASU 2016-02
Summary of Significant Accounting Policies [Line Items]
Right-of-use asset		$ 4,100
Lease liability		$ 3,800

XML

Investment Securities - Summary of Available-for-sale Investment Securities (Details) - USD ($) $ in Thousands	Jun. 26, 2022	Dec. 26, 2021
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost	$ 70,154	$ 68,992
Unrealized Losses	(1,897)	(371)
Investment securities, available-for-sale	68,257	68,621
Commercial Paper
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost	1,293	2,999
Investment securities, available-for-sale	1,293	2,999
U.S. Corporate Bonds and U.S. Dollar Denominated Foreign Bonds
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost	67,685	64,816
Unrealized Losses	(1,866)	(364)
Investment securities, available-for-sale	65,819	64,452
U.S. Treasury Securities
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost	1,176	1,177
Unrealized Losses	(31)	(7)
Investment securities, available-for-sale	$ 1,145	$ 1,170

XML

Investment Securities - Additional Information (Details)	3 Months Ended		6 Months Ended
	Jun. 26, 2022 USD ($) Security Position	Jun. 27, 2021 USD ($)	Jun. 26, 2022 USD ($) Security Position	Jun. 27, 2021 USD ($)	Dec. 26, 2021 USD ($)
Schedule Of Available For Sale Securities [Line Items]
Securities incurred unrealized losses	$ 501,000		$ 1,527,000
Securities related tax benefit	118,000	$ 7,000	361,000	$ 14,000
Unrealized Losses	$ 1,897,000		$ 1,897,000		$ 371,000
Unrealized Loss Position greater than 12 months | Position	4		4
Aggregate unrealized losses	$ 190,000		$ 190,000
Allowance for credit losses on the investment securities	0		0
Bonds | Minimum
Schedule Of Available For Sale Securities [Line Items]
Unrealized Losses	$ 82,000		$ 82,000
U.S. Corporate Bonds and U.S. Dollar Denominated Foreign Bonds
Schedule Of Available For Sale Securities [Line Items]
Number of Securities Issuances for unrealized losses | Security	97		97
Unrealized Losses	$ 1,866,000		$ 1,866,000		$ 364,000

XML

Investment Securities - Summary of Contractual Maturities of Investment Securities (Details) - USD ($) $ in Thousands	Jun. 26, 2022	Dec. 26, 2021
Investments Debt And Equity Securities [Abstract]
Due within one year Amortized Cost	$ 17,070
Due in 1-5 years Amortized Cost	53,084
Amortized Cost	70,154	$ 68,992
Due within one year Fair Value	16,826
Due in 1-5 years Fair Value	51,431
Total available-for-sale Fair Value	$ 68,257

XML

Investment Securities - Schedule of Financial Assets Measured at Fair Value (Details) - Recurring - USD ($) $ in Thousands	Jun. 26, 2022	Dec. 26, 2021
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	$ 80,259	$ 88,722
Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	12,002	20,101
Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	68,257	68,621
U.S. Corporate Bonds and U.S. Dollar Denominated Foreign Bonds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	65,819	64,452
U.S. Corporate Bonds and U.S. Dollar Denominated Foreign Bonds | Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	65,819	64,452
Commercial Paper
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	1,293	2,999
Commercial Paper | Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	1,293	2,999
Money Market
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	12,002	20,101
Money Market | Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	12,002	20,101
U.S. Treasury Securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	1,145	1,170
U.S. Treasury Securities | Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Assets measured at fair value	$ 1,145	$ 1,170

XML

Revenue Recognition - Summary of Net Revenue by Primary Product (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2022	Jun. 27, 2021	Jun. 26, 2022	Jun. 27, 2021
Disaggregation Of Revenue [Line Items]
Net revenue	$ 82,870	$ 60,324	$ 159,929	$ 118,869
Egg and Egg Related Products
Disaggregation Of Revenue [Line Items]
Net revenue	78,107	56,339	150,228	110,768
Butter and Butter Related Products
Disaggregation Of Revenue [Line Items]
Net revenue	$ 4,763	$ 3,984	$ 9,701	$ 8,101

XML

Revenue Recognition - Summary of Percentage of Net Revenue from Significant Customers (Details) - Customer Concentration Risk - Net Revenue	3 Months Ended		6 Months Ended
	Jun. 26, 2022	Jun. 27, 2021	Jun. 26, 2022	Jun. 27, 2021
Customer A
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	32.00%		33.00%
Customer B
Disaggregation Of Revenue [Line Items]
Concentration risk percentage		25.00%		25.00%
Customer C
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	10.00%	10.00%		11.00%
Customer D
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	13.00%	11.00%	12.00%	11.00%

XML

Revenue Recognition - Summary of Percentage of Accounts Receivable, Net Due from Significant Customers (Details) - Customer Concentration Risk - Accounts Receivable	6 Months Ended	12 Months Ended
	Jun. 26, 2022	Dec. 26, 2021
Customer A
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	23.00%	19.00%
Customer D
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	13.00%	13.00%

XML

Accounts Receivable - Additional Information (Details) - USD ($) $ in Thousands	Jun. 26, 2022	Mar. 27, 2022	Dec. 26, 2021
Receivables [Abstract]
Accounts receivable, net	$ 31,110		$ 26,938
Allowance for doubtful accounts	$ 282	$ 337	$ 269

XML

Accounts Receivable - Summary of Changes in Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 26, 2022	Mar. 27, 2022
Receivables [Abstract]
Allowance for doubtful accounts, Beginning balance	$ (337)	$ (269)
Provisions Charged or Released to Operating Results	24	(68)
Account Write-off and Recoveries	31
Allowance for doubtful accounts, Ending balance	$ (282)	$ (337)

XML

Inventories - Schedule of Inventory (Details) - USD ($) $ in Thousands	Jun. 26, 2022	Dec. 26, 2021
Inventory [Line Items]
Reserve for inventory obsolescence	$ (56)	$ (428)
Inventories	19,100	10,945
Eggs and Egg Related Products
Inventory [Line Items]
Inventories gross	8,795	5,850
Butter and Butter Related Products
Inventory [Line Items]
Inventories gross	4,182	2,359
Packaging
Inventory [Line Items]
Inventories gross	3,829	2,166
Pullets
Inventory [Line Items]
Inventories gross	1,708	267
Other
Inventory [Line Items]
Inventories gross	$ 642	$ 731

XML

Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Jun. 26, 2022	Dec. 26, 2021
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	$ 57,290	$ 53,454
Less: Accumulated depreciation and amortization	(9,403)	(8,846)
Property, plant and equipment, net	47,887	44,608
Land
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	552	525
Land improvements
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	835
Buildings and Improvements
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	28,407	14,214
Vehicles
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	689	695
Machinery and Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	22,832	15,523
Leasehold Improvements
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	918	830
Furniture and Fixtures
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	678	503
Construction in Progress
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	$ 2,379	$ 21,164

XML

Property, Plant and Equipment - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2022	Jun. 27, 2021	Jun. 26, 2022	Jun. 27, 2021	Dec. 26, 2021
Property Plant And Equipment [Line Items]
Depreciation and amortization of property, plant and equipment	$ 1,339	$ 835	$ 2,287	$ 1,620
Machinery and Equipment
Property Plant And Equipment [Line Items]
Finance leases included in property, plant and equipment	745		745		$ 876
Egg Central Station
Property Plant And Equipment [Line Items]
Construction in progress	$ 21,900		$ 21,900

XML

Leases - Additional Information (Details) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 26, 2022 USD ($)	Jun. 26, 2022 USD ($)
Lessee Lease Description [Line Items]
Variable lease cost	$ 32,100	$ 62,300
Option to extend		Our office lease for our corporate headquarters facility in Austin, Texas includes an option to renew, generally at our sole discretion, with renewal terms that can extend the lease term up to five years.
Renewal term	5 years	5 years
Option to terminate		In addition, certain leases contain termination options, where the rights to terminate are held by the Company, the lessor, or both parties.
Finance lease amortization expense	$ 79	$ 157
Minimum
Lessee Lease Description [Line Items]
Initial term of lease contract	1 year	1 year
Maximum [Member]
Lessee Lease Description [Line Items]
Initial term of lease contract	5 years	5 years

XML

Leases - Schedule of Components of Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 26, 2022	Jun. 26, 2022
Leases [Abstract]
Operating lease cost	$ 361	$ 722
Finance lease amortization expense	79	157
Finance lease cost - interest on lease liabilities	2	5
Short-term lease cost	11	14
Variable lease cost	32,814	63,415
Total lease cost	$ 33,267	$ 64,313

XML

Leases - Summary of Cash Flow Information related to Leases (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 26, 2022	Jun. 26, 2022
Leases [Abstract]
Operating cash outflows - payments on operating leases	$ 368	$ 735
Operating cash outflows - interest payments on finance leases	2	5
Financing cash outflows - principal payments on finance leases	$ 121	$ 247

XML

Leases - Summary of Right-of-Use Assets (Details) $ in Thousands	6 Months Ended
	Jun. 26, 2022 USD ($)
Leases [Abstract]
Finance leases	$ 26

XML

Leases - Summary of Supplemental Balance Sheet Information Related to Leases (Details) - USD ($) $ in Thousands	Jun. 26, 2022	Dec. 26, 2021
Leases [Abstract]
Operating lease right-of-use assets	$ 2,578
Operating lease liabilities	1,425
Operating lease liabilities, non-current	1,377
Total operating lease liabilities	2,802
Property, plant and equipment, net	745
Finance lease liabilities	88	$ 327
Other liabilities	19
Total finance leases	$ 107
Weighted-average remaining lease term (years)	2 years 5 months 23 days
Weighted-average discount rate	3.28%
Weighted-average remaining lease term (years)	1 year 1 month 28 days
Weighted-average discount rate	4.44%

XML

Leases - Summary of Operating and Finance Leases Future Undiscounted Cash Flows (Details) $ in Thousands	Jun. 26, 2022 USD ($)
Leases [Abstract]
Operating leases Remainder of 2022	$ 742
Operating leases 2023	1,254
Operating leases 2024	471
Operating leases 2025	338
Operating leases 2026	115
Total lease payments	2,920
Less imputed interest	(118)
Total present value of lease liabilities	2,802
Finance leases Remainder of 2022	85
Finance leases 2023	6
Finance leases 2024	6
Finance leases 2025	6
Finance leases 2026	6
Total lease payments	109
Less imputed interest	(2)
Total present value of lease liabilities	$ 107

XML

Accrued Liabilities - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands	Jun. 26, 2022	Dec. 26, 2021
Payables And Accruals [Abstract]
Accrued promotions and customer deductions	$ 5,883	$ 3,599
Accrued distribution fees and freight	4,204	3,875
Accrued employee related costs	4,011	3,039
Accrued purchases of inventory	934	1,197
Accrued marketing and broker commissions	1,138	769
Accrued property, plant and equipment	1,398	1,258
Accrued contract termination costs	70
Other	1,507	1,406
Accrued liabilities	$ 19,145	$ 15,143

XML

Product Exit Costs - Summary of Activity Related to Exit of Breakfast Products (Details) $ in Thousands	6 Months Ended
	Jun. 26, 2022 USD ($)
Restructuring Cost And Reserve [Line Items]
Charges Incurred	$ 2,341
Amounts Paid or Settled	(2,091)
Ending Liability Balance	250
Net Revenue | Customer Allowances
Restructuring Cost And Reserve [Line Items]
Charges Incurred	146
Amounts Paid or Settled	(111)
Ending Liability Balance	35
Cost of Goods Sold | Inventory Obsolescence
Restructuring Cost And Reserve [Line Items]
Charges Incurred	749
Amounts Paid or Settled	(723)
Ending Liability Balance	26
Cost of Goods Sold | Asset Write-downs
Restructuring Cost And Reserve [Line Items]
Charges Incurred	119
Ending Liability Balance	119
Cost of Goods Sold | Co-manufacturer Charges
Restructuring Cost And Reserve [Line Items]
Charges Incurred	135
Amounts Paid or Settled	(135)
Selling, General and Administrative | Asset Disposals
Restructuring Cost And Reserve [Line Items]
Charges Incurred	66
Amounts Paid or Settled	(66)
Selling, General and Administrative | Contract Terminations
Restructuring Cost And Reserve [Line Items]
Charges Incurred	1,126
Amounts Paid or Settled	(1,056)
Ending Liability Balance	$ 70

XML

Common Stock - Additional Information (Details) - USD ($)	1 Months Ended	6 Months Ended
	Aug. 31, 2021	Jun. 26, 2022	Dec. 26, 2021
Class Of Stock [Line Items]
Common stock, shares authorized		310,000,000	310,000,000
Common stock, shares issued		40,679,414	40,493,969
Common stock, shares outstanding		40,679,414	40,493,969
Common stock, par value		$ 0.0001	$ 0.0001
Common stock voting rights		Each share of the Company’s common stock is entitled to one vote on all matters submitted to a vote of the Company’s stockholders.
Common stock dividend declared or paid		$ 0
Treasury Stock
Class Of Stock [Line Items]
Retirement of common stock held in treasury	5,494,918

XML

Common Stock - Schedule of Reserved Shares of Common Stock for Issuance (Details) - shares	Jun. 26, 2022	Dec. 26, 2021
Class Of Stock [Line Items]
Common stock for issuance	16,729,841	15,028,087
Options to Purchase Common Stock
Class Of Stock [Line Items]
Common stock for issuance	4,712,898	4,927,033
Restricted Stock Units
Class Of Stock [Line Items]
Common stock for issuance	513,226	107,867
Shares Available for Grant | 2020 Equity Incentive Plan and 2020 Employee Stock Purchase Plan
Class Of Stock [Line Items]
Common stock for issuance	11,503,717	9,993,187

XML

Stock-Based Compensation - Additional Information (Details) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended		6 Months Ended
	Jan. 01, 2022	Jul. 31, 2020	Jun. 26, 2022	Jun. 27, 2021	Jun. 26, 2022	Jun. 27, 2021	Dec. 26, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense			$ 1,633	$ 1,141	$ 2,929	$ 1,994
Unrecognized stock-based compensation expense			13,469		$ 13,469
Expected weighted-average period of recognition					2 years 4 months 9 days
Fair value of shares vested			$ 1,251	608	$ 2,209	912
Common stock for issuance			16,729,841		16,729,841		15,028,087
2020 Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation award, description					Initially, the maximum number of the Company’s common stock that may be issued under the 2020 Incentive Plan was 8,595,871 shares. The 2020 Incentive Plan provides that the number of shares reserved and available for issuance under the 2020 Incentive Plan will automatically increase each January 1, beginning on January 1, 2021 and ending on (and including) January 1, 2030, by an amount equal to 4% of the outstanding number of shares of common stock on the immediately preceding December 31 or such lesser number of shares as determined by the Company’s board of directors.
2020 Equity Incentive Plan | Common Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Maximum number of shares issuable		8,595,871
Percentage of outstanding common stock		4.00%
Number of shares available for future grants			9,811,345		9,811,345
Number of new shares issued	1,619,758
2020 Employee Stock Purchase Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation award, description					. The 2020 ESPP authorizes the initial issuance of up to 900,000 shares of the Company’s common stock to eligible employees of the Company or, as designated by the Company’s board of directors, employees of a related company. The 2020 ESPP provides that the number of shares reserved and available for issuance under the 2020 ESPP will automatically increase each January 1, beginning on January 1, 2021 and ending on (and including) January 1, 2030, by an amount equal to the lesser of (i) 1% of the outstanding number of shares of common stock on the immediately preceding December 31 and (ii) 900,000, or such lesser number of shares as determined by the Company’s board of directors. As of June 26, 2022, 1,692,372 shares of
Common stock for issuance			1,692,372		1,692,372
2020 Employee Stock Purchase Plan | Common Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Maximum number of shares issuable		900,000
Percentage of outstanding common stock		1.00%
Number of new shares issued	404,939
Cost of Goods Sold
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense			$ 62	$ 38	$ 91	$ 60

XML

Stock-Based Compensation - Summary of Stock Option Activity (Details) $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 26, 2022 USD ($) $ / shares shares	Dec. 26, 2021 USD ($)
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Number of Options, Beginning balance | shares	4,927,033
Number of Options, Granted | shares	132,654
Number of Options, Exercised | shares	(130,894)
Number of Options, Cancelled | shares	(215,895)
Number of Options, Ending balance | shares	4,712,898
Number of Options, Options exercisable as of March 27, 2022 | shares	2,661,079
Number of Options, Options vested and expected to vest as of March 27, 2022 | shares	4,708,857
Weighted-Average Exercise Price, Beginning balance | $ / shares	$ 9.25
Weighted-Average Exercise Price, Options Granted | $ / shares	12.89
Weighted-Average Exercise Price, Options Exercised | $ / shares	3.04
Weighted-Average Exercise Price, Options Cancelled | $ / shares	11.69
Weighted-Average Exercise Price, Ending balance | $ / shares	9.41
Weighted-Average Exercise Price, Options exercisable as of March 27,2022 | $ / shares	5.81
Weighted-Average Exercise Price, Options vested and expected to vest as of March27, 2022 | $ / shares	$ 9.42
Weighted Average Remaining Contractual Life (Years), Balance	6 years 1 month 6 days
Weighted Average Remaining Contractual Life (Years), Options exercisable as of March 27, 2022	4 years 9 months 18 days
Weighted Average Remaining Contractual Life (Years), Options vested and expected to vest as of March 27, 2022	6 years 1 month 6 days
Aggregate Intrinsic Value | $	$ 17,381,476	$ 50,561,622
Aggregate Intrinsic Value, Exercised | $	1,304,528
Aggregate Intrinsic Value, Cancelled | $	1,026,027
Aggregate Intrinsic Value, Options exercisable as of March 27, 2022 | $	13,663,597
Aggregate Intrinsic Value, Options vested and expected to vest as of March 27, 2022 | $	$ 17,361,548

XML

Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units	6 Months Ended
	Jun. 26, 2022 $ / shares shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of RSUs, Beginning balance | shares	107,867
Number of RSUs, Granted | shares	491,698
Number of RSUs, Vested | shares	(51,350)
Number of RSUs, Forfeited | shares	(34,989)
Number of RSUs, Ending balance | shares	513,226
Weighted-Average Exercise Price, Beginning balance | $ / shares	$ 27.53
Weighted-Average Exercise Price, Granted | $ / shares	12.37
Weighted-Average Exercise Price, Vested | $ / shares	27.93
Weighted-Average Exercise Price, Forfeited | $ / shares	15.47
Weighted-Average Exercise Price, Ending balance | $ / shares	$ 13.79

XML

Income Taxes - Additional Information (Details)	3 Months Ended		6 Months Ended
	Jun. 26, 2022	Jun. 27, 2021	Jun. 26, 2022	Jun. 27, 2021
Income Tax Disclosure [Abstract]
Effective tax rate	78.00%	(22.00%)	55.00%	(16.00%)

XML

Net Income Per Share - Schedule of Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 26, 2022	Mar. 27, 2022	Jun. 27, 2021	Mar. 28, 2021	Jun. 26, 2022	Jun. 27, 2021
Numerator:
Net (loss) income	$ 192		$ 3,883		$ (1,346)	$ 7,365
Less: Net loss attributable to noncontrolling interests	(7)	$ (2)	(24)	$ (11)	(8)	(34)
Net income (loss) attributable to Vital Farms, Inc. common stockholders	$ 199	$ (1,536)	$ 3,907	$ 3,491	$ (1,338)	$ 7,399
Denominator:
Weighted average common shares outstanding — basic	40,628,416		40,000,136		40,580,598	39,767,127
Weighted average effect of potentially dilutive securities:
Weighted average common shares outstanding — diluted	42,694,767		43,375,668		40,580,598	43,444,101
Net income (loss) per share attributable to Vital Farms, Inc. stockholders:
Basic	$ 0.00		$ 0.10		$ (0.03)	$ 0.19
Diluted	$ 0.00		$ 0.09		$ (0.03)	$ 0.17
Options to Purchase Common Stock
Weighted average effect of potentially dilutive securities:
Effect of potentially dilutive stock	2,048,653		3,375,052			3,676,494
Restricted Stock Units
Weighted average effect of potentially dilutive securities:
Effect of potentially dilutive stock	17,698		480			480

XML

Net Income Per Share - Additional Information (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 26, 2022	Jun. 27, 2021	Jun. 26, 2022	Jun. 27, 2021
Earnings Per Share [Abstract]
Antidilutive securities excluded from computation of earnings per share	109,494	196,640	61,707	112,644

XML

Related Party Transactions - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 26, 2022	Jun. 27, 2021	Jun. 26, 2022	Jun. 27, 2021
Sandpebble Builders Preconstruction, Inc
Related Party Transaction [Line Items]
Paid to related party	$ 250	$ 326	$ 371	$ 625